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Abstract 
Nature has developed the use of proteins and RNA as enzymes, while DNA is used for 
the storage and transfer of genetic information. Proteins and RNA are biopolymers that can fold 
into specific secondary and tertiary structures to enable catalysis. Considering the structural 
similarity to RNA, single-stranded DNA should also be able to form complex structures capable 
of catalyzing reactions. DNA catalysts have not been identified in nature, but in vitro selection 
has led to the identification of DNA catalysts for a variety of chemical reactions. Identification of 
new catalysts favors the use of DNA for multiple reasons. Amplification of functional DNA 
sequences is directly possible using natural polymerases, whereas amplification of RNA requires 
an additional reverse transcription step and amplification of proteins is not possible. The total 
number of possible sequences is smaller for nucleic acids (4n, where n is the number of residues) 
than for proteins (20n). Within this sequence space a large number of random nucleic acid 
sequences will fold into secondary and tertiary structures unlike proteins which require specific 
amino acid sequences to form complex structures. Therefore, in vitro selection experiments to 
identify DNA catalysts will cover a large portion of sequence space, and a large fraction of the 
covered space will contain structured DNA sequences with the potential to be catalytically 
active. The ease of synthesis and stability of DNA compared to RNA or proteins also provides an 
advantage for its use as a catalyst.  
Natural post-translational modifications (PTMs) are important in biological systems. 
PTMs modulate protein activity resulting in rapid changes to cellular processes. Studying the 
role of specific PTMs is often limited to the ability to generate site-specific post-translationally 
modified proteins of interest. Phosphorylation of amino acid side chains is an abundant natural 
PTM that is essential for cellular function. Protein kinases, which catalyze phosphorylation, are 
often motif specific. Engineering these natural kinases to change motif requirements is 
challenging and often results in decreased substrate specificity. To identify new catalysts for the 
site-specific phosphorylation of a desired protein the use of DNA as a catalytic biomolecule is 
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advantageous because an initially random population of DNA sequences does not have substrate 
biases, and DNA is a large biopolymer with the possibility to interact specifically with the 
substrates. 
Both ribozymes and deoxyribozymes have been identified to catalyze the 
phosphorylation of oligonucleotides. However, previous efforts to identify kinase 
deoxyribozymes to catalyze the phosphorylation of amino acid side chains were unsuccessful 
because the γ-thiophosphoryl donor used was not stable in the selection conditions. As described 
herein, a new in vitro selection method was developed using a previously identified 
deoxyribozyme to separate the active deoxyribozymes from the inactive DNA sequences. This 
method led to the identification of the first kinase deoxyribozymes capable of phosphorylating 
tyrosine residues within a tethered peptide substrate using a bound 5′-triphosphorylated RNA 
oligonucleotide as the phosphoryl donor. Separate selection experiments were performed using 1 
mM GTP as the phosphoryl donor. The identified DNA catalysts are able to phosphorylate 
tyrosine within a peptide substrate and require only low micromolar concentrations of GTP. 
Site-specific modification of proteins is often desired. Most deoxyribozymes identified to 
modify peptide substrates have been identified using peptide substrates containing the reactive 
residue flanked by alanine residues. Peptide sequences derived from natural proteins contain a 
variety of amino acid residues with diverse functional groups that could be a point of interaction 
between the peptide substrate and DNA catalyst. Selection experiments were performed with 
biologically derived peptide sequences to identify tyrosine kinase deoxyribozymes with the 
ability to phosphorylate peptides sequence-specifically. Of the three peptide substrates evaluated 
the use of one led to deoxyribozymes that are peptide motif-specific, the second peptide led to 
deoxyribozymes with partial peptide sequence-selectivity, and the third did not lead to the 
identification of deoxyribozymes. The identification of peptide motif-specific deoxyribozymes 
demonstrates that DNA catalysts can interact specifically with peptide substrates, and individual 
DNA enzymes can interact with the same peptide substrate in a different manner.  
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The ability to phosphorylate substrates that are free in solution is desired. However, 
previously identified kinase deoxyribozymes are unable to phosphorylate untethered peptide 
substrates. Original efforts increased the length of the tether between the peptide substrate and 
DNA anchor to mimic a peptide free in solution. These selection experiments did not lead to 
deoxyribozymes, and further analysis of other deoxyribozymes with untethered peptide reactivity 
suggests the long tethers may interfere with catalysis. Further efforts have focused on the 
incorporation of hydrophobic modifications into the DNA catalysts to improve peptide binding. 
DNA aptamers containing hydrophobic modifications have improved protein binding. Increased 
binding affinity between the peptide substrate and DNA catalyst may enable untethered peptide 
reactivity.  
While initial efforts focused on tyrosine phosphorylation, serine phosphorylation is also 
abundant in nature. Serine kinase deoxyribozymes have been identified to phosphorylate serine 
within tightly tethered peptide substrates using 5′-triphosphorylated RNA as the phosphoryl 
donor. Subsequent efforts to increase the tether length or use ATP as the phosphoryl donor were 
unsuccessful. Efforts to improve DNA catalysts with the ability to phosphorylate serine include 
using biologically derived peptide sequences to increase interactions between the deoxyribozyme 
and peptide substrate, and incorporating catalytically participatory modifications into the DNA 
enzymes. 
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Introduction to Natural and Engineered Enzymes 
1.1 Enzymatic Catalysis 
Enzymes catalyze reactions by adopting three-dimensional structures to bind specifically 
to substrates and catalyze their modification. Enzymes catalyze reactions by destabilizing ground 
states and stabilizing transition states.1 Natural protein enzymes can have rates as high as 109  
M–1 s–1, at which point catalysis is limited by substrate diffusion.2 The large tertiary structure of 
macromolecular enzymes enables many interactions between the enzyme and substrate, leading 
to the high selectivity of enzymes for their reaction substrates. Biochemical reactions need to be 
specific to ensure proper cellular function, and for this reason enzymes are used in nature to 
catalyze most biochemical reactions.3 
Enzymatic catalysts are different from small-molecule catalysts, which are discrete 
molecules that catalyze specific chemical reactions. Small-molecule catalysts have been 
identified to catalyze a variety of chemical reactions. Unlike enzymes, small-molecule catalysts 
are often not site-specific and will react with any relevant functional group present.4-6  
1.2 Natural Enzymes 
1.2.1 Proteins 
Protein enzymes are the primary catalysts in cells, and they can catalyze biochemical 
reactions in a highly specific manner. Proteins are polymers of amino acids connected via amide 
linkages. The natural amino acids contain a variety of chemical functional groups to promote 
protein structure and enable catalysis (Figure 1.1). The diversity of the 20 natural amino acids is 
expanded by unnatural amino acids and post-translational modifications. A protein’s 
functionality is dependent upon its secondary, tertiary, and quaternary structure. The higher-
order structure forms based on the primary amino acid sequence. Specific amino acid sequences 
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are required to form secondary structures such as α-helices and β-sheets. These secondary 
structures combine to form unique tertiary structures, and quaternary structures containing 
multiple protein subunits can be formed. Within a structured protein enzyme is a small region, 
called the active site, where the chemical reaction is catalyzed. Substrate interactions with the 
amino acid side chains are a result of the protein structure and enable the high selectivity of 
protein enzymes. Intended substrates have favorable steric and electrostatic interactions within 
the substrate binding pocket, whereas unintended substrate binding is sterically and 
electrostatically hindered. The complex three-dimensional structures of protein enzymes enable 
catalysis by destabilizing the ground state of the substrate and stabilizing the transition state. 
 
Figure 1.1. Structures of the 20 natural amino acids, whose side chains contain various 
functional groups. Proteins are specific sequences of amino acids connected via amide bonds. 
Many natural protein enzymes catalyze chemical reactions in a highly selective and 
stereospecific manner. Natural proteins have been evolved to catalyze reactions in physiological 
conditions, which are relatively mild compared to some synthetic reactions. Most proteins have 
rates of ~105–109 M–1 s–1. The most efficient enzymes are limited by the rate of diffusion of the 
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substrates and products from the active site, and these enzymes have rates of 108–109 M–1 s–1. 
The ability of protein enzymes to catalyze chemical reactions in mild conditions in a highly 
selective manner is essential in biology. Problems in protein folding, substrate specificity, 
localization, substrate binding, or catalytic efficiency can result in disease. Protein enzymes have 
also been used in many industrial roles including in food applications, as detergents, and as 
therapeutic agents.7 
1.2.2 Ribozymes 
RNA was originally thought to be involved only in the transfer of information between 
the DNA data storage to the proteins that catalyzed essential cellular functions. However, RNA 
was discovered to be catalytic in the early 1980s.8,9 The catalytic ability of RNA was surprising 
because of the differences between proteins and nucleic acids. Compared to proteins, RNA 
contains limited functional group diversity (Figure 1.2A). In the secondary structure of RNA, the 
nucleobases are involved in base-pairing in the interior of the structure. Therefore, the 
nucleobases were thought to be only partially accessible for substrate binding or catalysis. 
Additionally, the abundance of available hydrogen bonding interactions was thought to lead to 
random folding of an RNA oligonucleotide into many different structures, not one discrete three-
dimensional structure. Due to the highly negatively charged RNA backbone, it was not clear that 
compact tertiary RNA structures could form. Despite these challenges, many natural ribozymes 
have been identified to catalyze chemical reactions.10,11 
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Figure 1.2. Ribozymes. (A) RNA structure. RNA contains ribonucleotides connected via 
phosphodiester linkages. Each ribonucleotide has one of four nucleobases; from top to bottom is 
guanine, uracil, adenine, and cytosine. (B) Group I intron from Tetrahymena thermophila. The 
self-splicing pathway for the group I intron is shown. A guanosine residue binds and attacks the 
5′-splice site. A conformation change follows and the 3′-hydroxyl group attacks the 5′-end of the 
exon, resulting in ligation. The active site is shown in the crystal structure of the group I intron. 
Part B adapted with permission from Ref. 11. 
The first ribozyme discovered in the early 1980s was the Tetrahymena thermophile group 
I intron, which catalyzes RNA cleavage as part of intron splicing (Figure 1.2B).8,12 The group I 
intron contains a ~200 nucleotide catalytic core that uses the 3′-hydroxyl of guanosine residue or 
the 3′-hydroxyl of an exogenous guanosine as a nucleophile. This catalytic core is conserved in 
many other group I introns in different organisms.13 The ribozyme RNase P was also discovered 
to catalyze cleavage of the RNA phosphodiester backbone in the early 1980s.9 However, RNase 
P catalyzes direct RNA hydrolysis using a water molecule. RNase P is a ribonucleoprotein 
complex (RNP), with RNA directly catalyzing the reaction.14 The RNA component alone is 
sufficient for catalysis in vitro, but in vivo activity requires the additional protein components. 
Many other natural ribozymes have since been discovered,10 including the hammerhead, 
hairpin, and twister ribozymes that acquired their names based on their structure. The 
5 
hammerhead ribozyme, identified in multiple organisms,15-18catalyzes RNA self-cleavage via 
transesterification resulting in a 5′-phosphate and 2′,3′-cyclic phosphate.19,20 Interestingly, the 
hammerhead ribozyme has also been shown to catalyze the reverse RNA ligation reaction.21 
Catalysis of both RNA transesterification and RNA ligation is also a feature of the hairpin 
ribozyme.22,23 In contrast, the twister ribozyme, which has also been identified in multiple 
organisms, only catalyzes RNA cleavage by transesterification.24,25 Another ribozyme, the 
hepatitis delta virus (HDV) ribozyme, is required for replication of the hepatitis delta virus.26,27 
The HDV ribozyme also catalyzes RNA transesterification and uses a cytosine nucleobase as a 
general acid for catalysis. 
Similar to RNase P, other RNA catalysts function as part of RNP complexes where both 
the RNA and protein are required, but the RNA performs the catalysis. The ribosome is the most 
abundant biological RNP in which the RNA is responsible for catalysis.28-31 The bacterial 
ribosome is a large complex containing three RNA molecules (rRNA) and over 50 proteins. 
Within the complex, RNA catalyzes the peptidyl transferase reaction, resulting in the translation 
of proteins.  
Ribozymes catalyze chemical reactions by folding into complex three-dimensional 
structures using Watson-Crick base-pairing interactions to form secondary structures that can 
further form complex tertiary structures.32 RNA misfolding is possible due to the limited number 
of monomers that can make similar interactions. The negatively charged RNA backbone enables 
interaction with metal ions, which can be important for structure or catalysis.33,34 The abundance 
of natural catalytic RNAs and their involvement in gene expression and protein synthesis 
indicate the important roles of catalytic RNAs in biological systems.  
1.3 Engineered Enzymes 
The catalytic efficiency and substrate specificity of natural protein and RNA enzymes 
result from billions of years of evolutionary pressure. Enzymes have been modified to catalyze 
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both biological and non-biological reactions for various purposes. Methods such as directed 
evolution, in vitro selection, and rational design have been developed to both engineer existing 
enzymes as well as identify or design new enzymes. Natural enzymes that have been modified 
for a desired purpose or have been artificially developed in the laboratory are referred to as 
engineered enzymes or artificial enzymes. 
1.3.1 Proteins 
Directed evolution and in vitro selection methods are based on accelerated evolution 
methodologies. In contrast, rational design of enzymes relies on the understanding of how 
enzyme function is related to its structure and mechanism. Using rational design, the earliest 
protein engineering attempts were site-directed mutagenesis using natural amino acids to site 
specifically modify enyzmes.35 Advances in this field have led to rational design assisted by 
computational modeling.36 
1.3.1.1 Directed Evolution 
Directed evolution enables engineering of proteins with desired properties (Figure 
1.3).37-42 A parent protein enzyme, a known protein enzyme with activity similar to that of the 
desired new enzyme, is required as a starting point. A library of mutants of this parent enzyme is 
created. The mutant library can be prepared by various genetic mutational methods including 
random mutagenesis and genetic recombination. The library can be individually screened or 
selected for the desired activity. 
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Figure 1.3. General diagram of the directed evolution of proteins. A gene for the parent protein 
is used as the starting point. The parent gene is subject to random mutations, resulting in a library 
of mutant genes. These genes are used to express protein mutants that are selected or screened 
for the desired property. Protein mutants that do not have the desired property are discarded, and 
the genes for the protein mutants with the desired property undergo mutagenesis to begin the 
next round. The cycle is iterated until proteins with the desired property are identified. Figure 
reprinted with permission from Ref. 39. 
Random mutagenesis techniques use error-prone DNA replication or unrepaired random 
DNA damage to induce mutations. Chemical mutagens including ethane methanesulfonate and 
nitrous acid cause DNA damage and result in errors during replication.43,44 However, mutations 
formed by these methods are biased, so they are not commonly used. Error-prone PCR can be 
used to incorporate genomic mutations, but mutation biases also exist.45-47 Incorporation of 
deoxyinosine during PCR results in an increased mutation rate due to the promiscuous base 
pairing of deoxyinosine.48 However, the redundancy of the genetic code can limit the protein 
library diversity generated by individual nucleotide mutations. 
Structural information of proteins can be used to aid in focusing mutations to a region of 
the protein likely to influence function, such as near the active site. These more precise 
mutations are made by using synthetic DNA to introduce mutations at the desired sites.49 If 
mutations are made only in specific regions of the protein, then more of the possible sequence 
variants can be included. The challenge with focused mutations is that the role of protein 
structure in catalysis is not fully understood, and mutation of residues outside of the active site 
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can have significant effects on enzymatic activity.50 Focused residue mutations often exclude 
these residues, thus limiting the structures assayed. Gene recombination methods such as 
homologous recombination can also be used to introduce mutations into a protein library. DNA 
shuffling is a method for homologous recombination and involves digestion of a gene followed 
by random reassembly.51-53 Homologous recombination methods work best when a library is 
based on a family of related protein sequences. 
Evolution of a protein for a desired property requires a method to identify mutants with 
the desired enzymatic activity. High-throughput screening can be used to identify active enzyme 
mutants, but this method limits evaluation to 102-104 mutants. Larger libraries of 106-1012 
mutants can be assayed if a selection method is developed in which protein function enables the 
active protein mutants to be separated or results in survival of a host organism.54 Selection 
methods need to be developed separately for each desired activity. Recent development of 
phage-assisted continuous evolution (PACE) enables many rounds of evolution on the timescale 
of days. The PACE method links the desired protein function with the survival and replication of 
phage.55 PACE has also been used to evaluate potential organismal drug resistance mechanisms 
by performing many rounds of evolution in a short time period.56 
Directed evolution of proteins has led to advances in biology and biotechnology. For 
example, enzymes have been identified with increased thermostability to increase their utility,57 
and cytochrome P450s have been engineered to catalyze organic chemical reactions that can be 
synthetically challenging.41,58-61 However, there are some disadvantages to directed evolution. A 
known parent protein enzyme is required to begin evolution. Evolution of many proteins has 
resulted in improved characteristics, but changing the substrate requirements often leads to 
relaxed selectivity to accommodate the new substrate instead of a change in selectivity.62  
1.3.1.2 In vitro Selection by mRNA Display 
Unlike protein design, in vitro selection of proteins from a random library does not 
require a known protein, mechanism, or structure as a starting point. While identifying new 
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proteins from a random population sounds desirable, in vitro selection of proteins cannot 
generally be performed. The main obstacle is the inability to amplify proteins. In vitro selection 
requires the separation of active sequences followed by their amplification to enable continued 
iterations of selection rounds. DNA can be directly amplified by natural polymerases, and RNA 
can be reverse transcribed into DNA and subsequently amplified. However, it is not possible to 
directly amplify proteins or reverse translate them into an amplifiable DNA sequence. Additional 
limitations include the ability to evaluate a large portion of the possible sequences. There are 20 
possible amino acids at each position, and therefore, 20n possible sequences for a protein of 
length n. For a small protein that is 100 amino acid residues in length, 20100 (~10130) sequences 
are possible, even though a much smaller sequence space is sampled. Protein structures require 
specific amino acid sequences, and unfolded proteins often aggregate and are not functional. 
Despite these limitations, several protein enzyme selection methods have been developed, 
and all link each protein to their genetic information to enable amplification. The most 
commonly used is mRNA display (Figure 1.4),63-66 but similar methods of ribosome display67 
and DNA display68 have been developed. The mRNA display method relies on a covalent 
linkage between the protein and the mRNA that encodes it. Active proteins are separated, and the 
linked mRNA sequence is amplified by reverse transcription and PCR. Subsequent selection and 
amplification rounds are performed. To prevent redundant protein sequences, a limited number 
of codons are usually chosen, and the initial mRNA library is derived from combinations of these 
codons. Once the population of proteins is highly active, the DNA sequences are determined, and 
individual enzymes are evaluated. However, protein enzymes identified from mRNA display 
have not been identified from a completely random protein sequence library due to the inability 
to amplify and the limitations in sequence space coverage. 
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Figure 1.4. The mRNA display method for in vitro selection of proteins. (A) The ribosome 
synthesizes the protein based on the mRNA sequence. (B) When the ribosome reaches the end, 
translation stalls because puromycin at the 3′-end of the mRNA binds to the nascent protein. (C) 
The mRNA-protein fusion is purified. (D) Selection strategy for mRNA display. The mRNA is 
reverse transcribed, and the DNA product base-pairs to the mRNA to prevent it from interacting 
during the selection. Next, selection is performed, and the desired products are separated. PCR 
amplification of the desired products enables subsequent rounds of selection. Figure adapted 
with permission from Ref. 64. 
1.3.1.3 Rational Protein Enzyme Design 
De novo protein design uses the knowledge of chemical reaction mechanisms and the 
functional groups available from amino acid side chains to design active sites in proteins.36,69,70 
A mechanism for the desired reaction is determined, and the location of relevant functional 
groups within an active site is designed to interact with the transition state (Figure 1.5).71 This 
theoretically designed active site, called a theozyme, is incorporated into a protein scaffold and 
optimized in silico. The optimized protein is expressed, and the enzyme activity is assayed.72 The 
computationally designed enzymes usually have modest activity, if at all. Due to the limitations 
in predicting enzyme active sites and scaffolds, directed evolution of the designed proteins is 
often performed to improve enzymatic activity. De novo protein design combined with directed 
evolution has been successfully used to engineer enzymes that catalyze Kemp elimination,73 a 
retro-aldol reaction,74 a Diels-Alder reaction,75 and ester hydrolysis.76  
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Figure 1.5. Schematic of the de novo design of protein enzymes. (A) The reaction mechanism as 
catalyzed by amino acid side chains is determined. (B) The theozyme is determined 
computationally by quantum mechanics optimization of the interactions between the substrate 
transition state and the catalytic residues. (C) Multiple active-site conformations are determined. 
(D) The active sites are mapped into potential scaffolds to determine compatible sites. (E) 
Further optimization is performed on the models with the active site in the scaffold. Figure 
reprinted with permission from Ref. 36. 
After directed evolution of the rationally designed enzyme, the intended structure or 
mechanism is not always conserved. The engineered active site of a retro-aldolase enzyme was 
designed to contain a reactive lysine residue. However, after optimization of the designed 
enzyme via directed evolution, a new catalytic lysine residue and substrate-binding pocket was 
created.77 These results highlight the limitations of rational design and the benefits of evolution 
and selection methods. 
While the ability to design active sites as a starting point is encouraging, the need for 
directed evolution indicates that there are still many challenges associated with designing and 
predicting enzymatic protein structures. The knowledge of the complex relationships between 
protein structure and function is incomplete. However, de novo protein design when coupled to 
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directed evolution can provide a starting point to identify enzymes catalyzing reactions for which 
there are no known natural enzymes.54 
1.3.2 Nucleic Acid Catalysts 
The discovery of natural ribozymes led to increased interest in the capabilities of nucleic 
acid catalysts. In the laboratory, both RNA and DNA enzymes have been identified to catalyze a 
variety of chemical reactions. In vitro selection methods to identify such catalysts have been 
developed and rely upon the ability to amplify active sequences.  
Nucleic acid selections can cover a much larger fraction of sequence space than protein 
selections. Nucleic acids have 4 monomers and a smaller sequence space compared to proteins 
which have 20 monomers. Within the sequence space evaluated a large fraction of nucleic acid 
sequences will fold into complex secondary and tertiary structures, whereas protein structures are 
formed from specific primary sequences, and most random protein sequences are unlikely to fold 
and thus aggregate. Therefore, nucleic acid catalysts can be more easily identified from a random 
population of sequences. Considering nucleic acid catalysts, DNA has some practical advantages 
compared to RNA in its stability, ease of synthesis, and simplicity in PCR amplification. 
Artificial nucleic acid enzymes can be used as sensors, catalysts for small-molecule synthesis, or 
catalysts for biochemical reactions.  
1.3.2.1 Ribozymes 
Artificial ribozymes are identified by in vitro selection, which begins with a large 
population of random RNA sequences (~1014 sequences). Each sequence in the pool is evaluated 
simultaneously, and the sequences with the desired activity are separated from the inactive 
sequences. The active sequences are then amplified via reverse transcription followed by PCR. 
Additional selection rounds are iterated until sequences with the desired activity dominate the 
population. This method enables the evaluation of a large number of random sequences at once.  
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Artificial ribozymes have been identified to modify RNA oligonucleotides including 
RNA cleavage via transesterification,78 ligation,79,80 polymerization,81,82 and phosphorylation.83,84 
Ribozymes have also been identified to catalyze the Diels-Alder reaction,85,86 aldol reaction,87 
and acyl transfer reaction.88,89 Therefore, RNA can catalyze a wide variety of chemical reactions. 
Despite the large number of artificial ribozymes identified, detailed structural and mechanistic 
understanding of their function is limited. Crystal structures have been reported for a RNA-
cleaving lead-dependent ribozyme90,91 a ribozyme that catalyzes the Diels-Alder reaction,92 and 
class I ligase ribozymes (Figure 1.6).93,94  
 
Figure 1.6. Structures of artificial ribozymes. (A) Crystal structure of a lead-dependent RNA-
cleaving deoxyribozyme. The ribozyme is shown with the magenta backbone, and the substrate 
strand is yellow. The red arrowhead indicates the cleavage site. (B) Crystal structure of a 
ribozyme that catalyzes the Diels-Alder reaction. The structure shows the ribozyme-product 
complex with the product in blue. The electron density shows the location of bound metal ions. 
Part A reprinted with permission from Ref. 90. Part B reprinted with permission from Ref. 92. 
1.3.2.2 Deoxyribozymes 
DNA is structurally similar to RNA. DNA lacks the 2′-hdyroxyl group, and the 
nucleobase thymidine is present in place of uridine (Figure 1.7A). Natural deoxyribozymes have 
not been identified. In nature, DNA is primarily double-stranded and is unable to form complex 
secondary and tertiary structures required for catalysis.95 However, single-stranded DNA can 
form complex structures similar to those of RNA. Based on these structural similarities, it was 
hypothesized that DNA could also catalyze chemical reactions, and in vitro selection 
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experiments were performed to identify DNA catalysts. In vitro selection to identify 
deoxyribozymes is similar to that for RNA, but the reverse transcription step is not required. The 
first DNA catalyst was reported in 1994 and catalyzes the cleavage of a single ribonucleotide in a 
DNA substrate (Figure 1.7B).96 
 
Figure 1.7. Deoxyribozymes. (A) DNA structure. DNA is made up of deoxyribonucleotides 
connected via phosphodiester linkages. Each deoxyribonucleotide has one of four nucleobases; 
from top to bottom is guanine, thymine, adenine, cytosine. (B) The first deoxyribozyme 
discovered catalyzes the cleavage of a ribonucleotide embedded within a DNA substrate. The 
cleavage site is indicated with an arrowhead, and the deoxyribozymes is Pb2+ dependent. (C). 
The 9DB1 deoxyribozyme catalyzes RNA ligation. The crystal structure of the 9DB1 
deoxyribozyme is shown. The deoxyribozyme and substrates are colored to match the diagram. 
Part B adapted with permission from Ref. 96. Part C adapted with permission from Ref 102 and 
Ref. 121.  
Many DNA catalysts have been identified to catalyze the modification of nucleic acid 
substrates, because base-pairing interactions can be engineered between the substrate and 
deoxyribozyme. These reactions include RNA cleavage via transesterification97,98 or 
hydrolysis,99 RNA ligation,100-102 DNA cleavage via hydrolysis103,104 or deglycosylation,105 DNA 
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ligation,106 and DNA phosphorylation.107 More recent efforts have pursued DNA enzymes that 
catalyze the modification of peptide substrates that are bound to the deoxyribozyme via a DNA 
anchor and tether.108,109 Deoxyribozymes have been identified to catalyze nucleopeptide 
formation between amino acid side chains (tyrosine, serine, lysine, phosphotyrosine, or 
phosphoserine) and a triphosphorylated or phosphorimidazolidated oligonucleotide.110-116 DNA 
catalysts have also been identified to catalyze dephosphorylation of tyrosine and serine,117 as 
well as elimination of phosphate from phosphoserine to form dehydroalanine.118 Some of these 
deoxyribozymes can also catalyze modification of untethered peptide substrates.115-120 
Similar to artificial ribozymes, structural and mechanistic understanding of 
deoxyribozyme function is limited. The first and only crystal structure of a DNA enzyme to date 
was identified in 2016 for the 9DB1 RNA-ligating deoxyribozyme (Figure 1.7C).121 The 
identification of the first deoxyribozyme structure over two decades after the first 
deoxyribozyme was identified highlights the challenges in obtaining deoxyribozyme structures.  
1.4 Kinases 
Protein kinases catalyze the phosphorylation of amino acid side chains including tyrosine, 
serine, threonine, and histidine. Phosphorylation results from the transfer of the γ-phosphate from 
adenosine triphosphate (ATP). Protein phosphorylation regulates the cell cycle, cell growth, cell 
death, metabolic pathways, and cell communication.122 Changes in protein kinase expression 
have been linked to many diseases including diabetes,122 cancer,123,124 cardiovascular 
disorders,125 and neurodegenerative disorders.126 
1.4.1 Protein Kinases 
There are over 500 known protein kinases, and their target specificity is determined by 
interactions with the amino acid sequence surrounding the phosphorylation site. Protein 
phosphorylation and dephosphorylation are highly regulated and can result in protein structural 
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changes. The introduction of a phosphate group increases the negative charge and results in 
conformational changes. Protein kinases are one of the largest protein families in eukaryotes, and 
genes for kinases make up ~2% of eukaryotic genomes.127 Approximately 80% of protein 
kinases are serine/threonine kinases, and the remaining ~20% are primarily tyrosine and histidine 
kinases.  
Despite the different residues that are phosphorylated, protein kinases have similar 
active-site structures where tyrosine kinases contain a deeper substrate pocket. The active sites of 
protein kinases contain an ATP-binding site and a protein substrate-binding site. Protein kinases 
have a conserved catalytic domain of ~250 amino acids with a small N-terminal lobe comprised 
of β-sheets and a larger C-terminal lobe comprised of α-helices.127 The ATP-binding pocket is 
located between the two lobes with the adenosine moiety in a hydrophobic pocket and the 
phosphates in solution. The substrate-binding pocket structure and amino acid composition 
impart the substrate specificity of the protein kinase. Surface and noncatalytic active-site 
residues can differ in charge and hydrophobicity, and these both determine substrate specificity. 
The protein-binding site is often specific for amino acids surrounding the phosphorylated 
residue, leading to phosphorylation that is specific to particular peptide sequence motifs. Free 
amino acids are poor substrates, and on average, protein kinases interact with four amino acids 
on each side of the phosphorylated residue. Substrate specificity can be further achieved by 
cellular localization of the kinase.  
Technological advances have resulted in the ability to do complex proteomic 
studies.128-130 In these studies, phosphorylated residues of many different proteins have been 
identified. However, the identity of biological kinases responsible for specific phosphorylation 
events are not determined via this method. In general, identifying kinases responsible for newly 
identified phosphorylation sites can be challenging.  
17 
1.4.2 Nucleic Acid Kinases 
Nucleic acid catalysts have been identified to catalyze oligonucleotide phosphorylation 
(Figure 1.8). Kinase ribozymes catalyze self-phosphorylation of their 5′-terminus or internal 2′-
hydroxyl groups,83,131 with ATPγS as the phosphoryl donor. These oligonucleotide kinase 
ribozymes have been characterized and related variants identified.84,132-134 Oligonucleotide kinase 
deoxyribozymes have also been identified to catalyze self-phosphorylation of their 5′-
terminus.107,135,136 More recently, a deoxyribozyme has been identified to catalyze 
oligonucleotide 3′-phosphorylation of discrete substrate oligonucleotides.137 Based on the ability 
of nucleic acid catalysts to phosphorylate oligonucleotide hydroxyls, attempting amino acid side 
chain phosphorylation seemed reasonable.  
 
Figure 1.8. Reactions of phosphoryl donor substrates (5′-triphosphorylated RNA or NTP, where 
X = RNA or N). Phosphorylation results from nucleophilic attack of a hydroxyl group at the γ-
phosphate. Ribozymes or deoxyribozymes have been identified to catalyze oligonucleotide 5′-
phosphorylation of RNA or DNA, oligonucleotide internal 2′-phosphorylation of RNA, and 
oligonucleotide 3′-phosphorylation of DNA. Ribozymes or deoxyribozymes have also been 
identified to catalyze RNA ligation and nucleopeptide formation in which the nucleophilic 
hydroxyl attacks the α-phosphate of the triphosphoryl donor.  
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Separately, deoxyribozymes have been identified to catalyze RNA ligation101 and 
nucleopeptide formation (Figure 1.8).110,111,115,119 These DNA enzymes catalyze the reaction of 
hydroxyl groups with the α-phosphate of a 5′-triphosphorylated oligonucleotide. DNA-catalyzed 
RNA ligation results when the 3′-hydroxyl group of an RNA oligonucleotide attacks the α-
phosphate of a 5′-triphosphorylated RNA oligonucleotide. Nucleopeptide formation occurs when 
the tyrosine or serine hydroxyl group attacks the α-phosphate of the 5′-triphosphorylated RNA 
oligonucleotide. Nucleopeptide formation is similar to amino acid phosphorylation, in which the 
tyrosine or serine side chain reacts with the γ-phosphate of a triphosphoryl donor. Therefore, 
based on the ability of DNA to catalyze modification of tyrosine and serine side chains with a 
similar phosphate electrophile, attempting amino acid side chain phosphorylation seemed 
reasonable. 
1.4.3 Preparation of Phosphoproteins 
The ability to study the role of a phosphorylated protein is limited by the availability of 
the desired phosphoprotein. An early method to study the role of protein phosphorylation was 
site-directed mutagenesis. Residues known or suspected to be phosphorylated can be mutated 
from their natural amino acid to a negatively charged amino acid such as aspartate or glutamate 
(Figure 1.9A).138,139 These negatively charged residues roughly approximate the charge resulting 
from phosphorylation. This method is not precise as the size and charge of a phosphorylated 
residue is not accurately mimicked.  
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Figure 1.9. Methods to synthesize phosphorylated proteins. (A) Phosphorylated amino acid 
mimics. The structures of commonly phosphorylated amino acids are shown. Phosphorylated 
amino acids are often mimicked by site-directed mutagenesis to incorporate the negatively 
charged amino acids aspartate or glutamate. (B) Expression of phosphoproteins. Overexpression 
of proteins that are phosphorylated by the host organism can be performed. The phosphorylated 
proteins can be purified by phosphoprotein-specific chromatography. (C) Phosphoprotein 
semisynthesis. A small peptide containing a phosphorylated residue is prepared by solid-phase 
peptide synthesis. Expression and purification of the remainder of the protein of interest is 
performed. The protein and phosphopeptide fragment are covalently linked by native chemical 
ligation to form the full-length phosphoprotein. (D) Unnatural amino acid mutagenesis. A gene 
encoding the phosphoprotein is modified to include an amber stop codon at the position of the 
phosphorylated amino acid. An engineered host system contains a tRNA that base-pairs to the 
stop codon charged with the phosphorylated amino acid. Based on the modified gene, the 
phosphoprotein is expressed and purified. Part C reprinted with permission from Ref. 144.  
Phosphoproteins can be overexpressed and isolated from cell culture (Figure 1.9B).140 
This method requires expression of the proteins in a natural system that has the ability to 
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phosphorylate it. The desired phosphoprotein is purified, but the purified proteins may contain a 
mixture of phosphorylated residues. The amount of phosphoprotein purified is dependent on the 
abundance of phosphorylation, and often yields are low. If a kinase is known to phosphorylate 
the protein of interest, then both the kinase and protein of interest can be expressed in a bacterial 
host.141,142 This method requires both the kinase and protein of interest can be expressed and 
remain active in the host system. The purification of the phosphoprotein is subject to the same 
challenges. 
Phosphorylated proteins can also be prepared by semisynthesis (Figure 1.9C).143,144 
Phosphorylated amino acids can be prepared synthetically and incorporated into peptides via 
solid-phase peptide synthesis. While proteins are too long to be prepared by solid-phase 
synthesis, a peptide fragment containing the phosphorylated residue can be synthesized. This 
peptide fragment is then incorporated into the protein via native chemical ligation, resulting in a 
site-specifically phosphorylated residue. This method works best when the phosphorylated 
residue is near one of the termini of the protein of interest. Incorporation of the phosphopeptide 
fragment into the middle of the protein requires multiple ligation steps. A cysteine residue needs 
to be included at the N-terminus of the peptide fragment to enable native chemical ligation, and 
the cysteine residue may not be naturally present in the protein.  
Another technique to incorporate phosphorylated amino acids into proteins is unnatural 
amino acid mutagenesis (Figure 1.9D).144,145 This method takes advantage of the rarely used 
amber stop codon in E. coli to incorporate a 21st amino acid. A tRNA synthetase is evolved to 
charge a modified tRNA with the unnatural amino acid. This modified tRNA base-pairs to the 
amber stop codon, thus incorporating the unnatural amino acid. The unnatural amino acid is 
incorporated site-specifically based on the location of the amber stop codon within the modified 
gene. Using this method, phosphotyrosine or a phosphotyrosine analog p-carboxymethyl-L-
phenylalanine,146 and phosphoserine or a phosphoserine analog 2-amino-4-phosphonobutyric 
acid,147 have been incorporated into proteins. The analogs are non-hydrolyzable by natural 
phosphatases making them stable, but also not the natural phosphorylated residues. Difficulties 
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expressing the full-length protein can arise depending on the protein and the location of the 
unnatural residue within the protein. Incorporation of more than one unnatural nucleotide 
remains challenging. 
The role of protein phosphorylation has been studied by generation of phosphoproteins 
using all four of these methods. Each method has its own advantages and limitations. However, a 
method to site-specifically phosphorylate any protein expressed will provide an additional tool to 
enable the study of phosphorylated proteins and their function in biological systems and disease.  
1.5 Thesis Research Focus 
The ability to site-specifically modify peptides and proteins will enable biochemical 
studies of post-translationally modified peptides and proteins. The role of phosphorylation in 
complex cellular regulation is incompletely understood.144 With phosphorylation playing a role 
in 30% of cellular proteins, new technologies are needed to aid in understanding cellular 
pathways and their regulation.127 Understanding these signaling pathways and manipulating them 
can aid in the understanding of biological processes and disease states. New catalysts to 
phosphorylate tyrosine and serine side chains are sought. For optimal practical utility, these new 
catalysts will need to phosphorylate untethered peptide and protein substrates using NTPs as 
phosphoryl donors. Towards this goal, new kinase deoxyribozymes are identified.  
Identification of new catalysts for peptide and protein phosphorylation favors the use of 
DNA as a catalytic biopolymer. In vitro selection experiments to identify nucleic acid catalysts 
can be performed due to the ability to amplify sequences using natural polymerases, whereas no 
amplification method is available for proteins. The amplification of RNA catalysts requires an 
additional reverse transcription step prior to amplification via PCR. Additionally, nucleic acid 
selection experiments evaluate a significantly larger fraction of the total number of possible 
sequences than protein selection experiments, and unlike proteins, most of the random nucleic 
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acid sequences can form secondary and tertiary structures. Compared to RNA, DNA is more 
stable, easier to synthesize, and directly amplifiable by natural polymerases. 
 Based on the ability to find new catalysts from random populations of DNA, and the 
ability of DNA to catalyze oligonucleotide phosphorylation and nucleopeptide formation, it is 
reasonable to hypothesize that kinase deoxyribozymes can be identified to phosphorylate amino 
acid side chains within peptide and protein substrates. The work described herein focused on the 
identification of kinase deoxyribozymes for peptide and protein modification. Chapter 2 reports 
the identification of the first tyrosine kinase deoxyribozymes using a novel in vitro selection 
strategy. These DNA enzymes catalyze the phosphorylation of tyrosine residues within a peptide 
substrate and use either a 5′-triphosphorylated RNA oligonucleotide or NTPs as phosphoryl 
donors. Chapter 3 discusses the development of a new phosphopeptide capture method and the 
resulting identification of peptide-sequence-specific tyrosine kinase deoxyribozymes. The DNA 
catalysts specifically interact with 2-4 amino acids within the peptide substrate. Chapter 4 
discusses efforts to identify kinase deoxyribozymes capable of catalyzing the phosphorylation of 
untethered peptide substrates. These efforts include the use of long tethers between the peptide 
substrate and DNA anchor oligonucleotide, and the use of hydrophobic modifications to increase 
the binding affinity between the DNA enzyme and peptide substrate. Chapter 5 focuses on the 
identification of serine kinase deoxyribozymes. DNA catalysts were identified to phosphorylate 
serine within a peptide substrate, and efforts for peptide-sequence-selectivity and untethered 
peptide reactivity were pursued. 
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Chapter 2: DNA Catalysts with Tyrosine Kinase Activity† 
2.1 Introduction 
2.1.1 Previous Efforts Towards DNA-Catalyzed Peptide Phosphorylation 
Previous in vitro selection experiments to identify deoxyribozymes have relied upon 
PAGE shift as a means to separate catalytically active DNA sequences from inactive ones.1-7 A 
substrate is ligated to each DNA sequence in the pool. Substrate modification catalyzed by the 
attached DNA sequence leads to a change in mass and subsequent PAGE shift. However, 
phosphorylation of a peptide substrate results in the addition of only a small phosphoryl group to 
a tyrosine, serine, or threonine side chain. The relatively small addition of mass and charge from 
the phosphoryl group added to the peptide substrate connected to the catalytic DNA sequence 
does not lead to a significant PAGE shift. Therefore, to isolate the active DNA sequences, a 
method is required to separate phosphopeptide products from unphosphorylated substrates.  
2.1.1.1 γ-Thiophosphoryl Donors 
The use of a γ-thiophosphoryl donor results in the addition of a thiophosphate to the 
hydroxyl-containing amino acid side chain within the peptide substrate. The thiophosphorylated 
product can then be separated from unreacted substrates on a bilayered polyacrylamide gel, 
                                                            
† This research has been published:  
Walsh, S. M.; Sachdeva, A.; Silverman, S. K. DNA Catalysts with Tyrosine Kinase Activity. J. 
Am. Chem. Soc. 2013, 135, 14928-14931. 
University of Illinois graduate student Amit Sachdeva performed initial efforts to identify kinase 
deoxyribozymes using γ-thiophosphoryl donors, developed the 8VP1 capture deoxyribozyme to 
specifically react with phosphopeptides, and performed the initial XA-XF selections to identify 
kinase deoxyribozymes using the 8VP1 capture deoxyribozyme.8 
University of Illinois graduate student Victor Dokukin performed selection experiments to 
identify modular tyrosine kinase deoxyribozymes containing an aptamer domain for ATP 
binding.12 
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where the lower layer contains (N-acryloylamino)phenyl mercuric chloride (APM). Selection 
experiments were performed by Amit Sachdeva using a 5′-thiotriphosphorylated RNA 
oligonucleotide or 5 mM GTPγS as the phosphoryl donor.8 Activity was observed after 5 rounds 
in the selection experiments for phosphorylation of 2′-hydroxyls of RNA and the 3′-hydroxyl of 
DNA. Both selections used 5 mM GTPγS as the phosphoryl donor. Surprisingly, the analogous 
selection experiments using a Watson-Crick base-paired 5′-thiotriphosphorylated RNA 
oligonucleotide as the phosphoryl donor were unsuccessful. The base-paired 5′-
thiotriphosphorylated RNA phosphoryl donor was thought to be more likely to lead to the 
identification of DNA catalysts because of the preprogrammed binding to the complementary 
binding arm next to the initially random region. 
Since the selection experiments with the 5′-thiotriphosphorylated RNA phosphoryl donor 
were unsuccessful, the stability of the phosphoryl donor was evaluated in the selection 
conditions.8 The 5′-thiotriphosphorylated RNA oligonucleotide was incubated in selection 
conditions of 50 mM HEPES, pH 7.5, 20 mM MnCl2, 40 mM MgCl2, 150 mM NaCl, and 2 mM 
KCl at 37 °C for 12 h. Matrix-assisted laser desorption ionization (MALDI) mass spectrometry 
analysis of the 5′-thiotriphosphorylated RNA oligonucleotide before and after incubation 
indicated that the γ-thiotriphosphate hydrolyzed completely, yielding 5′-diphosphorylated RNA. 
However, when the same experiment was performed with a 5′-triphosphorylated RNA 
oligonucleotide, only minor hydrolysis to 5′-diphosphorylated RNA was observed. Therefore, 
the instability of the 5′-thiotriphosphorylated RNA is due to the sulfur in the γ-phosphate of the 
thiotriphosphate.  
In selection experiments with the 5′-thiotriphosphorylated RNA phosphoryl donor, each 
deoxyribozyme was bound to one phosphoryl donor via Watson-Crick base pairs between the 
donor and the binding arm adjacent to the deoxyribozyme initially random region. The tightly 
base-paired thiophosphoryl oligonucleotide was unlikely to exchange with another 
thiophosphoryl oligonucleotide. Therefore, once the thiophosphoryl donor degraded the bound 
DNA sequence no longer had a phosphoryl donor available. The inability to exchange and the 
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rapid degradation of the thiophosphoryl oligonucleotide likely cause the failure of the selection 
experiments thought to be easier. In contrast, selection experiments with the large concentration 
of GTPγS phosphoryl donor, the GTPγS molecule bound to the deoxyribozyme was more likely 
to exchange with others in solution. Despite the increased challenge in binding the phosphoryl 
donor, the ability to exchange degraded thiophosphoryl donors led to the enrichment of enough 
active DNA sequences to dominate the pool. Based on their instability, the use of γ-
thiophosphoryl donors was discontinued. 
2.1.1.2 Development of Phosphotyrosine and Phosphoserine Capture Deoxyribozymes 
In many previous in vitro selection experiments, DNA-catalyzed reaction led to a 
significant mass change, and therefore a PAGE shift.1-5 To select for DNA catalysis of the 
desired reaction or at the desired reaction site, some selection experiments have included a 
subsequent capture step to catalyze a reaction of the desired product and add mass to enable a 
unique PAGE shift.6,7 One capture approach uses a deoxyribozyme to catalyze a reaction 
specifically with the desired product. A capture deoxyribozyme was first used during in vitro 
selection experiments to identify phosphatase deoxyribozymes.6 In these selection experiments, 
the desired product was a dephosphorylated tyrosine residue within the peptide substrate 
connected to the DNA sequence that catalyzed its dephosphorylation. To capture the 
dephosphorylated tyrosine products, a previously identified nucleopeptide-forming 
deoxyribozyme5 was used to catalyze the addition of an RNA oligonucleotide to the tyrosine 
residue. The addition of the RNA oligonucleotide led to PAGE shift of the active DNA 
sequences, and therefore separation of the active DNA sequences from the inactive DNA 
sequences. 
A similar capture deoxyribozyme was developed to enable PAGE-shift separation of 
phosphorylated peptide substrates attached to active kinase deoxyribozymes. In vitro selection 
was performed to identify DNA enzymes that covalently modify phosphorylated amino acid side 
chains of peptides (Figure 2.1).9 Specifically, DNA enzymes were sought to catalyze 
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nucleophilic attack of the phosphotyrosine side chain within a peptide substrate at the α-
phosphate of a 5′-triphosphorylated RNA oligonucleotide, resulting in nucleopeptide formation. 
A capture deoxyribozyme must be specific for phosphate to isolate the phosphotyrosine product 
connected to the active deoxyribozymes from the inactive DNA sequences. 
 
Figure 2.1. DNA-catalyzed covalent modification of phosphopeptide substrates. The 8VP1 
deoxyribozyme catalyzes the attachment of a 5′-triphosphorylated RNA oligonucleotide to the 
phosphorylated amino acid residue within a DNA-anchored hexapeptide substrate. YOH = Tyr; 
YP = pTyr; SOH = Ser; SP = pSer. 8VP1 has kobs of 0.15 h–1 with YP-containing substrates and kobs 
of 0.17 h–1 with SP-containing substrates. No activity was observed with either YOH or SOH-
containing substrates. Figure adapted with permission from Ref. 9.  
One deoxyribozyme identified from the selection experiment was 8VP1. The 8VP1 
deoxyribozyme has a yield of 40% in 24 h with the AAAYPAA peptide substrate used during the 
selection. 8VP1 also catalyzes reaction of the analogous phosphoserine-containing peptide, 
AAASPAA, with a yield of 46% in 24 h. Nucleic acid enzymes typically do not go to completion 
at 100% due to misfolding of some of the DNA sequences into inactive forms. This 
deoxyribozyme is highly selective for phosphorylated peptides; no activity is observed with the 
nonphosphorylated peptides AAAYAA and AAASAA. 8VP1 will lead to separation of the 
phosphopeptide products connected to active DNA sequences from the inactive DNA sequences. 
Therefore, based on its activity and selectivity, 8VP1 can be used as a capture deoxyribozyme 
during in vitro selection experiments for kinase deoxyribozymes.  
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2.1.1.3 Initial Kinase Deoxyribozyme Selection Experiments Using Capture Strategy 
All in vitro selection experiments are given alphanumeric codes in the following pattern: 
A-Z, AA-ZZ, AA1-ZZ1, etc. The XA-XF selection experiments were performed to identify 
tyrosine and serine kinase deoxyribozymes using a 5′-triphosphorylated RNA oligonucleotide 
(pppRNA) or 5 mM GTP as the phosphoryl donor.8 After the selection step in which the active 
DNA sequences catalyzed phosphorylation of the peptide substrate, the sample was purified on a 
spin column with a 30 kDa mass cutoff to remove salts and the pppRNA or GTP phosphoryl 
donor. Next, the capture step was performed in which the active DNA sequences connected to 
their phosphopeptide products were covalently modified by the 8VP1-catalyzed reaction, 
resulting in PAGE shift. 
Activity was observed by round 10 for most selection experiments. However, 
phosphorylation of the substrate was not observed when the active pools were assayed in trans 
(i.e. without ligating the DNA-anchored peptide substrate to the DNA pool). The selection 
activity was also observed if the capture step was not implemented. Therefore, the DNA 
sequences enriched after the capture step were not the desired kinase deoxyribozymes. The 
selection method needed to be modified to prevent the enrichment of these undesired, aberrantly 
migrating DNA sequences. 
2.2 Results and Discussion 
2.2.1 In Vitro Selection Strategy 
In the previous unsuccessful selection experiments to identify kinase deoxyribozymes, in 
vitro selection led to the enrichment of inactive DNA sequences that aberrantly migrated on the 
gel at the same position as the desired active DNA enzymes. The aberrant bands observed during 
capture were also observed after the selection step even if the capture reaction was not performed 
(Figure 2.2). When the desired selection product was excised and reanalyzed by PAGE, the 
aberrantly migrating material was successfully removed. Therefore, PAGE purification between 
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the selection and capture steps was incorporated into the next selection efforts to prevent 
enrichment of the aberrantly migrating DNA sequences.  
 
Figure 2.2. Aberrant migration observed in round 9 of the XA selection to identify tyrosine 
kinase deoxyribozymes using pppRNA as the phosphoryl donor. In the PAGE image, lane A is 
the product obtained after the selection step (without capture), showing the undesired material 
migrating higher in the lane. The undesired product migrates in the same position on the gel as 
the desired product would after the subsequent capture reaction. Lane B shows the selection 
product after PAGE purification. The undesired selection products are removed by PAGE 
purification of the pool after the selection step. 
The PAGE purification between the selection and capture steps also removes undesired 
DNA sequences that catalyze nucleopeptide formation (i.e. reaction of the hydroxyl group of the 
amino acid side chain with the α-phosphate of pppRNA). Nucleopeptide formation has 
previously been catalyzed by DNA.2,4,5 Additionally, the length and sequence of the pppRNA 
capture oligonucleotide was alternated to prevent aberrantly migrating bands from surviving the 
capture step. The different length of the pppRNA capture oligonucleotide (either 17 nt or 36 nt) 
results in migration of the capture product to different locations on the capture gel. Thus, the 
same aberrantly migrating DNA sequences would not be excised in consecutive selection rounds. 
Changing the sequence of the pppRNA capture oligonucleotide in alternate rounds prevents the 
DNA sequences that can bind to and react with one capture oligonucleotide from surviving the 
alternate rounds that uses a different capture oligonucleotide. 
With a way to remove the aberrantly migrating DNA sequences that resulted in the 
previous selection efforts, a modified in vitro selection method was developed to identify kinase 
deoxyribozymes. In order to isolate active DNA enzymes, the phosphoryl acceptor needs to be 
connected to the DNA sequence that catalyzed the phosphoryl transfer reaction. The hexapeptide 
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substrate containing a tyrosine flanked by alanine residues with an N-terminal cysteine 
(CAAYAA) was synthesized by solid-phase peptide synthesis. The peptide was connected to a 
DNA-anchor via a disulfide bond and a hexa(ethylene glycol) [HEG] tether. This DNA-anchored 
peptide substrate was ligated to the initially random DNA pool using T4 DNA ligase. The 
pppRNA phosphoryl donor was prepared by in vitro transcription using a DNA template and T7 
RNA polymerase. The initially random region of the DNA sequences was flanked by fixed-
sequence regions to enable PCR amplification of the DNA sequences and substrate binding.  
The in vitro selection began with ligation of the initially random DNA pool to the DNA-
anchored peptide substrate (Figure 2.3). The ligation product was isolated by PAGE. Next, the 
selection step was performed in which the DNA sequences were incubated with the phosphoryl 
donor and divalent metal ions in a buffered solution to enable DNA catalysis. PAGE purification 
was then performed to remove undesired products and reagents. To isolate the active DNA 
sequences connected to the desired phosphopeptide products, the capture step was performed to 
add additional mass, thus providing a PAGE shift. The previously identified deoxyribozyme, 
8VP1, was used specifically to add mass to phosphopeptides.9 PCR was then performed to 
amplify the catalytic DNA sequences that survived the previous selection and capture steps. The 
entire selection round was repeated, each time enriching the population with catalytically active 
sequences, until the catalytically active sequences dominated the population.  
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Figure 2.3. Diagram of in vitro selection procedure for kinase deoxyribozymes using the 8VP1 
capture deoxyribozyme method. First, the DNA-anchored peptide substrate was ligated to the 
DNA sequences in the initially random pool. Next, the DNA sequences were incubated with the 
pppRNA phosphoryl donor and divalent metal ions to enable the DNA enzymes to phosphorylate 
the peptide substrate. In the subsequent capture step, the 8VP1 capture deoxyribozyme 
selectively added mass to the phosphopeptide products connected to the active DNA sequences. 
The surviving catalytic DNA sequences were then PCR-amplified. PAGE purification was 
performed between each step. The selection process was repeated until the catalytically active 
DNA sequences dominated the population. Figure adapted with permission from Ref. 11.  
New selection experiments AA1-AF1 for kinase deoxyribozymes were performed with 
the modified selection procedure, including PAGE purification between the selection and capture 
steps. Selection conditions successful for identifying nucleopeptide-forming deoxyribozymes 
were used for all selections: 50 mM HEPES, pH 7.5, 20 mM MnCl2, 40 mM MgCl2, and 150 
mM NaCl at 37 °C for 14 h. After six rounds of selection, smeary bands were observed 
migrating near the capture standards (Figure 2.4A). The smeary bands were also observed if the 
phosphoryl donor required for substrate phosphorylation was not included in the selection step, 
indicating the smeary bands were not the desired phosphorylated product. The smearing was 
likely the result of the enrichment of DNA sequences that tightly interacted with the 8VP1 
deoxyribozyme and did not quickly dissociate upon entering the gel, despite the presence of 7 M 
urea as a denaturant. A decoy oligonucleotide that is complementary to the 8VP1 capture 
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deoxyribozyme base-pairs to the capture deoxyribozyme and displaces the interactions between 
8VP1 and the DNA pool. When the decoy oligonucleotide was added to the capture sample 
immediately prior to loading on the gel, the undesired smears were removed.  
 
Figure 2.4. Modification to the in vitro selection strategy to identify kinase deoxyribozymes. (A) 
Decoy oligonucleotide. PAGE image shows the undesired smeary product observed migrating 
higher than the substrate on the capture gel. The smeary band is observed regardless of whether a 
phosphoryl donor is included during the selection step, indicating the smear is not related to the 
desired phosphorylation product. The undesired smear migrates near the position of the desired 
capture products. Upon addition of a decoy oligonucleotide that is complementary to the 8VP1 
capture deoxyribozyme prior to loading the sample on the gel, the undesired products are not 
observed. (B) Capture oligonucleotide length. To prevent the excision of overlapping regions of 
the gel during capture, alternation of a 17 nt (lane 1) and 54 nt (lane 2) capture oligonucleotide 
provides a substantially different PAGE shift of the products.  
In addition to adding decoy oligonucleotides, the difference in length between the 
alternating capture oligonucleotides was increased to prevent overlap of excised regions of the 
gel in consecutive rounds (Figure 2.4B). Previously, a 17 nt and 36 nt capture oligonucleotide 
were used in alternating rounds. Increasing the length of the long capture oligonucleotide to 54 nt 
provided a larger difference in gel migration between the two capture products. The 54 nt capture 
oligonucleotide is an pppRNA-DNA chimera made by ligating a 17 nt pppRNA oligonucleotide 
to a 37 nt DNA oligonucleotide using a DNA splint and T4 DNA ligase.  
The in vitro selection procedure was modified to include the addition of the 8VP1 decoy 
oligonucleotide prior to loading the capture sample on the gel and the pppRNA capture 
oligonucleotide length was alternated between 17 nt and 54 nt. New selection experiments (AY1-
BD1) to identify kinase deoxyribozymes were initiated using the same selection conditions 
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successful for identifying nucleopeptide-forming deoxyribozymes: 50 mM HEPES, pH 7.5, 20 
mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h. Unfortunately, after 14 rounds 
of selection no activity was observed in any of the selection experiments, and they were 
discontinued. 
2.2.2 Identification and Characterization of Tyrosine Kinase Deoxyribozymes 
New kinase deoxyribozyme in vitro selection experiments CF1-CK1 were designed for 
tyrosine phosphorylation using pppRNA as the phosphoryl donor with N30, N40, or N50 random 
region lengths with selection conditions (A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM 
MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h or (B) 50 mM CHES, pH 9.0, 40 
mM MgCl2, and 150 mM NaCl at 37 °C for 14 h (Figure 2.5). Multiple initially random region 
lengths were evaluated because random region length has been shown to be an important 
variable in previous deoxyribozyme selection experiments.10 Selection condition A is similar to 
the conditions previously used in kinase deoxyribozyme selections, but also include Zn2+ as a 
divalent metal ion cofactor because Zn2+ is required for both DNA-hydrolyzing and peptide-
dephosphorylating deoxyribozymes.3,6 Selection condition B include a higher pH, and Mn2+ and 
Zn2+ are excluded at this pH because they will oxidize and precipitate, respectively. 
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Figure 2.5. Design for the CF1-CL1 in vitro selection experiments to identify tyrosine kinase 
deoxyribozymes. In all selections, the peptide substrate CAAYAA was connected to a DNA 
anchor via a disulfide bond and HEG tether, and the phosphoryl donor was pppRNA. CF1-CG1, 
CH1-CJ1, and CK1-CL1 have N30, N40, and N50 initially random regions, respectively. The CF1, 
CH1, and CK1 selections were performed in condition A, and the CG1, CJ1, and CL1 selections 
were performed in condition B.  
The CF1, CH1, and CK1 selections led to phosphorylation activity in condition A with all 
three initially random region lengths (Figure 2.6), but no activity was observed for the selections 
performed in condition B.11 To identify individual deoxyribozyme sequences, active pools were 
cloned from round 6, 7, and 8 for N30, N40, and N50, respectively. From the N30, N40, and N50 
selection experiments five, three, and nine unique sequences were identified (Figure 2.7). 
Sequence alignment revealed a conserved 11-nucleotide segment at the 5′-end of each 
deoxyribozyme, despite the different lengths of the initially random region. This conserved 
region is near the pppRNA phosphoryl donor binding site. Changes to the pppRNA sequence or 
replacement with GTP were not tolerated by the deoxyribozymes. 
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Figure 2.6. Selection progression of the in vitro selection experiments for kinase 
deoxyribozymes that use pppRNA as the phosphoryl donor. In each round, “control” refers to the 
yield for the 8VP1-catalyzed capture reaction using a CAAYPAA substrate, and “selection” 
refers to the yield for the 8VP1-catalyzed capture reaction for the indicated selection experiment. 
Arrows mark the cloned rounds. The CF1, CH1, and CK1 selections have N30, N40, and N50 
random region, respectively. Figure adapted with permission from Ref. 11. 
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Figure 2.7. Sequences of the initially random region of the tyrosine kinase deoxyribozymes 
using pppRNA as the phosphoryl donor. Only the initially random region is shown. A dot 
denotes conservation with the uppermost sequence, and a dash denotes a gap. Next to the 
sequence length on the right, in parentheses, is the number of times each sequence was found. A 
strongly conserved 11 nt region is observed at the 5′-end of the sequences, indicated by the grey 
box, regardless of the deoxyribozyme random region length. Figure reprinted with permission 
from Ref. 11. 
Tyrosine phosphorylation was verified (Figure 2.8). MALDI mass spectrometry of the 
product confirmed the addition of a phosphoryl group to the DNA-anchored peptide substrate. 
Additionally, the phosphorylation products were PAGE-purified and subjected to 8VP1-
catalyzed reaction with the pppRNA capture oligonucleotide. The same rate and yield of 8VP1 
product formation was observed with the CAAYPAA positive control and the phosphorylation 
products generated by the deoxyribozymes. Therefore, the DNA enzymes catalyze the 
phosphorylation of tyrosine within the peptide substrate.  
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Figure 2.8. MALDI mass spectrometry and 8VP1 reactivity for tyrosine kinase deoxyribozymes. 
The mass is that of the DNA-HEG-CAAYPAA product. 8VP1-catalyzed reaction of the 
phosphopeptide product has the same rate and yield as the YP positive control. This confirms that 
the phosphoryl group is attached at the tyrosine hydroxyl within the peptide substrate. Figure 
adapted with permission from Ref. 11. 
The 6CF1 (N30), 7CH1 (N40), and 8CK1 (N50) kinase deoxyribozymes were 
characterized. The 6CF134 deoxyribozyme has kobs of 1.54 ± 0.22 h–1 (n = 7) and 71% yield in 
12 h (Figure 2.9). All other kinase deoxyribozymes have kobs of 0.1-0.5 h–1 and 11-70% yield in 
24 h. All kinase deoxyribozymes were identified by using 1 mM Zn2+, 20 mM Mn2+, and 40 mM 
Mg2+ during the selection step. Individual deoxyribozymes have slightly different Zn2+ 
concentration dependencies, but in all cases 0.5 mM was highly effective and was used for 
characterization. Phosphorylation activity was evaluated in the presence of all combinations of 
the three metal ions (Figure 2.10). Both Zn2+ and Mn2+ were required for catalysis, except in the 
case of 6CF134, which required only Zn2+. In all cases Mg2+ was dispensable for catalysis. 
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Figure 2.9. Activity of the tyrosine kinase deoxyribozymes that use pppRNA. The PAGE image 
shows representative time points (t = 30 s, 5 h, 24 h) for six of the deoxyribozymes as indicated. 
YOH = substrate; YP = product. The kinetic plots for all of the identified deoxyribozymes are 
shown. All assays were performed in trans. Incubation conditions were 70 mM HEPES, pH 7.5, 
0.5 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C. Figure adapted with 
permission from Ref. 11. 
52 
 
Figure 2.10. Metal dependence of the tyrosine kinase deoxyribozymes. (A) Data at t = 24 h for 
all deoxyribozymes. Incubation conditions are 70 mM HEPES, pH 7.5, 150 mM NaCl and 
combinations of 0.5 mM ZnCl2, 20 mM MnCl2, and 40 mM MgCl2 as indicated at 37 °C. The 
metal ion combinations not shown did not have activity for any deoxyribozyme. (B) Kinetic 
plots for six representative deoxyribozymes with the indicated metal ion conditions. Figure 
reprinted with permission from Ref. 11. 
Deoxyribozymes were assayed for their peptide sequence, peptide length, and tether 
length dependence. All of the kinase deoxyribozymes were inactive with serine in place of 
tyrosine within the peptide substrate and thus specifically are tyrosine kinase deoxyribozymes. 
The deoxyribozymes were tolerant to changes in the amino acid residues flanking the tyrosine 
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(Figure 2.11A). Peptide substrates with a hydrophobic (phenylalanine, Phe), negatively charged 
(glutamate, Glu), or positively charged (lysine, Lys) residue on either side of the tyrosine residue 
were phosphorylated by the six deoxyribozymes. Additionally, the peptide substrate GPYSGN 
containing a tyrosine residue surrounded by non-alanine residues was successfully 
phosphorylated. Therefore, all of the kinase deoxyribozymes are peptide sequence-general. 
 
Figure 2.11. Dependence of deoxyribozyme activity on peptide sequence and length. (A) 
Peptide sequence dependence. The indicated peptide substrate was connected via a disulfide 
bond and HEG tether to the DNA anchor. Data are shown for six representative deoxyribozymes 
(t = 24 h). All deoxyribozymes tolerate the incorporation of Phe (F), Glu (E), or Lys (K) at either 
position flanking the reactive Tyr (Y) residue. The substrate GPYSGN was evaluated as a 
peptide sequence with Tyr surrounded by non-alanine residues. (B) Peptide length dependence. 
The substrate included the indicated peptide connected via a HEG tether or only a DNA 3′-
hydroxyl group for phosphorylation. Kinetic plots are for three representative deoxyribozymes. 
Figure reprinted with permission from Ref. 11. 
Decreasing the length of the CAAYAA hexapeptide to a shorter CYA tripeptide or CY 
dipeptide did not affect deoxyribozyme activity (Figure 2.11B). Only 6CF134 had some 
phosphorylation activity with a DNA 3′-hydroxyl group. All deoxyribozymes maintained activity 
with a shorter C3 tether in place of the HEG tether used during the selections (Figure 2.12). 
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However, no phosphorylation activity was observed with a longer HEG10 tether or an untethered, 
free peptide in solution. 
 
Figure 2.12. Dependence of deoxyribozyme activity on the length of the tether between the 
DNA anchor and CAAYAA hexapeptide substrate. The structures of the three different tether 
lengths are shown. The HEG tether was used during the selection experiments. Here, a shorter C3 
and a longer HEG10 tether were evaluated. Kinetic plots are for six representative 
deoxyribozymes. Figure reprinted with permission from Ref. 11. 
Reselection of the 6CF134 deoxyribozyme was performed in the EE1 selection by 
generating a partially randomized pool (25% randomization). The constant binding arm 
sequences flanking the initially random region were changed to prevent contamination of the 
reselection experiment from the parent deoxyribozyme. Activity was observed in the reselection 
and was cloned from round 7 with 17% activity (Figure 2.13A). To compare the parent 6CF134 
deoxyribozyme to the reselected variants, all deoxyribozymes were synthesized with both the 
reselection and 6CF134 parent binding arms. Unfortunately, the change in the binding arm 
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sequences significantly decreased the activity of the parent deoxyribozyme, 6CF134 (Figure 
2.13B). Therefore, the subsequent improvement in activity observed with the reselected variants 
is difficult to evaluate. In future reselection efforts, deoxyribozyme tolerance of binding arm 
sequence changes will be evaluated prior to changing the binding arm sequences for reselection 
experiments.  
 
Figure 2.13. EE1 selection experiment, reselection of the 6CF134 deoxyribozyme. (A) Selection 
progression of the EE1 reselection for improved kinase deoxyribozymes that use pppRNA as the 
phosphoryl donor. In each round, “control” refers to the yield for the 8VP1-catalyzed capture 
reaction using a CAAYPAA substrate, and “selection” refers to the yield for the 8VP1-catalyzed 
capture reaction for the EE1 selection experiment. The arrow marks the cloned round. (B) A 
kinetic plot for the identified deoxyribozymes is shown. For each deoxyribozyme, “parent” refers 
to the binding arms used in the initial CF1 selection, and “reselection” refers to the binding arms 
used during the EE1 selection. All assays were performed in trans. Incubation conditions were 70 
mM HEPES, pH 7.5, 0.5 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C.  
2.2.3 Tyrosine Kinase Deoxyribozymes that use GTP Phosphoryl Donors 
Natural kinases use ATP or in some cases GTP as their phosphoryl donor. Kinase 
deoxyribozymes would be more easily utilized to phosphorylate proteins if small-molecule NTP 
donors could be used instead of pppRNA oligonucleotides. Kinase deoxyribozyme selection 
experiments EA1-EC1 were performed using GTP as the phosphoryl donor (Figure 2.14) instead 
of pppRNA as used by the previous kinase deoxyribozymes. Successful tyrosine kinase 
deoxyribozymes need to bind to the phosphoryl donor and catalyze phosphorylation. Whereas 
the previously used pppRNA phosphoryl donor was bound to the deoxyribozyme binding arm 
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via preprogrammed Watson-Crick binding interactions. Selection experiments for tyrosine 
phosphorylation were performed with N30, N40, or N50 random region lengths and 1 mM GTP 
instead of pppRNA as the phosphoryl donor. Condition A was used for all selection experiments. 
 
Figure 2.14. Design for the EA1-EC1 in vitro selection experiments to identify tyrosine kinase 
deoxyribozymes using small-molecule NTP donors. In all selections, the peptide substrate was 
CAAYAA connected to a DNA anchor via a disulfide bond and HEG tether, and 1 mM GTP was 
the phosphoryl donor. EA1, EB1, and EC1 have N30, N40, and N50 initially random regions, 
respectively. All selections were performed in selection condition A. 
Activity was observed in all three selection experiments (Figure 2.15), and a single active 
DNA sequence was identified from each selection (Figure 2.16). 8EA101 (N30) and 16EC103 
(N50) have substantial catalytic activity (Figure 2.17). 8EA101 has kobs = 0.2 h–1 with 44% 
phosphorylation yield in 24 h, and 16EC103 has kobs = 0.2 h–1 with 34% yield in 24 h. 21EB121 
(N40) has a modest 5% phosphorylation yield and was not further characterized. Phosphorylation 
of the tyrosine within the peptide substrate was confirmed by MALDI mass spectrometry and 
8VP1 reactivity, as done with the previously identified tyrosine kinase deoxyribozymes (Figure 
2.18).  
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Figure 2.15. Selection progression of the in vitro selection experiments for kinase 
deoxyribozymes that use GTP as the phosphoryl donor. In each round, “control” refers to the 
yield for the 8VP1-catalyzed capture reaction using a CAAYPAA substrate, and “selection” 
refers to the yield for the 8VP1-catalyzed capture reaction for the indicated selection experiment. 
Arrows mark the cloned rounds. The EA1, EB1, and EC1 selections have a N30, N40, and N50 
random region, respectively. Figure adapted with permission from Ref. 11. 
 
Figure 2.16. Sequences of the initially random regions of the tyrosine kinase deoxyribozymes 
that use GTP as the phosphoryl donor. Only the initially random region is shown. Next to the 
sequence length on the right, in parentheses, is the number of times each sequence was found. 
Figure reprinted with permission from Ref. 11. 
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Figure 2.17. Activity of the tyrosine kinase deoxyribozymes 8EA101 (N30) and 16EC103 (N50) 
that use GTP as the phosphoryl donor. The PAGE image shows representative time points (t = 30 
s, 5 h, 24 h). YOH = substrate; YP = product. The kinetic plots for the identified deoxyribozymes 
are shown. All assays were performed in trans. Incubation conditions were 70 mM HEPES, pH 
7.5, 100 µM GTP, 0.5 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C. 
Figure reprinted with permission from Ref. 11. 
 
Figure 2.18. MALDI mass spectrometry and 8VP1 reactivity for tyrosine kinase 
deoxyribozymes that use GTP as the phosphoryl donor. The mass of the DNA-HEG-CAAYPAA 
product. 8VP1-catalyzed reaction of the phosphopeptide product has the same rate and yield as 
the YP positive control. This confirms that the phosphoryl group is attached at the tyrosine 
hydroxyl within the peptide substrate. Figure adapted with permission from Ref. 11. 
The NTP requirement was evaluated for both deoxyribozymes (Figure 2.19). 16EC103 
maintains activity with dGTP, but no activity is observed with any other NTP or dNTP, 
indicating a requirement for guanosine. In contrast, 8EA101 maintains comparable activity with 
all NTPs, dNTPs, and even inorganic triphosphate as the phosphoryl donor.  
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Figure 2.19. NTP requirement of the kinase deoxyribozymes identified using GTP. Both 
deoxyribozymes were evaluated with all four NTPs and dNTPs. 8EA101 was additionally tested 
with inorganic triphosphate (ppp). Incubation conditions were 70 mM HEPES, pH 7.5, 100 µM 
phosphoryl donor, 0.5 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C. 
Both 8EA101 and 16EC103 had significant GTP concentration dependence with an 
apparent Km(GTP) of ~20 and 42 µM, respectively (Figure 2.20). Substantial inhibition was 
observed for both deoxyribozymes above 100-200 µM GTP. Despite the increased kobs of 
8EA101 with inorganic triphosphate as the phosphoryl donor, the apparent Km(ppp) was ~19 
µM, which is the same as for GTP. These results show that DNA catalysts can use small-
molecule NTPs as phosphoryl donors and each deoxyribozyme can interact with the NTP 
phosphoryl donor in a different way.  
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Figure 2.20. Apparent Km analysis of 8EA101 and 16EC103. The kobs values were determined 
from initial-rate kinetics (linear fits to plots of yield versus time from 0 to 2 h). The kobs are 
shown as mean ± standard deviation (n = 3 at each GTP concentration). Data were fit to 
kobs = kcat•[Cn/(Kmn+Cn)]•[1-Cm/(Kim+Cm)], where kcat is the apparent kcat value, C is the GTP 
concentration, Km is the apparent Km(GTP) value for the productive GTP binding, Ki is the 
inhibition constant for unproductive GTP binding, and n and m are Hill coefficients for 
productive and unproductive GTP binding, respectively. For 8EA101, the apparent Km(GTP) = 
20 ± 1 µM and the apparent Ki(GTP) = 240 ± 4 µM. The apparent Km(ppp) = 19 ± 2 µM and the 
apparent Ki(ppp) = 841 ± 33 µM. For 16EC103, the apparent Km(GTP) = 42 ± 7 µM and the 
apparent Ki = 284 ± 17 µM. Figure adapted with permission from Ref. 11. 
2.2.4 Tyrosine Kinase Deoxyribozymes that use ATP Phosphoryl Donors 
The EA1, EB1, and EC1 selection experiments used 1 mM GTP as the phosphoryl donor, 
but the resulting deoxyribozymes are inhibited by GTP concentrations above 100 µM. 
Additionally, one deoxyribozyme, 8EA101, could use any NTP as the phosphoryl donor. 
Therefore, new selection experiments HR1-HT1 were designed to identify tyrosine kinase 
deoxyribozymes using 100 µM ATP during the selection step. The lower NTP concentration 
seems ideal for kinase deoxyribozymes and ATP is the common biological phosphoryl donor. 
Selection experiments were performed using N30, N40, and N50 random region lengths and 
condition A that were previously found to enable DNA-catalyzed phosphorylation.  
Activity was observed for both HR1 (N30) and HS1 (N40) (Figure 2.21A). Selection 
pressure of 10 µM ATP was implemented at rounds 11 and 9 for HR1b and HS1b, respectively. 
Activity did not recover after several rounds of selection pressure. Therefore, each selection was 
cloned from its original population without the ATP concentration pressure applied, at rounds 10 
and 8 for HR1 and HS1, respectively. The HR1 and HS1 selections led to the identification of 
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one and two deoxyribozymes, respectively (Figure 2.21B). No activity was observed for HT1 
(N50), and the selection was discontinued after 16 rounds. 10HR114, 8HS119, and 8HS122 have 
phosphorylation yield of 38%, 47%, and 63%, respectively (Figure 2.21C). None of these 
deoxyribozymes phosphorylate serine in place of tyrosine.  
 
Figure 2.21. Tyrosine kinase deoxyribozymes identified using 100 µM ATP as the phosphoryl 
donor. (A) Selection progression of the in vitro selection experiments for kinase deoxyribozymes 
that use ATP as the phosphoryl donor. In each round, “control” refers to the yield for the 8VP1-
catalyzed capture reaction using a CAAYPAA substrate, and “selection” refers to the yield for 
the 8VP1-catalyzed capture reaction for the indicated selection experiment. Arrows mark the 
cloned rounds. The HR1 and HS1 selections have N30 and N40 random regions, respectively. 
HR1b and HS1b are the rounds in which selection pressure was applied by decreasing the ATP 
concentration to 10 µM. (B) Sequences of the initially random regions. Only the initially random 
region is shown. Next to the sequence length on the right, in parentheses, is the number of times 
each sequence was found. (C) The PAGE image shows representative time points (t = 30 s, 2 h, 
16 h). YOH = substrate; YP = product. Assays were performed in trans. Incubation conditions 
were 70 mM HEPES, pH 7.5, 100 µM ATP, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 
150 mM NaCl at 37 °C. 
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Independent selection experiments were performed by Victor Dokukin to evaluate 
modular deoxyribozymes containing an N40 initially random catalytic region and a separate 
aptamer domain for substrate binding (Figure 2.22).12 Tyrosine kinase deoxyribozyme selections 
were performed using the 8VP1 deoxyribozyme capture method. The substrates were a DNA-
anchored CAAYAA peptide and 30 µM ATP as the phosphoryl donor. The DNA pool contained 
an N40 initially random region and a separate ATP phosphoryl donor binding site provided by a 
DNA aptamer region. Selection conditions were 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM 
MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h. The resulting deoxyribozymes 
needed to catalyze the phosphoryl transfer reaction by interacting with the bound ATP, but the 
ATP binding site was preprogrammed via the DNA aptamer.  
 
Figure 2.22. Nonmodular and modular tyrosine kinase deoxyribozymes. (A) A nonmodular 
DNA catalyst. The initially random region both binds the small-molecule ATP substrate and 
performs catalysis. (B) A modular DNA catalyst. A predefined ATP aptamer region is included 
adjacent to the initially random region, which is responsible for catalysis. Figure reprinted with 
permission from Ref. 12. 
The tyrosine kinase deoxyribozyme 14JS101 was identified. 14JS101 requires the ATP 
aptamer domain for activity, suggesting that the ATP phosphoryl donor used for catalysis is 
bound to the aptamer region. However, 14JS101 does not have improved rate, yield, or Km(ATP) 
compared to the tyrosine kinase deoxyribozymes 8EA101 or 16EC103 that were identified 
without the preprogrammed aptamer domain for NTP substrate binding. These results show that 
modular deoxyribozymes can be identified. However, the incorporation of the modular ATP 
binding site does not provide an advantage in identifying tyrosine kinase deoxyribozymes 
compared to nonmodular tyrosine kinase deoxyribozymes. 
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2.3 Summary and Future Directions 
Deoxyribozymes had previously been identified to catalyze oligonucleotide 
phosphorylation and nucleopeptide formation. The ability of DNA to catalyze oligonucleotide 
phosphorylation and separately to react with peptide substrates suggested that DNA-catalyzed 
peptide phosphorylation was possible. Initial efforts used γ-thiophosphoryl donors to enable 
separation of active DNA sequences. However, due to the instability of γ-thiophosphoryl donors 
in selection conditions, their use was discontinued. The 8VP1 capture deoxyribozyme was 
identified, and a capture method was optimized to separate active DNA sequences from inactive 
sequences. The kinase deoxyribozyme in vitro selection process was optimized to prevent 
enrichment of undesired sequences. The first tyrosine kinase deoxyribozymes were identified, 
and phosphorylate tyrosine residues within DNA-anchored peptide substrates.  
To expand upon the capabilities of tyrosine kinase deoxyribozymes, subsequent in vitro 
selection experiments used small-molecule NTPs as phosphoryl donors. DNA catalysts need to 
bind to the NTP phosphoryl donor and catalyze phosphorylation of the peptide substrate. 
Tyrosine kinase deoxyribozymes were identified from selection experiments in which 1 mM 
GTP was present. Surprisingly, the resulting deoxyribozymes had optimum activity at ~100 µM 
GTP and were inhibited at higher GTP concentrations. The different NTP requirements of each 
deoxyribozyme demonstrated that deoxyribozymes can interact with the phosphoryl donor in 
different ways. Future efforts to identify kinase deoxyribozymes will use ATP for simplicity and 
relevance as the most common biological phosphoryl donor. Lower ATP concentration of 100 
µM will also be used, because the current deoxyribozymes were inhibited GTP concentrations 
above 100 µM. 
Modular tyrosine kinase deoxyribozymes were also identified. These deoxyribozymes 
had an ATP aptamer domain adjacent to the initially random region. The ATP phosphoryl donor 
bound to the aptamer domain decreasing the requirements of the initially random region. While a 
modular tyrosine kinase deoxyribozyme was identified, the incorporation of the ATP binding site 
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did not provide an advantage compared to the nonmodular tyrosine kinase deoxyribozymes that 
use GTP as the phosphoryl donor. The ability of DNA catalysts to phosphorylate tyrosine side 
chains within peptide substrates expands the functionality of DNA to include an important 
biological regulatory post-translational modification. Some challenges remain, and future efforts 
are focused on peptide-sequence selectivity, and the phosphorylation of free peptides and 
proteins. 
2.4 Materials and Methods 
2.4.1 Substrate Preparation Procedures 
Oligonucleotides and peptides. DNA oligonucleotides were obtained from Integrated 
DNA Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 
instrument using reagents from Glen Research. 5′-Triphoshorylated RNA (pppRNA) 
oligonucleotides were prepared by in vitro transcription using synthetic DNA templates and T7 
RNA polymerase.13 All oligonucleotides were purified by 7 M urea denaturing PAGE with 
running buffer 1× TBE (89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3) as 
described.14,15 Peptides were synthesized via solid-phase synthesis as described.6  
Table 2.1: Oligonucleotide sequences of the pools, substrates, and primers used in the selection 
experiments. 
oligonucleotide purpose oligonucleotide sequence 
  
Selections with pppRNA or 1 mM GTP phosphoryl donors 
DNA-HEG-CAAYAA substrate GGATAATACGACTCACTAT-HEG-CAAYAA 
pppRNA phosphoryl donor pppGAUGUUCUAGCGCUUCG 
forward primer for selection CGAAGCGCTAGAACAT 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAAGCGCTAGAACAT-NX-ATAGTGAGTCGTATTAAGCTGATCCTGATGG 
splint for ligation step during selection ATAGTGAGTCGTATTATCCTCCATCAGGATCAGCTTAATACGACTCACTAT 
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Table 2.1 (cont.) 
oligonucleotide purpose oligonucleotide sequence 
  
Reselection of 6CF134 and 7CH102 
DNA-HEG-CAAYAA substrate GGACTACCTTTATGCGTAT-HEG-CAAYAA 
pppRNA phosphoryl donor pppGGAAGGAGGCUUUCGGG 
forward primer for selection CGAACGAAAGCCTCCTTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
partially randomized pool for selection CGAACGAAAGCCTCCTTC-NX-ATACGCATAAAGGTAGAGCTGATCCTGATGG 
splint for ligation step during selection ATACGCATAAAGGTAGTCCTCCATCAGGATCAGCTCTACCTTTATGCGTAT 
  
Selections with 100 µM ATP phosphoryl donor and N30 random region 
DNA-HEG-CAAYAA substrate GGACTACCTTTATGCGTAT-HEG-CAAYAA 
forward primer for selection CGAACGAAAGCCTCCTTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAACGAAAGCCTCCTTC-N30-ATACGCATAAAGGTAGAGCTGATCCTGATGG 
splint for ligation step during selection ATACGCATAAAGGTAGTCCTCCATCAGGATCAGCTCTACCTTTATGCGTAT 
 
Selections with 100 µM ATP phosphoryl donor and N40 random region 
DNA-HEG-CAAYAA substrate GGAATATCTCGTTTCTTAT-HEG-CAAYAA 
forward primer for selection CGAATTAAGACTGAATTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAATTAAGACTGAATTC-N40-ATAAGAAACGAGATATAGCTGATCCTGATGG 
splint for ligation step during selection ATAAGAAACGAGATATTCCTCCATCAGGATCAGCTATATCTCGTTTCTTAT 
  
Synthesis of DNA-anchored peptide conjugates. DNA-anchored peptide conjugates were 
synthesized by disulfide formation between a DNA HEG-tethered 3′-thiol and the N-terminal 
cysteine side chain of the peptide (Figure 2.23). The DNA anchor oligonucleotide was 5′-
GGATAATACGACTCACTAT-HEG-p-C3-SS-C3-OH-3′. The 3′-disulfide linker was introduced via 
standard solid-phase DNA synthesis and reduced to a 3′-thiol by DTT treatment. A 50 µL sample 
containing 5 nmol of DNA anchor oligonucleotide in 100 mM HEPES, pH 7.5, and 50 mM DTT 
was incubated at 37 °C for 2 h. The reduced product was precipitated to remove DTT by addition 
of 50 µL of water, 10 µL of 3 M NaCl, and 300 µL of ethanol. The precipitated product (DNA-
HEG-p-C3-SH) was dissolved in 35 µL of water and 10 µL of 100 mM triethylammonium 
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acetate, pH 7.0. Activation as the pyridyl disulfide was achieved by adding 5 µL of 100 mM 2,2′-
dipyridyl disulfide in DMF and incubating at 37 °C for 2 h. The product (DNA-HEG-p-C3-SSPy) 
was precipitated by addition of 50 µL of water, 10 µL of 3 M NaCl and 300 µL of ethanol and 
dissolved in 35 µL of water. Conjugation to the peptide was performed by adding 10 µL of 100 
mM triethylammonium acetate, pH 7.0, and 5 µL of 20 mM peptide (100 nmol, 20 equivalents). 
The sample was incubated at 37 °C for 12 h, and the DNA-anchored peptide was purified by 
20% PAGE.  
 
Figure 2.23. Synthesis and structure of the DNA-anchored CAAYAA hexapeptide substrate. A 
hexa(ethylene glycol), or HEG, tether connects the DNA oligonucleotide anchor to the peptide. 
The 3′-HEG-linked thiol DNA is synthesized as a disulfide, which is reduced, activated, and then 
conjugated to the peptide substrate via a disulfide bond with the N-terminal cysteine residue. 
Figure reprinted with permission from Ref. 11. 
2.4.2 In Vitro Selection Procedures 
Procedure for ligation step in round 1. A 35 µL sample containing 1 nmol of DNA pool, 
800 pmol of DNA splint, and 500 pmol of 5′-phosphorylated DNA-anchored hexapeptide 
substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 
°C for 3 min and cooling on ice for 5 min. To this solution was added 4 µL of 10× T4 DNA 
ligase buffer (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) and 1 µL of 5 U/µL T4 
DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h and separated by 8% 
PAGE. 
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Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5-10 pmol), 25 pmol of DNA splint, and 50 pmol of 5′-phosphorylated 
DNA-anchored hexapeptide substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 
mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this solution was 
added 2 µL of 10× T4 DNA ligase buffer and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). The 
sample was incubated at 37 °C for 12 h and separated by 8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 20 µL sample containing 200 pmol of ligated pool and 300 pmol of 
pppRNA phosphoryl donor was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction was 
initiated by bringing the sample to 40 µL total volume containing 70 mM HEPES, pH 7.5, 1 mM 
ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl. The Mn2+ was added from a 10× stock 
solution containing 200 mM MnCl2. The Zn2+ was added from a 10× stock solution containing 
10 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES, pH 7.5; this stock solution was freshly 
prepared from a 100× stock of 100 mM ZnCl2 in 200 mM HNO3. The metal ion stocks were 
added last to the final sample. For selections with NTP as the phosphoryl donor, the pppRNA 
was omitted and 1 mM NTP was added from a 10 mM stock solution after annealing. The 
sample was incubated at 37 °C for 14 h and separated by 8% PAGE. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing ligated 
pool and 50 pmol of pppRNA phosphoryl donor was annealed in 5 mM HEPES, pH 7.5, 15 mM 
NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The 
selection reaction was initiated by bringing the sample to 20 µL total volume containing 70 mM 
HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl. For selections 
with NTP as the phosphoryl donor, the pppRNA was omitted and 1× NTP was added from a 10× 
stock solution after annealing. The sample was incubated at 37 °C for 14 h and separated by 8% 
PAGE. 
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Procedure for capture step in round 1. A 28 µL sample containing ligated pool, 500 pmol 
of 54 nt 5′-triphosphorylated RNA-DNA chimera substrate, and 300 pmol of 8VP1 capture 
deoxyribozyme was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by 
heating at 95 °C for 3 min and cooling on ice for 5 min. The capture reaction was initiated by 
bringing the sample to 40 µL total volume containing 50 mM HEPES, pH 7.5, 20 mM MnCl2, 
and 150 mM NaCl. The sample was incubated at 37 °C for 14 h. Before PAGE purification, to 
the sample was added 500 pmol of a 60 nt decoy oligonucleotide complementary to the 40 nt 
8VP1 catalytic region and 10 nt of binding arm on each side, to ensure complete removal of the 
capture deoxyribozyme from the pool. The sample was separated by 8% PAGE. 
Procedure for capture step in subsequent rounds. A 14 µL sample containing ligated pool, 
50 pmol of 17 nt pppRNA substrate (in even rounds) or 54 nt 5′-triphosphorylated RNA-DNA 
chimera substrate (in odd rounds), and 25 pmol of 8VP1 capture deoxyribozyme was annealed in 
5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and 
cooling on ice for 5 min. The capture reaction was initiated by bringing the sample to 20 µL total 
volume containing 50 mM HEPES, pH 7.5, 20 mM MnCl2, and 150 mM NaCl. The sample was 
incubated at 37 °C for 14 h. Before PAGE purification, to the sample was added 100 pmol of a 
60 nt decoy oligonucleotide complementary to the 40 nt 8VP1 catalytic region and 10 nt of 
binding arm on each side (note that the decoy sequence is different in even-numbered and odd-
numbered rounds). The sample was separated by 8% PAGE. 
Procedure for PCR in subsequent rounds. In each selection round, two PCR reactions 
were performed, 10-cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared 
containing the PAGE-separated capture product, 200 pmol of forward primer, 50 pmol of reverse 
primer, 20 nmol of each dNTP, and 10 µL of 10× Taq polymerase buffer (200 mM Tris-HCl, pH 
8.8, 100 mM (NH4)2SO4, 100 mM KCl, 20 mM MgSO4, and 1% Triton X-100), and Taq 
polymerase. This sampled was cycled 10 times according to the following PCR program: 94 °C 
for 2 min, 10× (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Taq polymerase 
was removed by phenol/chloroform extraction. Second, a 50 µL sample was prepared containing 
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1 µL of the 100 µL 10-cycle PCR product, 100 pmol of forward primer, 25 pmol of reverse 
primer, 10 nmol of each dNTP, 20 µCi of α-32P-dCTP (800 Ci/mmol), 5 µL of 10× Taq 
polymerase buffer, and Taq polymerase. This sample was cycled 30 times according to the 
following PCR program: 94 °C for 2 min, 30× (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 
°C for 5 min. Samples were separated by 8% PAGE. 
2.4.3 Cloning and Screening 
Using 1 µL of a 1:1000 dilution of the 10-cycle PCR product from the end of the 
selection round being cloned, 30-cycle PCR was performed using the above procedure, omitting 
α-32P-dCTP and using 25 pmol of forward primer and 25 pmol of reverse cloning primer, where 
the extensions with TAA stop codons in each frame were included to suppress false negatives in 
blue-white screening.16 The PCR product was purified on 2% agarose and cloned using a TOPO 
TA cloning kit (Invitrogen). Miniprep DNA samples derived from individual E. coli colonies 
were assayed by digestion with EcoRI to ascertain the presence of the expected inserts. Using the 
miniprep DNA samples, PCR (same conditions as 30-cycle PCR during selection, omitting α-
32P-dCTP) was performed to obtain the deoxyribozymes. Half of the PCR product was used to 
perform screening assays. Each screening assay used ~0.1 pmol of 5′-32P-radiolabeled DNA-
anchored hexapeptide substrate, 50 pmol of pppRNA phosphoryl donor, ~20 pmol of 
deoxyribozyme and followed the single-turnover assay procedure described in the subsequent 
section. 
2.4.4 Deoxyribozyme Activity Assay Procedure 
The DNA-anchored hexapeptide substrate was 5′-32P-radiolabeled using γ-32P-ATP and 
T4 polynucleotide kinase (Fermentas), using 10× buffer that lacks DTT (500 mM Tris, pH 7.6, 
100 mM MgCl2, and 1 mM spermidine). A 10 µL sample containing 0.25 pmol of 5′-32P-
radiolabeled DNA-anchored peptide substrate, 10 pmol of deoxyribozyme, and 20 pmol of 
pppRNA phosphoryl donor was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM 
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EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. For assays with NTP as the 
phosphoryl donor, the pppRNA was omitted and 2 µL of NTP was added from a 10× stock 
solution after annealing in an 8 µL volume. The DNA-catalyzed phosphorylation reaction was 
initiated by bringing the sample to 20 µL total volume containing 70 mM HEPES, pH 7.5, 0.5 
mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl (or other ion concentrations as 
appropriate). The Mn2+ was added from a 10× stock solution containing 200 mM MnCl2. The 
Zn2+ was added from a 10× stock solution containing 5 mM ZnCl2, 10 mM HNO3, and 100 mM 
HEPES at pH 7.5; this stock solution was freshly prepared from a 200× stock of 100 mM ZnCl2 
in 200 mM HNO3. The metal ion stocks were added last to the final sample, which was divided 
into 2 µL aliquots that were all incubated at 37 °C. At appropriate time points, 2 µL aliquots 
were quenched with 5 µL stop solution (80% formamide, 1× TBE [89 mM each Tris and boric 
acid and 2 mM EDTA, pH 8.3], 50 mM EDTA, 0.025% bromophenol blue, 0.025% xylene 
cyanol). Samples were separated by 20% PAGE and quantified with a PhosphorImager. Values 
of kobs were obtained by fitting the yield versus time data directly to first-order kinetics; i.e., yield 
Y = Ymax•(1 – e–kt), where k = kobs and Ymax is the final yield. Errors in kobs values were calculated 
as the standard deviation from the indicated number of independent determinations. 
2.4.5 Mass Spectrometry 
The DNA-anchored CAAYPAA phosphorylation product was prepared from a 10 µL 
sample containing 300 pmol of DNA-anchored HEG-tethered CAAYOHAA substrate, 350 pmol 
of deoxyribozyme, and 400 pmol of pppRNA phosphoryl donor, which were annealed in 5 mM 
HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on 
ice for 5 min. For samples with GTP as the phosphoryl donor, the pppRNA was omitted and 1× 
NTP was added from a 10× stock solution after annealing. The DNA-catalyzed phosphorylation 
reaction was initiated by bringing the sample to 20 µL total volume containing 70 mM HEPES, 
pH 7.5, 0.5 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl. The sample was 
incubated at 37 °C for 14 h and separated by 8% PAGE (only the lower one-fourth to one-half of 
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the product band was excised, to suppress extraneous signals due to unreacted substrate). The 
PAGE-purified sample was desalted by a Millipore C18 ZipTip and analyzed by MALDI mass 
spectrometry (Bruker UltrafleXtreme; matrix 3-hydroxypicolinic acid). 
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Chapter 3: Peptide Sequence-Specific Tyrosine Kinase Deoxyribozymes† 
3.1 Introduction 
3.1.1 Site-Specific Modification of Proteins 
Natural proteins are modified by many types of post-translational modifications at 
specific amino acid residues.16 Protein kinases phosphorylate specific amino acid residues within 
their protein substrates based on the local sequence, and many known kinase sequence 
recognition motifs have been reported.713 High-throughput screening methods have been 
developed to determine kinase substrate requirements.1416 Phosphorylation motifs have been 
cataloged and incorporated into searchable databases with algorithms to predict phosphorylation 
sites in proteins of interest.1724 Despite the large number of known or predicted protein 
phosphorylation sites, protein kinases that are able to phosphorylate proteins of interest at 
specific sites are not always known. 
Artificial catalysts that catalyze the covalent modification of proteins in a highly selective 
manner are valuable for biochemical studies. Small-molecule catalysts for protein modification 
usually modify any accessible reactive side chain without regard to the sequence context.25 
Natural protein enzymes that catalyze the post-translational modification of proteins can be 
                                                            
† This research has been published:  
Walsh, S. M.; Konecki, S. N.; Silverman, S. K. Identification of Sequence-Selective Tyrosine 
Kinase Deoxyribozymes. J. Mol. Evol. 2015, 81, 218-224. 
University of Illinois undergraduate student Stephanie N. Konecki synthesized the complex 
peptide substrates. 
University of Illinois graduate student Chih-Chi Chu identified and characterized the 
nucleopeptide-forming deoxyribozymes with peptide-sequence specificity.40 
University of Illinois graduate student Puzhou Wang identified and characterized DNA enzymes 
for tyrosine adenylylation.52 
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subjected to directed evolution26,27 for a higher rate constant and other improved practical 
characteristics.28 However, directed evolution of known enzymes for the desired sequence 
selectivity is often difficult, and tolerance for new substrates often leads to relaxed substrate 
specificity.29 Therefore, identification of new catalysts for site-specific protein modifications is 
valuable.  
3.1.2 Deoxyribozymes with Peptide-Sequence Specificity 
Nucleic acid aptamers specifically bind to peptide and protein substrates based on their 
sequence and structure.3036 Considering the substrate specificity of protein catalysts and DNA 
aptamers, it is likely that DNA enzymes that are complex biomolecular catalysts can also interact 
specifically with peptide and protein substrates. 
Deoxyribozymes have been identified to catalyze the modification of peptide substrates37 
including via nucleopeptide formation,38-41 phosphorylation,42,43 dephosphorylation,44 and 
phosphoserine lyase activity.45 However, in all of these previous selection experiments, only a 
few of the resulting deoxyribozymes discriminate among peptide substrates based on the peptide 
sequence (Figure 3.1).46 These selective nucleopeptide-forming deoxyribozymes were identified 
using untethered peptide substrates during the in vitro selection experiments. DNA enzymes that 
catalyze the modification of untethered peptide substrates may require a stronger interaction 
between the deoxyribozyme and peptide substrate. All other peptide-modifying deoxyribozymes 
were identified from selection experiments in which DNA-anchored peptide substrates were 
used. This includes tyrosine kinase deoxyribozymes that do not discriminate among peptide 
substrates based on their amino acid sequences.42,43 The presence of a tethered peptide substrate 
may not require the deoxyribozyme to interact as specifically with the peptide substrate as the 
deoxyribozyme may with an untethered peptide substrate.  
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Figure 3.1. Peptide-sequence-selective nucleopeptide-forming deoxyribozymes with untethered 
peptide reactivity. DNA-catalyzed nucleopeptide formation was evaluated with multiple peptide 
substrates. The parent (par) peptide sequence with N-terminal azido group used during the 
selection is indicated. Peptides A-D with an N-terminal acetyl group are as follows: 
A = RTRYERN; B = FSDYIHP; C = EKIYIHP; D = QAGYKGR. 8XJ105 is peptide sequence-
general, 11EM103 is peptide sequence-specific, and 11EP104 is partially peptide sequence-
specific. Incubation conditions are 1 mM peptide, 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 
mM MnCl2, 1.0 mM (8XJ105) or 0.4 mM (11EM103, 11EP104) ZnCl2, and 150 mM NaCl at 37 
°C for 16 h. Figure adapted with permission from Ref. 40. 
With nucleopeptide-forming deoxyribozymes as the sole exception, all known 
deoxyribozymes that catalyze peptide modification were identified using peptide substrates 
containing the reactive amino acid flanked solely by alanine residues (i.e. AAYAA). 
Incorporation of more diverse amino acids surrounding the reactive residue may increase the 
interactions between the deoxyribozyme and the peptide substrate.  
3.2 Results and Discussion 
3.2.1 Development of the Phosphotyrosine Immunoprecipitation Capture Method 
The previously used 8VP1 gel-based capture method to identify tyrosine kinase 
deoxyribozymes enables the isolation of active DNA sequences based on both product reactivity 
and physical size. Bead-based methods only required reactivity for the product to be separated. 
Phosphotyrosine (pTyr) antibodies specifically bind to phosphorylated tyrosine residues, and the 
binding interaction requires only the phosphotyrosine side chain. Therefore, antibody binding of 
the phosphotyrosine products should be unaffected by the length of the tether between the 
peptide substrate and the DNA anchor.  
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A bead-based immunoprecipitation method was developed to capture phosphotyrosine-
containing peptide products (Figure 3.2). After the selection step, the sample was precipitated 
and incubated with a phosphotyrosine antibody (pY20) and protein A immobilized on an agarose 
resin. Protein A binds to the constant Fc region of an antibody, and the variable region of the 
pTyr antibody binds specifically to phosphotyrosine. Therefore, the active DNA sequences 
connected to their phosphorylated peptide product were bound to the resin via the pTyr antibody-
protein A interaction. After incubation, the resin was washed, removing the unbound non-
phosphorylated peptide substrates connected to the inactive DNA sequences. The bound 
deoxyribozymes were then eluted from the resin, and scintillation counting of the wash and 
elution fractions was used to quantify activity in the selection experiment.  
 
Figure 3.2. Phosphotyrosine immunoprecipitation capture method. The phosphotyrosine-
containing peptide product connected to the active DNA sequences were immunoprecipitated by 
binding to a pTyr antibody immobilized on a protein A-coated agarose resin. The plot shows the 
capture of DNA-anchored peptides (mean ± sd, n = 3). YP = CAAYPAA; YOH = CAAYAA. 
Phosphotyrosine-containing peptides were captured independently of the length of the tether 
between the peptide and DNA anchor, but the tyrosine-containing substrate was not captured. 
The table shows capture results of the mock selection round. During the ligation step, the 
indicated amount of phosphotyrosine-containing peptide substrate was included. The capture 
yield is shown, and the yield is normalized to the selection experiment with 100% CAAYPAA.  
The phosphotyrosine immunoprecipitation capture method was optimized for use during 
in vitro selection of kinase deoxyribozymes. To prevent the DNA pool from adhering to the 
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reaction tube, low-retention tubes were coated with a 5% PEG solution, incubated at room 
temperature overnight, and rinsed prior to use. To the sample was also added 50 pmol of a 
sacrificial oligonucleotide (AAC)20. Incubation of the DNA pool with the pTyr antibody prior to 
addition of the protein A resin resulted in the same capture yield as adding both the pTyr 
antibody and resin to the sample at the same time. Therefore, to simplify the capture method, 
both the pTyr antibody and protein A resin were added at once. Shaking the sample on a vortexer 
at the lowest setting was the most effective method to mix the small 35 µL sample. Mixing the 
sample at room temperature for 1 h led to the same capture yield as mixing at 4 °C for 16 h. The 
shorter 1 h incubation at room temperature was used. The immunoprecipitation capture method 
was highly selective for phosphotyrosine with a 30% capture yield, whereas <1% of the tyrosine 
substrate was captured. A mock selection round was performed to validate the phosphotyrosine 
immunoprecipitation capture method. Varying amounts of phosphotyrosine-containing peptide 
product were doped in with the tyrosine-containing substrate during the ligation step. Capture 
yields using the immunoprecipitation method were consistent with the added amount of 
phosphotyrosine-containing peptide. Therefore, the phosphotyrosine immunoprecipitation 
capture method was viable for use during the in vitro selection of tyrosine kinase 
deoxyribozymes. 
One concern with the bead-based capture method is the unintended enrichment of DNA 
aptamers that bind to the antibody, protein A, or resin. To avoid this, a preclear step was 
performed between the ligation and selection step. In this step, the DNA sequences ligated to the 
substrate were subjected to the immunoprecipitation capture. The DNA sequences that did not 
bind to the pTyr antibody, protein A, or resin were recovered in the wash and taken on to the 
selection step. During the preclear step only the substrate (YOH) was present. Therefore, DNA 
sequences that were aptamers to the antibody, protein A, or resin were removed.  
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3.2.2 In Vitro Selection for Peptide Sequence-Specific Tyrosine Kinase Deoxyribozymes 
In vitro selection experiments were performed to identify peptide sequence-specific 
tyrosine kinase deoxyribozymes using complex, biologically derived peptide substrates.47 
Peptide substrates were octapeptide sequences derived from biologically phosphorylated 
proteins, and the peptide sequences were more complex than the previously used CAAYAA 
peptide substrate (Chapter 2). The more complex peptide sequences may enable more 
interactions between the DNA enzyme and the peptide substrate, resulting in deoxyribozymes 
with peptide-sequence selectivity. Three different peptide sequences were used in the selection 
experiments: CMTGYVAT, CADPYDQS, and CKVIYDFI. The CMTGYVAT and 
CADPYDQS peptide sequences correspond to amino acids 179-185 and 320-326, respectively, 
from the MAPK14/p38α protein (mitogen-activated protein kinase 14).48,49 The CKVIYDFI 
peptide sequence corresponds to amino acids 253-259 from N-WASP (neuronal Wiskott-Aldrich 
Syndrome protein).50 The tyrosine residue within each peptide sequence is naturally 
phosphorylated in the corresponding protein substrate. Each peptide included an artificial 
cysteine residue on the N-terminus to enable disulfide conjugation of the peptide to the DNA 
anchor oligonucleotide. 
In vitro selection was performed similarly to the previous kinase deoxyribozyme 
selection experiments (Chapter 2), except with a different capture step using an immobilized 
phosphotyrosine (pTyr) antibody to separate the catalytically active DNA sequences in each 
selection round (Figure 3.3). The octapeptide substrates were prepared by solid-phase peptide 
synthesis and connected to a DNA anchor via a disulfide bond and a hexa(ethylene glycol) 
[HEG] tether. The pppRNA phosphoryl donor was prepared by in vitro transcription using a 
DNA template and T7 RNA polymerase. The DNA-anchored peptide substrate was ligated to the 
initially random DNA pool using T4 DNA ligase and PAGE-purified. Next, the selection step 
was performed in which the DNA sequences were incubated with a phosphoryl donor and 
divalent metal ions in a buffered solution to enable DNA-catalyzed peptide phosphorylation. A 
subsequent capture step was performed to isolate the desired active DNA sequences connected to 
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their phosphopeptide product. The capture step was a bead-based immunoprecipitation method to 
isolate the active DNA sequences. The immunoprecipitation capture method enabled more 
selection experiments to be performed in parallel than the 8VP1 capture deoxyribozyme method. 
Immobilized pTyr antibody binds specifically to the phosphotyrosine-containing peptide 
products connected to the active DNA sequences. The bound, active DNA sequences were 
separated from the unbound, inactive DNA sequences. PCR was then performed to amplify the 
catalytic DNA sequences that survived the selection and capture steps. The entire selection round 
was repeated, each time the population was enriched with catalytically active sequences, until 
they dominated the population. 
 
Figure 3.3. Selection strategy for tyrosine kinase deoxyribozymes using an pTyr antibody. After 
the selection step, the active DNA sequences connected to the phosphopepetide products are 
captured via immunoprecipitation with an immobilized pTyr antibody. Figure reprinted with 
permission from Ref. 47.  
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An additional preclear step was performed in some selection rounds to prevent DNA 
sequences that bind to the pTyr antibody, protein A, or resin from surviving the capture step and 
being enriched throughout the selection rounds. In these rounds with the preclear step, the 
ligation product was incubated with the immobilized antibody and processed with the same 
procedure as for the capture step. However, in the preclear step the DNA sequences were 
connected to the tyrosine-containing peptide substrate. Therefore, the DNA sequences that did 
not bind to the resin continued on to the selection step. 
In vitro selection experiments RG1-RT1 were designed to identify peptide sequence-
specific tyrosine kinase deoxyribozymes (Figure 3.4). Selection experiments with each of the 
three different biologically derived, complex peptide sequences were performed with an N40 or 
N80 initially random region. The length of the initially random region has been shown to be an 
important variable in deoxyribozyme selection experiments,51 and tyrosine kinase 
deoxyribozymes have been identified from N30, N40, and N50 initially random region lengths 
(Chapter 2).42,43 Larger random regions may enable more complex catalytic DNA structures and 
may lead to more interactions between the DNA enzyme and the peptide substrate. However, all 
selection experiments evaluate 1014 DNA sequences, and this only a small fraction of the 1048 
possible N80 sequences compared to of the 1024 possible N40 sequences. Therefore, for the 
random region length used during selection experiments, a compromise is made between the 
structural complexity and the sequence-space coverage. Each of these selection experiments 
were performed with either no preclear step or a preclear step every third round beginning in 
round 1, for a total of twelve selection experiments. All selections were performed in 70 mM 
HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 
h. 
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Figure 3.4. Design for the RG1-RT1 in vitro selection experiments to identify peptide sequence-
specific tyrosine kinase deoxyribozymes. In each selection, the peptide substrate is connected to 
a DNA anchor via a disulfide bond and HEG tether, and the phosphoryl donor is pppRNA. The 
RG1-RK1, RL1-RP1, and RQ1-RT1 selections were with the peptide substrate CMTGYVAT, 
CADPYDQS, and CKVIYDFI, respectively. The initially random region was N40 or N80 as 
indicated. The selections were performed without the preclear step or the preclear step every 
three rounds beginning in round 1 as indicated. Incubation conditions for each selection was 70 
mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C 
for 14 h.  
Three selection experiments incorporating the preclear step every third round led to the 
identification of deoxyribozymes with kinase activity: N40 with CMTGYVAT (RJ1), N40 with 
CADPYDQS (RN1), and N80 with CADPYDQS (RP1) (Figure 3.5). Phosphorylation of the 
peptide substrate by the active pools was confirmed in trans (without ligating the DNA-anchored 
peptide substrate to the DNA pool) by directly assessing the DNA-anchored peptide substrate. 
These three selection experiments were cloned, and individual deoxyribozymes were identified. 
The other three selection experiments with the preclear step did not lead to activity, and they 
were discontinued after 11 rounds of selection.  
82 
 
Figure 3.5. Selection progression of the in vitro selection experiments. Control refers to a 
capture reaction performed each round using the CADPYPDQS peptide (YP = pTyr). A, B, and C 
refer to the N40 CADPYDQS (RN1), N80 CADPYDQS (RP1), and N40 CMTGYVAT (RJ1) 
selection experiments which were halted after round 9, 10, and 11, respectively. Arrows indicate 
the rounds at which individual deoxyribozymes were cloned from each selection. Figure 
reprinted with permission from Ref. 47. 
Some of the selection experiments in which no preclear step was performed also led to 
activity. However, phosphorylation of the DNA-anchored peptide substrate was not observed 
when the pools were evaluated in trans. These results indicate that the enriched sequences were 
not kinase deoxyribozymes, and the preclear step was required to prevent the enrichment of 
DNA sequences that bind to the immobilized antibody during the capture step. Therefore, future 
selection experiments using the bead-based pTyr immunoprecipitation capture method will 
include the preclear step every third round.  
3.2.3 Characterization of Peptide Sequence-Specific Deoxyribozymes 
Three unique N40 and two unique N80 tyrosine kinase deoxyribozymes were identified 
using the CADPYDQS peptide substrate and designated TyrKinA1-3 and TyrKinB1-2, 
respectively (Figure 3.6). One unique tyrosine kinase deoxyribozyme, TyrKinC1, was identified 
from the N40 selection with the CMTGYVAT peptide substrate. Matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry confirmed phosphorylation of the DNA-anchored 
peptide substrate by each deoxyribozyme (Figure 3.7). 
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Figure 3.6. Sequences of the initially random regions (N40 or N80) of the tyrosine kinase 
deoxyribozymes. Only the initially random region is shown. Next to the sequence length on the 
right, in parentheses, is the number of times each sequence was found. 
 
Figure 3.7. MALDI mass spectrometry of the tyrosine kinase deoxyribozyme catalyzed product. 
The mass is for the DNA-HEG-phosphopeptide product. Parent peptide substrates were used; 
CADPYDQS for TyrKinA1-3 and TyrKinB1-2 and CMTGYVAT for TyrKinC1. Figure adapted 
with permission from Ref. 47. 
Phosphorylation activity was evaluated with all three peptide substrates from the 
selection experiments. TyrKinC1 has kobs of 0.09 h–1 and 79% phosphorylation yield at 48 h with 
CMTGYVAT, the peptide substrate used during the selection (Figure 3.8). The TyrKinC1 
deoxyribozyme poorly discriminates against the CADPYDQS peptide substrate with kobs of 0.06 
h–1 and 63% yield at 48 h. However, TyrKinC1-catalyzed phosphorylation of the CKVIYDFI 
peptide substrate was only 13% at 48 h with kobs of 0.04 h–1. Therefore, TyrKinC1 has partial 
peptide-sequence selectivity but is not highly selective for the peptide substrate used during the 
selection experiment. 
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Figure 3.8. Activity of the partially peptide-sequence-selective tyrosine kinase deoxyribozyme 
TyrKinC1. Phosphorylation activity was evaluated with each of the three peptide substrates 
CMTGYVAT, CADPYDQS, and CKVIYDFI. The CMTGYVAT peptide substrate was used 
during the selection. Incubation conditions were 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM 
MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C. 
The TyrKinA1-3 and TyrKinB1-2 kinase deoxyribozymes identified from selection with 
the CADPYDQS peptide substrate have kobs values ranging from 0.05-0.11 h–1 and yields as high 
as 62% in 48 h (Figure 3.9). Each deoxyribozyme was assayed with the three different peptide 
substrates from the selection experiments, and in all cases only the peptide substrate used during 
the selection, CADPYDQS, was phosphorylated. Therefore, all five kinase deoxyribozymes 
selectively phosphorylate the DNA-anchored CADPYDQS peptide substrate. 
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Figure 3.9. Activities of the peptide-sequence-selective tyrosine kinase deoxyribozymes. Each 
of the five deoxyribozymes was evaluated with each of the three peptide substrates 
CADPYDQS, CMTGYAT, and CKVIYDFI. The PAGE image shows representative data for 
TyrKinA1 with all three peptide substrates and for the four other deoxyribozymes with the 
CADPYDQS peptide substrate used during the selection (t = 30 s, 12 h, 48 h). YOH = substrate, 
YP = product. As with TyrKinA1, the other four deoxyribozymes had no activity with the two 
peptide substrates not shown. The kobs for TyrKinA1 = 0.11 ± 0.02 h–1, TyrKinA2 = 0.08 ± 0.02 
h–1, TyrKinA3 = 0.05 ± 0.02 h–1, TyrKinB1 = 0.05 ± 0.01 h–1, and TyrKinB2 = 0.06 ± 0.01 h–1 
(n = 4, mean ± sd). The kinetic plot shows the phosphorylation of CADPYDQS by each of the 
five deoxyribozymes. Incubation conditions were 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM 
MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C. Figure reprinted with permission from Ref. 
47. 
The metal dependence was evaluated for the TyrKinA1-3 and TyrKinB1-2 kinase 
deoxyribozymes (Figure 3.10). The selection experiments were performed in the presence of 1 
mM Zn2+, 20 mM Mn2+, and 40 mM Mg2+. Each of the five deoxyribozymes was evaluated with 
combinations of these metal ions to determine the metal ions required for catalysis. The presence 
of all three divalent metal ions was optimal for all of the deoxyribozymes.  
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Figure 3.10. Metal dependence of the peptide-sequence-selective tyrosine kinase 
deoxyribozymes. Each of the five deoxyribozymes was incubated in 70 mM HEPES, pH 7.5, 150 
mM NaCl and combinations of 1 mM ZnCl2, 20 mM MnCl2, and 40 mM MgCl2 as indicated at 
37 °C. No activity was observed when no divalent metal ions were included. 
The peptide-sequence dependence for each deoxyribozyme was analyzed further by 
testing peptide-sequence mutations (Figure 3.11). As expected for tyrosine phosphorylation, 
mutation of the tyrosine residue to phenylalanine abolished all kinase activity. Mutation of the 
tyrosine residue to serine also abolished kinase activity. Therefore, all deoxyribozymes 
specifically phosphorylate tyrosine. To identify the peptide sequence motif required for kinase 
activity, each non-alanine amino acid residue flanking the tyrosine within the peptide substrate 
CADPYDQS was systematically and individually replaced with alanine. Interestingly, for the 
three highest-yielding deoxyribozymes, three different peptide sequence motifs were identified. 
For TyrKinA1, TyrKinA2, and TyrKinB1, the respective peptide sequence motifs are DPYD, 
DPY, and YD. The motifs of the other two deoxyribozymes could not be confidently assigned 
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due to their low phosphorylation yields with the parent peptide substrate. The three highest-
yielding kinase deoxyribozymes were evaluated for their ability to phosphorylate an untethered 
peptide substrate. Unfortunately, phosphorylation of the CADPYDQS peptide was not observed 
by MALDI mass spectrometry for any of the deoxyribozymes, despite the tight interaction 
between the peptide substrate and DNA enzyme leading to peptide-sequence selectivity. 
 
Figure 3.11. Peptide substrate mutations to determine the peptide sequence requirements of the 
deoxyribozymes. Phosphorylation yields at 48 h are shown for TyrKinA1, TyrKinA2, and 
TyrKinB1. Each deoxyribozyme was assayed with the series of DNA-anchored peptide 
substrates indicated (n = 5-8 for original sequence peptides and n = 3 for mutant peptides, mean 
± sd). Figure reprinted with permission from Ref. 47. 
Efforts by Puzhou Wang for DNA-catalyzed tyrosine adenylylation using diverse peptide 
sequences during the selection experiments led to the identification of the peptide motif-specific 
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deoxyribozyme DzAz2.52 Separate selection experiments were performed with four unique 
peptide sequences. Selections with three of the peptides led to the identification of only peptide-
sequence general deoxyribozymes. Four of the five deoxyribozymes identified with the fourth 
peptide sequence, CLQTYPRT, were general or partially selective, and only one deoxyribozyme 
DzAz2 was highly selective for the YPR motif. Similar to the peptide sequence-specific tyrosine 
kinase deoxyribozymes, the peptide sequence-specific tyrosine adenylylation deoxyribozyme 
DzAz2 did not catalyze the adenylylation of untethered peptide substrates. 
3.3 Summary and Future Directions 
Presenting a variety of side chains within the peptide substrate during the selection can 
lead to deoxyribozymes that are peptide-sequence-selective. In the context of a DNA-anchored 
peptide substrate, these results show that DNA catalysts can interact tightly with peptide 
substrates, even though strong interactions are not required for substrate binding. The peptide-
sequence selectivity of the previous nucleopeptide-forming deoxyribozymes combined with the 
current tyrosine kinase and adenylylation deoxyribozymes indicate that using peptide substrates 
of varied sequence during in vitro selection fosters emergence of peptide-sequence-selective 
DNA catalysts. The observation of three distinct peptide sequence motifs for the different 
tyrosine kinase deoxyribozymes demonstrates that DNA enzymes can interact in different ways 
with the same peptide sequence. The short motifs of 2-4 amino acids suggest the practical utility 
of peptide-modifying deoxyribozymes.  
These results show that DNA enzymes are capable of interacting specifically with peptide 
substrates, and peptide-sequence selectivity is not limited to one type of DNA-catalyzed reaction. 
While some peptide-sequence-specific deoxyribozymes were identified, not all peptide 
sequences used in selection led to the identification of highly selective deoxyribozymes. More 
experiments are required to understand the relationship between the peptide sequence and the 
selectivity of the emergent deoxyribozymes. No selection pressure was imposed to require 
89 
peptide-sequence selectivity. Therefore, the deoxyribozymes can interact with the peptide 
substrate, but tight interactions are not required. Kinase deoxyribozymes with peptide-sequence 
selectivity did not catalyze the phosphorylation of untethered peptide substrates, and this remains 
a focus for kinase deoxyribozymes.  
3.4 Materials and Methods 
3.4.1 Substrate Preparation Procedures 
Oligonucleotides, peptides, and DNA-anchored peptide conjugates were prepared as 
described in Chapter 2.  
Table 3.1: Oligonucleotide sequences of the pools, substrates, and primers used in the selection 
experiments. 
oligonucleotide purpose oligonucleotide sequence 
  
Selections with Peptide Sequence CMTGYVAT 
DNA-HEG-CMTGYVAT substrate GGATCAGGTTACTAATTAT-HEG-CMTGYVAT 
pppRNA phosphoryl donor pppGGAAUGAUAAUCUAUGG 
forward primer for selection CGAAATAGATTATCATTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAAATAGATTATCATTC-NX-ATAATTAGTAACCTGAAGCTGATCCTGATGG 
splint for ligation step during selection ATAATTAGTAACCTGATCCCCATCAGGATCAGCTTCAGGTTACTAATTAT 
  
Selections with Peptide Sequence CADPYDQS 
DNA-HEG-CADPYDQS substrate GGATCCTGGATACAAATAT-HEG-CADPYDQS 
pppRNA phosphoryl donor pppGGAACAGGUUUAUACGG 
forward primer for selection CGAAGTATAAACCTGTTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAAGTATAAACCTGTTC-NX-ATATTTGTATCCAGGAAGCTGATCCTGATGG 
splint for ligation step during selection ATATTTGTATCCAGGATCCCCATCAGGATCAGCTTCCTGGATACAAATAT 
  
3.4.2 In Vitro Selection Procedures 
Procedures for ligation, selection, and PCR were performed as described in Chapter 2. 
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Procedure for the preclear step in every third round. To prevent the enrichment of 
noncatalytic DNA sequences capable of binding either the pTyr antibody or protein A agarose, 
an additional preclear step was included in every third round beginning with round 1. After the 
ligation step and prior to the selection step, the preclear step was performed using the same 
procedure as the capture step (described below), except that the wash fraction was collected and 
taken onward to the selection step. 
Procedure for phosphotyrosine antibody capture step in all rounds. Low-retention 
microcentrifuge tubes were treated by allowing to stand overnight with 2 mL of 5% (w/v) 
poly(ethylene glycol) (PEG, average molecular weight 3,350) and rinsing with 3 × 1 mL of 
water. All centrifugation steps were performed at 1000×g for 1 min. After the selection step (37 
°C, 14 h), the sample was precipitated with ethanol and redissolved in a PEG-treated tube to 10 
µL containing 25 mM Tris, pH 7.2, 150 mM NaCl, 2 mM EDTA, 0.01% Triton X-100, 50 pmol 
DNA oligonucleotide (AAC)20 [as a sacrificial oligo to suppress adhesion of DNA pool 
molecules], 2 µg pTyr antibody (Thermo Scientific Pierce PY20). To this sample was added 25 
µL of protein A agarose suspension (Thermo Scientific Pierce), previously buffer-exchanged to 
water by centrifugation and washing (3 × 500 µL). Protein A binds to the constant Fc region of 
the PY20 antibody. The 35 µL sample was shaken on a vortexer at the lowest setting for 1 h at 
room temperature, transferred to a spin column, centrifuged, and washed with 3 × 50 µL of 25 
mM Tris, pH 7.2, and 150 mM NaCl. The washes were combined into a single wash fraction. At 
this point, the catalytic DNA pool sequences that phosphorylated their attached peptide were 
bound to the agarose-immobilized antibody, whereas other DNA sequences had been washed 
away. The bound sequences were centrifugally eluted with 3 × 50 µL of 8 M urea, which were 
combined into a single elution fraction (each portion of urea solution was allowed to stand in the 
spin column for 5 min at room temperature before centrifugation). Scintillation counting of the 
wash and elution fractions was used to quantify selection activity. The elution fraction was 
precipitated with ethanol and taken onward to the PCR step of the in vitro selection procedure.  
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3.4.3 Cloning and Screening 
Cloning and screening were performed as described in Chapter 2. 
Table 3.2: Names and clone numbers of deoxyribozymes identified from the RN1, RP1, and RJ1 
selection experiments.  
deoxyribozyme clone 
TyrKinA1 6RN101 
TyrKinA2 6RN109 
TyrKinA3 6RN108 
TyrKinB1 7RP108 
TyrKinB2 7RP110 
TyrKinC1 9RJ101 
  
3.4.4 Deoxyribozyme Activity Assay Procedure 
The DNA-anchored hexapeptide substrate was 5′-32P-radiolabeled using γ-32P-ATP and 
T4 polynucleotide kinase (Fermentas), using 10× buffer that lacks DTT (500 mM Tris, pH 7.6, 
100 mM MgCl2, and 1 mM spermidine). A 10 µL sample containing 0.25 pmol of 5′-32P-
radiolabeled DNA-anchored peptide substrate, 10 pmol of deoxyribozyme, and 20 pmol of 
pppRNA phosphoryl donor was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The DNA-catalyzed 
phosphorylation reaction was initiated by bringing the sample to 20 µL total volume containing 
70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl. The 
Mn2+ was added from a 10× stock solution containing 200 mM MnCl2. The Zn2+ was added from 
a 10× stock solution containing 10 mM ZnCl2, 10 mM HNO3, and 100 mM HEPES at pH 7.5; 
this stock solution was freshly prepared from a 200× stock of 100 mM ZnCl2 in 200 mM HNO3. 
The metal ion stocks were added last to the final sample, which was divided into 2 µL aliquots 
that were all incubated at 37 °C. At appropriate time points, 2 µL aliquots were quenched with 5 
µL stop solution (80% formamide, 1× TBE [89 mM each Tris and boric acid and 2 mM EDTA, 
pH 8.3], 50 mM EDTA, 0.025% bromophenol blue, 0.025% xylene cyanol). For assays with the 
DNA-anchored CKVIYDFI substrate, in addition to the 5′-32P-radiolabeled substrate, 20 pmol of 
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unrelated 5′-phosphorylated DNA oligonucleotide and 1 nmol of free peptide were added to 
suppress loss of signal due to nonspecific binding of the substrate to the microcentrifuge tube. 
Samples were separated by 20% PAGE and quantified with a PhosphorImager. Values of kobs 
were obtained by fitting the yield versus time data directly to first-order kinetics; i.e., yield 
Y = Ymax•(1 – e–kt), where k = kobs and Ymax is the final yield. Errors in kobs values were calculated 
as the standard deviation from the indicated number of independent determinations. 
3.4.5 Mass Spectrometry 
The DNA-anchored CAAYPAA phosphorylation product was prepared from a 10 µL 
sample containing 300 pmol of DNA-anchored HEG-tethered CAAYOHAA substrate, 350 pmol 
of deoxyribozyme, and 400 pmol of pppRNA phosphoryl donor, which were annealed in 5 mM 
HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on 
ice for 5 min. The DNA-catalyzed phosphorylation reaction was initiated by bringing the sample 
to 20 µL total volume containing 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM 
MgCl2, and 150 mM NaCl. The sample was incubated at 37 °C for 14 h. The sample was 
desalted by Millipore C18 ZipTip and analyzed by MALDI mass spectrometry (Bruker 
UltrafleXtreme; matrix 3-hydroxypicolinic acid). 
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Chapter 4: Efforts towards Untethered Peptide Reactivity† 
4.1 Introduction 
4.1.1 Deoxyribozymes with Untethered Peptide Reactivity 
DNA enzymes with the ability to catalyze modification of untethered peptide and protein 
substrates will expand the applications of deoxyribozymes. These site-specifically modified 
peptides and proteins can then be studied to determine their biological function. Development of 
methods to identify DNA catalysts with the ability to catalyze the reaction of untethered peptides 
will be valuable in pursuit of peptide and protein modification. 
4.1.1.1 In Vitro Selection with Tethered Peptide Substrates 
Deoxyribozymes with phosphatase activity (hydrolysis of phosphorylated amino acid 
side chains) have been identified.1 In vitro selection experiments to identify phosphatase 
deoxyribozymes were performed using HEG-tethered peptide substrates. Some of the 
phosphatase deoxyribozymes were able to dephosphorylate untethered peptide substrates. 
Therefore, they did not require the tether that was present during the in vitro selection. Similarly, 
nucleopeptide formation,2 phosphoserine lyase3 and tyrosine adenylylation4 deoxyribozymes 
were identified from selection experiments in which HEG-tethered peptide substrates were used. 
                                                            
† University of Illinois graduate student Chi-Chih Chu performed selections for nucleopeptide-
forming deoxyribozymes with untethered peptides and performed experiments to phosphorylate 
untethered, His-tagged tyrosine-containing peptide substrates.9,33 
University of Illinois graduate student Cong Zhou identified deoxyribozymes containing 
modified nucleotides for amide hydrolysis.15 
University of Illinois undergraduate student Stephanie N. Konecki performed selections to 
evolve nucleopeptide-forming deoxyribozymes into kinase deoxyribozymes and initiated 
selection experiments to identify kinase deoxyribozymes with carboxyl and amino modifications. 
University of Illinois undergraduate student Tiyaporn Tangpradabkul performed selections to 
identify kinase deoxyribozymes with carboxyl and amino modifications. 
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For each of these reactions, at least one deoxyribozyme identified was able to catalyze the 
reaction of untethered peptide substrates.  
Unfortunately, the kinase deoxyribozymes identified via a similar in vitro selection 
method using HEG-tethered peptide substrates all require the DNA-anchored HEG-tethered 
peptide substrate (Chapter 2, 3).5 Similarly, deoxyribozymes for lysine modification also require 
tethered peptide substrates.6 Therefore, the use of HEG-tethered peptide substrates during 
selection experiments may lead to deoxyribozymes able to react with untethered peptide 
substrates in some cases, but untethered peptide reactivity is not required to survive the selection 
experiment.  
4.1.1.2 In Vitro Selection with Untethered Peptides 
Initial efforts for DNA-catalyzed peptide modification focused on nucleopeptide 
formation, particularly the reaction of a nucleophilic tyrosine or serine side chain with the α-
phosphate of a 5′-triphosphorylated RNA oligonucleotide, resulting in attachment of the RNA 
oligonucleotide to the amino acid side chain. The first efforts for DNA-catalyzed amino acid side 
chain modification used amino acids embedded within a DNA oligonucleotide, and this substrate 
was bound to the deoxyribozyme via a 3-helix junction.7,8 Subsequent efforts moved to a less 
structured, open conformation in which the peptide substrate was tethered to a DNA anchor 
oligonucleotide.2 Using this open conformation enabled peptides to be attached via different 
tether lengths. The resulting deoxyribozymes, while selected with a tethered substrate, were able 
to modify untethered peptide substrates, albeit only at high peptide concentrations (1 mM). 
To improve upon this outcome, subsequent in vitro selection experiments were performed 
by Chih-Chi Chu using untethered peptide substrates (Figure 4.1).9 The 5′-triphosphorylated 
RNA oligonucleotide (pppRNA) was ligated to the pool, and upon DNA-catalyzed nucleopeptide 
formation the peptide was attached to the RNA oligonucleotide that was connected to the DNA 
sequence that catalyzed its reaction. The catalytically active DNA sequences were then separated 
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by reaction of an azide on the N-terminus of the peptide with an alkyne-modified 
oligonucleotide, enabling a PAGE shift.  
 
Figure 4.1. In vitro selection to identify deoxyribozymes with untethered peptide reactivity for 
nucleopeptide formation. The untethered peptide substrate has an N-terminal C6-tethered azido 
group. During the selection step, the active DNA sequences catalyzed the attachment of the 
peptide to the pppRNA. The active DNA sequences were then captured by a DNA-splinted 
reaction of the azide with a 3′-alkyne oligonucleotide, resulting in PAGE-shift separation from 
the inactive DNA sequences. Figure adapted with permission from Ref. 9.  
This in vitro selection method enabled identification of DNA catalysts with the ability to 
modify untethered peptides and have lower Km(peptide) than the previously identified 
nucleopeptide-forming deoxyribozymes. In vitro selection of DNA enzymes requires that the 
desired product is attached to the DNA sequence that catalyzed its reaction. Therefore, this 
selection method using untethered peptide substrates cannot be applied to selection experiments 
for peptide phosphorylation. If the peptide is free in solution, successful phosphorylation will 
result in the transfer of a γ-phosphate from a phosphoryl donor to the peptide, and the 
phosphopeptide product will not remain associated with the catalytic DNA sequence. Therefore, 
the peptide substrate must be tethered to the DNA pool during selection experiments for kinase 
deoxyribozymes. The use of loosely tethered peptide substrates may be similar to untethered 
peptide substrates. While HEG tethers are sufficient to identify deoxyribozymes with untethered 
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peptide reactivity in some cases, longer tethers may be needed to more reliably mimic untethered 
peptides. 
4.1.2 Modified Nucleotides Incorporated into Deoxyribozymes and Aptamers 
4.1.2.1 Modifications for Improved Scope of DNA Catalysis 
Proteins are the most common biological catalysts, and they contain diverse functional 
groups that are not present in nucleic acids. Incorporation of protein-like functional groups into 
deoxyribozymes has been achieved via modified nucleotides. DNA-catalyzed RNA cleavage via 
transesterification has been achieved with natural nucleotides. However, the incorporation of 
modified nucleotides reduces the divalent metal ion requirements of the resulting 
deoxyribozymes, which is important for biological applications (Figure 4.2).10-14 DNA catalysts 
requiring reduced or no divalent metal ions were identified by incorporating modified 
nucleotides with a primary amino, imidzaolyl, or guanidinium group. Up to three modified 
nucleotides have been successfully incorporated into a DNA pool and used to identify 
deoxyribozymes that catalyze RNA cleavage.  
 
Figure 4.2. The Dz925-11 deoxyribozyme that catalyzes RNA cleavage in a divalent metal ion 
independent manner. The deoxyribozyme contains imidazolyl-modified dA and amino-modified 
dU. Figure adapted with permission from Ref. 10.  
Separately, the incorporation of modified nucleotides has led to the identification of DNA 
catalysts that hydrolyze amide bonds, which was previously not possible with only natural DNA 
nucleotides (Figure 4.3).15 Modified nucleotides were 5-substituted 2′-deoxyuridine derivatives 
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with a primary amino, carboxyl, hydroxyl, or imidazolyl group characteristic of lysine, 
aspartate/glutamate, serine, and histidine residues, respectively. Amide-cleaving deoxyribozymes 
were identified from separate selection experiments with the amino, carboxyl, and hydroxyl 
modifications. In this case, the incorporation of modified nucleotides led to the identification of 
deoxyribozymes to catalyze a reaction that was previously unsuccessful with natural nucleotides. 
Therefore, the modifications were required to identify DNA enzymes for this reaction. 
 
Figure 4.3. Identification of deoxyribozymes containing modified nucleotides for amide bond 
hydrolysis. The substrate had an amide bond embedded between two DNA oligonucleotide 
strands that base-paired to the fixed DNA sequences flanking the initially random region. 
Amino-modified dU (AmdU), carboxyl-modified dU (COOHdU), or hydroxyl-modified dU (HOdU) 
was incorporated into the initially random region of the DNA pool in place of dT. Amide-
cleaving DNA enzymes were identified from each selection experiment. PAGE image shows 
cleavage of the amide substrate by the AmdU-modified AmideAm1 deoxyribozyme. Figure 
adapted with permission from Ref. 15.  
4.1.2.2 Modifications for Improved Protein Binding 
DNA aptamers have been identified to bind to many protein substrates. To increase the 
binding affinity between the aptamer and protein substrate, DNA aptamers with hydrophobic 
modifications have been identified (Figure 4.4A).16,17 In many cases unmodified aptamers have 
weak binding affinities (Kd > 100 nM), and upon incorporation of hydrophobic modifications, 
selection experiments result in the identification of aptamers with stronger binding affinities with 
103 
dissociation constants in the low nanomolar range. These aptamers are called slow off-rate 
modified aptamers (SOMAmers) due to their increased binding affinity. The SOMAmers were 
optimized by minimizing the sequence to only the required nucleotides and testing the identity of 
the hydrophobically modified nucleotides. SOMAmers for platelet-derived growth factor BB 
(PDGF-BB) and Interleukin-6 (IL-6) were identified from N40 initially random regions and 
respectively contained 9 and 10 benzyl-modified nucleotides (BndU).18,19 Optimization resulted in 
the 24 nt PDGF-BB SOMAmer SL5 with 8 hydrophobically modified residues and Kd = 0.02 
nM, while the 32 nt IL-6 SOMAmer SL1025 contains 10 hydrophobically modified residues and 
Kd = 0.2 nM. SOMAmers SL5 and SL1025 were crystallized bound to their respective protein 
targets.18,20 Crystal structures of the SOMAmer-protein complexes revealed that the 
hydrophobically modified residues within the aptamers are interacting via hydrophobic 
interactions with their respective protein substrates. The 8 modified residues of SL5 have 
hydrophobic interactions with 24 PDGF-BB residues, and the 10 modified residues of SL1025 
have hydrophobic interactions with 11 IL-6 residues.  
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Figure 4.4. (A) Hydrophobic modifications at the 5-position of deoxyuridine. Side chain 
abbreviations: Bn, benzyl; Pe, 2-phenylethyl; Pyr, 4-pyridinylmethyl; Nap, 1-naphthylmethyl; 
Trp, 3-indole-2-ethyl; iBu, isobutyl. (B) Binding affinities of SELEX libraries selected for 
binding to the 14 different proteins indicated with either unmodified, Bn-modified, iBu-
modified, or Trp-modified DNA. Binding affinities are shown (Kd, nM). Figure adapted with 
permission from Ref. 17.  
Since hydrophobic modifications improve binding between DNA aptamers and protein 
substrates, incorporating hydrophobic modifications into DNA enzymes may similarly improve 
the binding affinity between the deoxyribozyme and the peptide or protein substrate. This 
improved binding may enable deoxyribozymes to catalyze the reaction of untethered peptide 
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substrates. Selection experiments were performed to identify aptamers for 14 protein targets with 
various hydrophobic modifications (Figure 4.4B).17 Using natural nucleotides, aptamers with Kd 
<100 nM were identified for only 2 of the 14 protein targets. The incorporation of BndU or 
isobutyl-modified nucleotides (iBudU) led to tight-binding aptamers for 9 and 7 of the 14 protein 
targets, respectively. Incorporation of a tryptamine-modified nucleotide (TrpdU) led to the 
identification of aptamers with Kd values of 0.05-7 nM with all 14 proteins. Based on the 
evaluation of these different hydrophobic modifications, the incorporation of TrpdU most often 
led to the identification of tight-binding aptamers. Therefore, the incorporation of TrpdU 
modifications into DNA enzymes may result in improved binding between the deoxyribozyme 
and peptide or protein substrates. 
4.2 Results and Discussion 
4.2.1 Use of Long Tethers to Mimic Untethered Peptides 
To identify kinase deoxyribozymes, the phosphopeptide product must be connected to the 
deoxyribozyme that catalyzed the reaction, and therefore a tethered peptide substrate must be 
used. However, deoxyribozyme-catalyzed untethered peptide reactivity is desired. In vitro 
selection experiments performed can be performed with a long tether between the peptide 
substrate and the DNA anchor oligonucleotide base-paired to the binding arm flanking the 
initially random region of the DNA pool. If a sufficiently long tether is present, then the peptide 
substrate will essentially be untethered with respect to the deoxyribozyme.  
4.2.1.1 Selection for New Phosphopeptide Capture Deoxyribozymes 
To enable selection experiments for kinase deoxyribozymes with long tethers, a method 
to separate the catalytically active deoxyribozymes from the inactive DNA sequences is needed. 
The capture deoxyribozyme 8VP1 was identified to catalyze nucleopeptide formation between a 
phosphotyrosine residue in a peptide substrate and an RNA oligonucleotide.21 The 8VP1-
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catalyzed capture yield of HEG-tethered CAAYPAA is 45%, and the 8VP1 capture method was 
used successfully in selection experiments performed with HEG-tethered peptide substrates.5,22 
The 8VP1 capture deoxyribozyme was evaluated for its ability to catalyze the reaction of 
phosphopeptides connected to the DNA anchor via longer tethers (Figure 4.5). When the tether 
length was increased to HEG3, HEG6, or HEG10, the capture yield decreased to 20%, 15%, and 
5%, respectively. Capture yield <15% is not reliable for use during in vitro selection 
experiments.  
 
Figure 4.5. Dependence of the 8VP1 deoxyribozyme on the length of the tether between the 
DNA anchor and CAAYPAA hexapeptide substrate. The structures of the tethers between the 
DNA anchor and peptide substrate are shown. Capture was evaluated for longer HEG3, HEG6, 
and HEG10-tethered phosphopeptide substrates. The plot shows capture yield at t = 16 h (mean ± 
sd, n = 3). Incubation conditions were 50 mM HEPES, pH 7.5, 20 mM MnCl2, and 150 mM 
NaCl at 37 °C.  
To enable in vitro selection for tyrosine kinase deoxyribozymes using longer HEG10-
tethered peptide substrates, a new capture deoxyribozyme similar to 8VP1 was needed. 8VP1 
was identified by in vitro selection using HEG-tethered CAAYPAA with 20 mM MnCl2 and 40 
mM MgCl2 at pH 7.5, but had slightly higher yield at 16 h with 20 mM MnCl2 alone. Therefore, 
in vitro selection experiments were performed to identify capture deoxyribozymes that catalyze 
nucleopeptide formation between a HEG6 or HEG10-tethered CAAYPAA peptide substrate and a 
5′-triphosphorylated RNA oligonucleotide (Figure 4.6). The initial pool was either a random N40 
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population or a partially randomized N40 population based on 8VP1 (25% randomization). 
Selection experiments were performed at pH 7.5 with the following conditions: HY1 = 20 mM 
MnCl2, 40 mM MgCl2; HZ1 = 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2; LA1 = 20 mM 
MnCl2 alone. Unfortunately, none of these selection experiments led to the identification of 
deoxyribozymes capable of catalyzing nucleopeptide formation with the increased tether length. 
Since these selection experiments for new capture deoxyribozymes were unsuccessful, other 
phosphopeptide capture methods were evaluated. 
 
Figure 4.6. Design for the HY1, HZ1, and LA1 in vitro selection experiments to identify 
phosphotyrosine capture deoxyribozymes. In all selections, the CAAYPAA peptide substrate was 
connected to a DNA anchor via a disulfide bond and a HEG6 or HEG10 as indicated. The pool 
was partially randomized based on 8VP1 for HY1, and an N40 random pool for HZ1 and LA1. 
The selection step was performed at 37 °C for 14 h in the indicated conditions. 
4.2.1.2 Selection for Tyrosine Kinase Deoxyribozymes Using HEG6-Tethered Peptides 
Based on the limitations of the 8VP1 deoxyribozyme, the HEG6 tether is the longest that 
can be used with acceptable capture yield (~15%) during kinase deoxyribozyme selection 
experiments. Therefore, the KS1-KV1 selection experiments were designed using a HEG6-
tethered peptide substrates with pppRNA or 100 µM ATP as the phosphoryl donor (Figure 4.7). 
For KT1, the CAKKYKKA peptide contains multiple positively charged lysine (K) residues that 
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may increase binding interactions between the peptide substrate and the negatively charged DNA 
backbone of the deoxyribozyme. This increased binding affinity may result in untethered peptide 
reactivity. All selection experiments were performed at pH 7.5 with 1 mM ZnCl2, 20 mM MnCl2, 
and 40 mM MgCl2. Selection experiments were continued through round 15, but no activity was 
observed. Based on these results, the inability to identify kinase deoxyribozymes may be because 
deoxyribozymes were not able to interact with the peptide substrate or the low 8VP1 capture 
yield did not enable sufficient enrichment of the catalytic DNA sequences. 
 
Figure 4.7. Design for the KS1-KV1 in vitro selection experiments to identify tyrosine kinase 
deoxyribozymes. In all selections, the initially random region was N40, and the peptide substrate 
was connected to a DNA-anchor via a disulfide bond and a HEG6 tether. The peptide substrate 
and phosphoryl donor are indicated. The selection step was performed in 70 mM HEPES, pH 
7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h. 
Untethered peptide reactivity is observed with some of the nucleopeptide-forming 
deoxyribozymes that have been identified.2,9 While the use of untethered peptides during in vitro 
selection cannot be applied to the selection of kinase deoxyribozymes, nucleopeptide formation 
and phosphorylation are similar reactions. Phosphorylation is the reaction of the tyrosine side 
chain hydroxyl group with the γ-phosphate of a triphosphoryl donor, whereas nucleopeptide 
formation is reaction with the α-phosphate of the triphosphoryl donor (Figure 4.8). The 
nucleopeptide-forming deoxyribozymes 15MZ36, 8XJ105, and 11EM103 can catalyze the 
reaction of untethered peptide substrates (15MZ36 and 8XJ105 with AYA; 11EM103 with 
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GPYSGN). If these nucleopeptide-forming deoxyribozymes with untethered peptide reactivity 
are evolved to catalyze the reaction of the γ-phosphate instead of the α-phosphate, thus 
phosphorylating tyrosine within a peptide substrate, then they may retain their ability to catalyze 
the modification of untethered peptides. 
 
Figure 4.8. Reactions of phosphoryl donor substrates (5′-triphosphorylated RNA or NTP, where 
X = RNA or N). In nucleopeptide formation, the nucleophilic hydroxyl of the tyrosine side chain 
attacks the α-phosphate of the triphosphoryl donor. Phosphorylation results from nucleophilic 
attack of the hydroxyl of the tyrosine side chain at the γ-phosphate. To evolve nucleopeptide-
forming deoxyribozymes, a partially randomized pool based on the nucleopeptide-forming 
deoxyribozyme sequence was prepared. In vitro selection was performed to select for kinase 
deoxyribozymes from the partially randomized pool. 
Selection experiments for kinase deoxyribozymes were performed with a partially 
randomized pool (25% randomization) based on the sequence of the parent nucleopeptide-
forming deoxyribozyme 15MZ36, 8XJ105, or 11EM103. Peptide substrates used by the parent 
deoxyribozyme were connected to the pool via a HEG6 tether and a DNA anchor. Selection 
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conditions were 70 mM HEPES, pH7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 
mM NaCl at 37 °C for 14 h. In each round, active deoxyribozymes connected to the 
phosphorylated peptide products were captured using the 8VP1 capture deoxyribozyme with 
~15% yield. Unfortunately, none of these selection experiments led to the identification of kinase 
deoxyribozymes. These results indicated one of three likely explanations. First, the population 
could not be evolved to phosphorylate peptides. Second, the DNA enzymes were unable to 
phosphorylate peptides connected via a longer HEG6 tether. Third, the ~15% 8VP1 capture yield 
did not enable sufficient enrichment of the catalytically active DNA sequences.  
4.2.1.3 Selection for Tyrosine Kinase Deoxyribozymes Using HEG10-Tethered Peptides 
The 8VP1 capture deoxyribozyme exhibits a decrease in capture yield as the length of the 
tether between the DNA-anchor and peptide substrate increases (Figure 4.5). Therefore, to use 
longer tethers in kinase deoxyribozyme selection experiments, a different capture method was 
required. The phosphotyrosine antibody capture method is independent of the length of the tether 
between the peptide substrate and DNA anchor (Chapter 3), new kinase deoxyribozyme selection 
experiments NR1-NZ1 were designed with DNA-anchored HEG10-tethered CAAYAA peptide 
substrates. Each of N40, N60, and N80 initially random region lengths were used with pppRNA as 
the phosphoryl donor, and N60 and N80 initially random region lengths were used with 100 µM 
ATP as the phosphoryl donor (Figure 4.9). In two additional selection experiments with either 
N60 or N80 initially random region lengths, the peptide substrate was alternately anchored to 
either the left or right binding arm in successive selection rounds, and 100 µM ATP was used as 
the phosphoryl donor. The goal of using the long HEG10 tether was to mimic an untethered, free 
peptide substrate. By alternating the peptide anchoring site, the peptide substrate was the only 
constant part of the substrate in all rounds. Any resulting deoxyribozymes will hopefully interact 
only with the peptide and catalyze the phosphorylation of untethered peptide substrates. The 
preclear step was performed every round. A control selection experiment was performed with a 
HEG-tethered peptide substrate to validate the new immunoprecipitation selection method. All 
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selections were performed in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM 
MgCl2 and 150 mM NaCl at 37 °C for 14 h.  
 
Figure 4.9. Design for the NR1-NZ1 in vitro selection experiments to identify tyrosine kinase 
deoxyribozymes. In all selections, the peptide substrate CAAYAA was connected to a DNA 
anchor via a disulfide bond and a HEG10 tether. NR1 was the sole exception with a shorter HEG 
tether instead. Initially random region lengths are indicated. The phosphoryl donor was pppRNA 
or 100 µM ATP for NR1-NV1 and NW1-NZ1, respectively. For the NY1-NZ1 selections, the 
DNA-anchored peptide substrate was bound to the opposite binding arm in successive selection 
rounds. The selection step was performed in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM 
MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h. 
No activity was observed for any of these selection experiments after 12 rounds. This was 
particularly surprising for the NR1 selection, because the same design had been successful when 
the 8VP1 capture method was used. To investigate the lack of NR1 activity, after nine rounds of 
selection, the preclear step was no longer included. The selection was continued eight more 
rounds, and 6% activity was observed in round 14 (Figure 4.10A). The round 14 and 15 pool was 
assayed in trans (without the substrate ligated to the pool), and phosphorylation of the DNA-
anchored peptide substrate was observed. A parallel selection effort, NR1b, was performed in 
112 
which the preclear step was performed only in round 1. After nine rounds of selection 4% 
activity was observed, and phosphorylation of the DNA-anchored peptide substrate was verified 
in trans (Figure 4.10B). The active DNA sequences were enriched significantly slower when the 
preclear step was included for many rounds compared to the selection experiment in which only 
the first round included the preclear step. These results also show that after the preclear step was 
no longer included, DNA aptamer sequences did not take over the population and prevent the 
enrichment of catalytic DNA sequences. Therefore, in subsequent selection experiments using 
the phosphotyrosine immunoprecipitation capture method would not incorporate the preclear 
step every round. 
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Figure 4.10. Selection progression and in trans assay of the pool for several variants of the NR1 
selection experiment. In each round, “control” refers to the yield for the pTyr 
immunoprecipitation capture reaction using a CAAYPAA substrate, and the selection experiment 
is indicated. (A) Progression of the initial NR1 selection experiment. The preclear step was 
performed during rounds 1-9 and not performed during rounds 10-17. The PAGE image shows 
the in trans assay of the NR1 pool at round 14 and 15 (t = 30 s, 2 h, 16 h). The pool catalyzes 
phosphorylation of the DNA-anchored peptide substrate only when the phosphoryl donor 
pppRNA (indicated as “ppp”) is present. In 16 h, 14% and 28% phosphorylation yield were 
observed for the round 14 and 15 pools, respectively. (B) Progression of the NR1b selection 
experiment. The preclear step was performed only during round 1 and not performed during 
rounds 2-9. The PAGE image shows the in trans assay of the NR1b pool at round 8 and 9 (t = 30 
s, 2 h, 16 h). In 16 h, 5% and 44% phosphorylation yield were observed for the round 8 and 9 
pool, respectively. 
Deoxyribozymes were not identified from any of the selection experiments in which 
tethers longer than HEG were used. Therefore, the tether dependence was evaluated for the 
nucleopeptide-forming 8XJ105 deoxyribozyme that was identified from a selection experiment 
using untethered peptide substrates (Figure 4.11). Use of a tethered peptide substrate was 
expected to result in an increased yield compared to an untethered peptide substrate, and the 
peptide substrate connected via a longer tether was expected to react similarly to the untethered 
peptide substrate. As expected with the untethered peptide substrate, 8XJ105 catalyzed 
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nucleopeptide formation in 30% yield. The nucleopeptide formation yield increased to 50% with 
the DNA-anchored HEG-tethered peptide substrate. Surprisingly, the HEG6 and HEG10-tethered 
peptide substrates were modified with only <5% yield. These results suggested that the initial 
hypothesis was incorrect; and increasing the length of the tether between the DNA anchor and 
peptide substrate did not mimic an untethered peptide substrate. The long tether was not inert as 
expected and instead prevented the 8XJ105 deoxyribozyme from catalyzing the reaction of the 
peptide substrate. These results are similar to those observed for the 15MZ36 deoxyribozyme as 
well.2 15MZ36 catalyzed nucleopeptide formation in 75%, 60%, and 10% yield with C3-tethered, 
HEG-tethered, and untethered CYA, respectively. However, HEG10-tethered CYA was not 
modified by 15MZ36. Combined, these results suggest that the use of tethers longer than HEG 
interfere with DNA-catalyzed peptide modification. On this basis, the use of tethers longer than 
HEG during selection experiments was discontinued. 
 
Figure 4.11. The tether dependence of the nucleopeptide-forming 8XJ105 deoxyribozyme. 
Untethered and tethered peptide substrates were evaluated. 8XJ105 successfully catalyzes the 
reaction of a free peptide and HEG-tethered peptide substrate. However, peptide substrates 
connected via a HEG6 or HEG10 tether were not accepted as substrates. 
4.2.2 Incorporation of Modified Nucleotides into Kinase Deoxyribozymes 
Since long tethers between the peptide substrate and DNA anchor oligonucleotide does 
not mimic untethered peptide substrates, a new method to find deoxyribozymes with untethered 
peptide reactivity was needed. Hydrophobic modifications on nucleobases improve aptamer 
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binding affinity to proteins through an increased number of hydrophobic interactions.16-20 
Incorporation of these hydrophobic modifications into deoxyribozymes may increase the binding 
interaction between the peptide substrate and deoxyribozyme, leading to untethered peptide 
reactivity. Based on the hydrophobic aptamer data available, Trp-modified DNA led to aptamers 
with tight binding affinity to all 14 protein substrates evaluated (Figure 4.4).17 Therefore, kinase 
deoxyribozymes with modified TrpdU were sought. 
4.2.2.1 Synthesis and Purification of TrpdUTP 
The Trp-modified dUTP was synthesized to be incorporated into the DNA pool (Figure 
4.12). The synthesis of TrpdUTP was similar to the synthesis of ImdUTP performed by Cong 
Zhou. Tryptamine was condensed with the commercially available NHS-activated COOHdU [(E)-
5-(2-carbomethoxyvinyl)-2′-deoxyuridine N-hydroxysuccinimide ester], and the Trp-modified 
nucleoside was chromatographically purified. For incorporation into the DNA pool by primer 
extension, the modified nucleotide triphosphate was needed. The TrpdU nucleoside was 
triphosphorylated and purified by HPLC to yield the 5′-triphosphorylated Trp-modified 
nucleotide. Primer extension incorporating the TrpdUTP product was successful, and an in vitro 
selection method to identify tyrosine kinase deoxyribozymes was developed to incorporate TrpdU 
into the DNA pool. 
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Figure 4.12. Synthesis of TrpdUTP. Commercially available NHS-activated COOHdU was 
condensed with tryptamine. The purified TrpdU was 5′-triphosphorylated and purified to yield 
TrpdUTP for incorporation into the DNA pool via primer extension. 
4.2.2.2 Expression of KOD Polymerase 
KOD polymerase from Thermococcus kodakaraensis has high accuracy and processivity 
in DNA replication.23,24 KOD XL (Novagen) is a commercially available mixture of wild-type 
KOD polymerase and the KOD exonuclease minus (exo–) mutant polymerase. KOD XL has been 
used during in vitro selection experiments for aptamers with hydrophobic modifications16 and 
deoxyribozymes in which modified nucleotides are incorporated.15 This includes the selection 
experiments performed in the Silverman lab by Cong Zhou to identify modified deoxyribozymes 
for amide hydrolysis that incorporated the modified nucleotides AmdU, ImdU, COOHdU, and HOdU. 
Of the polymerases tested, KOD XL polymerase also led to the highest primer extension yield 
with TrpdU. KOD XL is known to be a mixture of the wild-type KOD polymerase and KOD exo– 
polymerase, but the composition of the mixture is unknown. In the literature, KOD Dash 
polymerase is a 40:1 mixture of KOD exo– and wild-type KOD polymerase.24 Therefore, the 
KOD polymerase and KOD exo– polymerase genes were synthesized, incorporated into 
plasmids, expressed, purified, and the optimal polymerase mixture determined for use in primer 
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extension and PCR during in vitro selection for deoxyribozymes that contain modified 
nucleotides. 
Expression plasmids containing the polymerase genes were synthesized (Figure 4.13). 
The introns from the full-length KOD polymerase gene (GenBank D29671.2) were combined, 
and the gene was codon-optimized for expression in E. coli.25 The full-length KOD polymerase 
gene was constructed from two IDT gBlock gene fragments that were double-stranded, 
sequence-verified genomic blocks. The first gBlock contained the first half of the gene and a 
NdeI restriction site at the beginning. The second gBlock contained the second half of the gene 
and a BamHI restriction site at the end. The two gBlocks were designed with a 30 bp 
complementary region, and the full-length KOD polymerase gene was prepared by PCR 
amplification. The KOD exo– polymerase contains the single point mutation N210D.24 Site-
directed mutagenesis of the full-length KOD polymerase gene was performed using mutagenic 
primers to generate the KOD exo– polymerase gene with the single nucleotide mutation A631G. 
This nucleotide mutation changes the AAT codon for N210 to the GAT codon for D210. 
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Figure 4.13. Synthesis of the KOD and KOD exo– genes. (A) Gene map of the KOD polymerase 
gene from Thermococcus kodakaraensis. The exons are denoted by the thick boxes and the 
introns are the lines. The intron sequences were removed, resulting in a 2322 bp gene for the 774 
amino acid protein. The KOD exo– polymerase results from the single point mutation N210D. 
(B) The full-length gene was synthesized from two gBlocks, each containing half of the gene 
with a 30 bp overlapping region in the middle. PCR amplification resulted in the full-length 
KOD polymerase gene. The agarose gel shows the full-length PCR product of the KOD gene. 
In the Silverman Lab, Pfu polymerase was expressed from a pET-16b vector containing 
the Pfu gene.26 The Pfu gene was removed from the vector and the KOD polymerase genes were 
inserted. The pET-16b vector contains ampicillin and chloramphenicol resistance genes and 
encodes an N-terminal His10 tag on the protein. The Pfu gene was removed from the pET-16b 
vector by digestion with NdeI and BamHI restriction enzymes. The resulting cut sites were 
dephosphorylated with alkaline phosphatase to prevent religation, and the empty vector was 
purified on an agarose gel. The full-length KOD and KOD exo– polymerase genes were digested 
with the same BamHI and NdeI restriction enzymes and purified on an agarose gel. The KOD 
polymerase genes were then ligated into the empty pET-16b vector and transformed into E. coli 
strain DH5α by heat shock. Individual colonies were cultured, and the plasmid was purified by 
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miniprep. Sequencing of the new plasmids verified that the KOD and KOD exo– polymerase 
genes were correct.  
The KOD and KOD exo– polymerase plasmids were transformed into E. coli strain BL21 
(DE3) pLysS by heat shock for expression. The cells were pelleted and lysed. The polymerase 
was purified by heating the cell lysate to 75 °C for 30 min, followed by centrifugation. The 
desired polymerase is heat-stable and remains in solution, while the other cell components are 
precipitated. The polymerases were stored in 50% glycerol at –20 °C. Both KOD and KOD exo– 
polymerase were used successfully in 30-cycle PCR with natural nucleotides. Therefore, both 
polymerases were used in primer extension from a random pool incorporating AmdU, ImdU, 
COOHdU, HOdU, or TrpdU. Each polymerase was used separately or as a mixture of the wild type 
and exo– mutant (Figure 4.14A). The 40:1 mixture of the KOD exo– and wild-type KOD resulted 
in primer extension yields comparable to the yields from the commercial KOD XL polymerase 
for all modified nucleotides evaluated. For in vitro selection experiments, the polymerase also 
needs to be able to copy a modified DNA template into natural nucleotides (Figure 4.14B). 
Primer extension of DNA templates with each of the five different modifications with wild-type 
KOD, KOD exo–, or the 40:1 mixture of the KOD exo– and wild-type KOD resulted in yields 
similar to the yields from the commercial KOD XL polymerase. Therefore, the 40:1 mixture of 
the KOD exo– and KOD wild-type polymerase was comparable to the commercial KOD XL 
polymerase and was used during in vitro selection experiments for deoxyribozymes containing 
modified nucleotides. 
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Figure 4.14. Polymerase activity of the purified wild-type KOD and KOD exo– enzymes. KOD 
XL = commercial polymerase with a mixture of KOD and KOD exo– (Novagen); KOD 
wt = wild-type KOD polymerase; KOD exo– = KOD exonuclease minus mutant; 40:1  
exo–:wt = 40:1 mixture of KOD exo– and KOD wt. All yields are normalized to the primer 
extension yields with the commercial KOD XL polymerase. (A) Primer extension to incorporate 
the modified nucleotides indicated. (B) Primer extension from the modified DNA template 
incorporating natural nucleotides. 
4.2.2.3 Selection for Kinase Deoxyribozymes Containing Hydrophobic Modifications 
The in vitro selection strategy to identify kinase deoxyribozymes (Chapter 2, 3) was 
modified to enable use of the TrpdU-modified nucleotide (Figure 4.15). The initially random pool 
containing TrpdU was generated by primer extension from a reverse-complement random pool 
and was PAGE-purified. This pool was ligated to the DNA-anchored HEG-tethered tyrosine-
containing peptide substrate, and the product was PAGE-purified. Every three rounds beginning 
with round 1, the preclear step was performed to remove DNA aptamers that bind to the pTyr 
antibody, protein A, or resin used during the capture step. DNA sequences that did not bind were 
separated and precipitated. In the selection step, the DNA sequences were incubated with a 
phosphoryl donor and divalent metal ions to enable catalysis. The sample was precipitated, and 
the phosphotyrosine immunoprecipitation capture step was performed to isolate the active DNA 
sequences connected to their phosphopeptide products. The 10-cycle PCR with natural 
nucleotides was altered to include an initial 30 min extension step to ensure that the polymerase 
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copied the modified deoxyribozymes, followed by 10 cycles of PCR. A 30-cycle PCR was 
performed to amplify the pool using all-natural dNTPs. The resulting reverse-complement strand 
was PAGE-purified, and primer extension from this template was performed incorporating the 
modified nucleotides into the pool for the next selection round.  
 
Figure 4.15. Diagram of the in vitro selection procedure to identify kinase deoxyribozymes 
containing modified nucleotides. The initially random pool was prepared by primer extension 
from a reverse-complement random pool. The DNA-anchored peptide substrate was ligated to 
the DNA pool. The subsequent preclear step was performed every third round, beginning in 
round 1, to remove DNA sequences that bind to components of the bead-based 
immunoprecipitation capture step. In the selection step, the DNA sequences were incubated with 
the pppRNA phosphoryl donor and divalent metal ions to enable DNA-catalyzed 
phosphorylation of the peptide substrate. In the subsequent capture step, the active DNA 
sequences connected to the phosphopepetide products were captured via immunoprecipitation 
with an immobilized pTyr antibody. The surviving catalytic DNA sequences were then PCR-
amplified. PAGE purification was performed after each of the the PCR, primer extension, and 
ligation steps. The selection process was repeated until the catalytically active DNA sequences 
dominated the population. 
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All steps in the in vitro selection process were validated to ensure that TrpdU could be 
incorporated. A reverse-complement template was generated by 30-cycle PCR with natural 
nucleotides from the previous 1FS1 10-cycle PCR product (the FS1 selection performed by Cong 
Zhou was for amide bond hydrolysis with a HOdU-modified pool). Primer extension with TrpdU 
from the reverse-complement template was successful using KOD XL polymerase (Figure 
4.16A). TrpdU was incorporated as well as the natural dT or HOdU control. The Trp-modified pool 
was purified and ligated to the DNA-anchored peptide substrate. Both an n splint (base-pairs 
exactly to the DNA pool binding arm and the DNA anchor of the substrate) and an n + 1 splint 
(which includes an extra nucleotide in the splint to account for an untemplated nucleotide 
incorporated at the 3′-end of the DNA pool) were evaluated (Figure 4.16B). KOD XL 
polymerase is a mixture of the wild-type enzyme with proofreading ability and the exo– mutant 
of the enzyme without proofreading capability. Therefore, the composition of the 3′-end of the 
DNA pool was unknown. Ligation with both splints was successful; and the n splint had slightly 
higher yield and was used during the selection experiments.  
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Figure 4.16. Evaluation of the use of Trp-modified pools during in vitro selection experiments. 
(A) Primer extension to incorporate TrpdU. The PAGE image shows the results of primer 
extension from a reverse-complement pool template incorporating natural (nat) nucleotides, 
TrpdU, or HOdU using KOD XL polymerase. (B) Ligation of the Trp-modified pool to the DNA-
anchored peptide substrate. The plot shows the yield of ligation between the DNA-anchored 
peptide substrate and Trp-modified pool using either an n or n + 1 splint (mean ± sd, n = 3). (C) 
Phosphotyrosine immunoprecipitation capture yield of phosphopeptide products connected to 
either a natural DNA pool or a Trp-modified DNA pool. Peptide substrates with either pTyr (YP) 
or Tyr (YOH) were as follows: A = CMTGYVAT; B = CKVIYDFI; C = CEDIYTPG; D = 
CARHTDDEMTGYVATRWAYRAPE; E = CNPDWEIGEDIYTPGKAGDALR. (D) PCR 
amplification of the Trp-modified DNA pool. The PAGE image shows the results of the 
subsequent round 30-cycle PCR with natural nucleotides using Pfu polymerase. The polymerase 
used during the previous 10-cycle PCR is indicated. The two DNA strands were separable 
because the reverse primer contained a nonamplifiable spacer. 
The presence of Trp-modified DNA during the pTyr immunoprecipitation capture step 
was evaluated (Figure 4.16C). Incorporation of hydrophobic modifications into DNA can 
improve aptamer binding to proteins, and the capture step includes the use of two proteins, a 
pTyr antibody and protein A-coated resin. The capture yield of the phosphotyrosine-containing 
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peptide products was not affected by the presence of TrpdU in the connected DNA pool. A small 
increase in background capture of the tyrosine-containing peptide substrate was observed when 
the peptide was connected to a Trp-modified DNA pool (~2%) compared to a natural DNA pool 
(~1%). A small 2% background should not interfere with the selection experiments. 
After the capture step, 10-cycle PCR was performed incorporating natural nucleotides 
based on the Trp-modified DNA template. Different polymerases were evaluated for use in 10-
cycle PCR to determine their ability to copy the Trp-modified DNA template. Using the 10-cycle 
PCR product, a 30-cycle PCR with natural nucleotides and Pfu polymerase was performed to 
amplify the catalytic DNA sequences (Figure 4.16D). All polymerases used during 10-cycle PCR 
led to expected 30-cycle PCR product yields. For simplicity, KOD XL was used during 10-cycle 
PCR and Pfu polymerase was used for 30-cycle PCR during the selection experiments. 
Therefore, TrpdU was successfully incorporated, and all steps of the selection process were 
validated.  
Selection experiments with TrpdU were designed with various peptide substrates (Figure 
4.17). All selections used an N40 initially random region. The selection experiments used peptide 
substrates derived from natural proteins with an artificial cysteine residue at their N-terminus to 
enable disulfide conjugation to the DNA anchor oligonucleotide. The WP1 selection used the 
CMTGYVAT peptide substrate corresponding to residues 179-185 of MAPK14/p38a (mitogen-
activated protein kinase 14) containing the naturally phosphorylated Tyr182 residue.27,28 The 
TyrKinC1 deoxyribozyme was previously identified to phosphorylate this peptide substrate in a 
partially selective manner, but TyrKinC1 was not highly selective and did not catalyze the 
phosphorylation of untethered peptide substrates (Chapter 3).29 When new Trp-modified 
deoxyribozymes are identified, their sequence selectivity and untethered peptide reactivity will 
be compared to that of TyrKinC1. The WQ1 selection used the CKVIYDFI peptide substrate 
corresponding to residues 253-259 of N-WASP (neuronal Wiskott-Aldrich Syndrome protein) 
where Tyr256 is naturally phosphorylated.30 The previous selection experiment using natural 
nucleotides with this peptide substrate did not result in activity (Chapter 3). Therefore, the TrpdU 
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may enable DNA-catalyzed phosphorylation of this peptide sequence. Two selection 
experiments WR1-WS1, with either natural or Trp-modified nucleotides, used the new peptide 
substrate CEDIYTPG corresponding to residues 440-446 of CNP (cereus neutral protease).31,32 
 
Figure 4.17. Design for the WP1-WX1 in vitro selection experiments to identify tyrosine kinase 
deoxyribozymes containing hydrophobic modifications. In all selections, the peptide substrate 
was connected to a DNA anchor oligonucleotide via a disulfide bond and a HEG tether, pppRNA 
was used as the phosphoryl donor, and the initially random region was N40. Selections used only 
natural nucleotides or incorporated TrpdU as indicated. The peptide substrate for each selection is 
shown. The selection step was performed in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM 
MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h.  
The SOMAmers SL5 with 8 modified nucleotides and SL1025 with 10 modified 
nucleotides have hydrophobic interactions with 24 and 11 amino acids in their respective protein 
substrates.18,20 Based on these results, the increased binding affinity of the SOMAmers may be in 
part due to the large number of interactions between the hydrophobically modified aptamers and 
the amino acid residues in the protein target. Therefore, four selection experiments, WT1-WX1, 
used longer peptide substrates to enable more interactions between the deoxyribozyme and 
peptide substrate. The long peptide substrates with 22 residues were expanded versions of the 
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short peptide substrates based on the natural protein sequences. The peptides 
CARHTDDEMTGYVATRWYRAPE and CNPDWEIGEDIYTPGKAGDALR, respectively, 
correspond to the residues flanking Tyr182 of MAPK14/p38a (172-192) and Tyr443 of CNP 
(433-453). Each of these peptide substrates was used in selection experiments with either natural 
or Trp-modified DNA pools. The selection experiments were performed with the pTyr 
immunoprecipitation capture method, because the long, 22 residue peptide substrates were 
capturable by the pTyr immunoprecipitation method and not capturable by the 8VP1 
deoxyribozyme.  
The WP1-WX1 selections were initiated and all five selection experiments with Trp-
modified nucleotides resulted in no or very little 30-cycle PCR product to begin round 2, while 
all three selection experiments with natural nucleotides were successful (Figure 4.18). When the 
WP1, WR1, and WS1 selection experiments were repeated with the 8VP1 capture method, 
similar results were observed. The other selection experiments could not be performed with the 
8VP1 capture method because the long peptide substrates could not be captured or an 8VP1 
capture deoxyribozyme with binding arms complementary to the pool was not available. The 
problem with PCR amplification was unexpected based on the success of the previous control 
experiments. However, in all of the control experiments the amount of DNA sequences expected 
to survive the first round was estimated to be 0.01 pmol, but this is still 1010 DNA sequences. 
The actual number of DNA sequences that catalyze the desired reaction and survive the selection 
pressure may be orders of magnitude lower than 1010. Therefore, the control experiments may 
not have accurately represented the population during the actual selection experiments. 
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Figure 4.18. PCR gel for round 2 of the WP1-WX1 selection experiments. The two DNA strands 
were separable because the reverse primer contained a nonamplifiable spacer. Round 1 was 
performed using the pTyr immunoprecipitation capture method. The PAGE image shows the 
results of 30-cycle PCR to begin round 2 for the WP1-WX1 selections. All three selection 
experiments with natural nucleotides led to PCR product. However, no or very little PCR product 
was observed for the five selection experiments that incorporated modified TrpdU. To continue 
the selection round, the reverse-complement strand is needed as the template for primer 
extension. 
The only reported Trp-modified aptamer sequence was identified from an N40 random 
pool and contained 9 TrpdU residues.16 Surprisingly, none of the modified residues in the aptamer 
are adjacent. Therefore, it was hypothesized that in the WP1-WX1 selection experiments the 
initially random region with 25% TrpdU contained too many modifications to survive the 
amplification step or to be able to catalyze the phosphorylation of the peptide substrate. To test 
the effect the percentage of TrpdU has on the ability to execute selection experiments, the WP1 
selection was performed with 0%, 5%, 10%, 15%, 20%, and 25% TrpdU in the initially random 
region (Figure 4.19). The remaining three natural nucleotides equally composed the remainder of 
the initially random region for each pool. The pools with different percentages of TrpdU residues 
were used in a round 1 selection experiment with the 8VP1 capture method and, separately, the 
pTyr immunoprecipitation capture method. The 30-cycle PCR product for round 2 was 
quantified based on the intensity of the desired product band (the reverse-complement) in each 
experiment relative to the intensity of the product band in the selection experiment with 0% 
TrpdU (all natural nucleotides). As previously observed, 25% TrpdU led to very little PCR product. 
However, reducing the average amount of TrpdU in the initially random region led to an increase 
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in the amount of round 2 PCR product. Pools containing 10-20% TrpdU resulted in 40% PCR 
yield compared to the unmodified control, which was acceptable for selection experiments with 
modified nucleotides. Based on these results, all of the Trp-modified selection experiments were 
restarted using an initially random pool with 15% TrpdU modification, providing a compromise 
between reliable PCR product yields and a large number of modified nucleotides in the initially 
random region. 
 
Figure 4.19. Evaluation of pools containing varying percentage of TrpdU in the N40 initially 
random region for use during in vitro selection experiments. The plot shows the round 2 WP1 
30-cycle PCR yields for selection experiments with initially random pools containing the 
indicated average percentage of TrpdU residues. PCR yields were normalized to the yield of the 
PCR product with 0% TrpdU. Each pool was used in a selection experiment with the 8VP1 
capture method and the pTyr immunoprecipitation capture method. The table shows the average 
number of TrpdU residues in the initially random region of an N40 pool at the various percentages 
used.  
No activity was observed in any of the WP1-WX1 selection experiments, and they were 
discontinued after 12 rounds. It is not clear why the selection experiments with natural 
nucleotides were not successful. The challenges incorporating the TrpdU modified nucleotides 
into the in vitro selection experiments may contribute to the lack of success in the selections with 
Trp-modified pools. Despite the encouraging literature results showing that the incorporation of 
TrpdU into DNA aptamers led to the identification of aptamers with low nanomolar Kd values for 
all 14 of the proteins tested,17 very few Trp-modified aptamers have been reported. Most of the 
129 
SOMAmers reported have been identified from aptamer selection experiments using benzyl-
modified residues. Based on the lack of reported Trp-modified aptamers and the experimental 
difficulties of incorporating TrpdU into the in vitro selection experiments to identify kinase 
deoxyribozymes, the large, hydrophobic indole modification of TrpdU may be challenging to use 
in selection experiments. The use of the smaller benzyl hydrophobic modification may still 
provide improved binding interactions between the peptide substrate and the deoxyribozyme. 
Additionally, BndU has been used successfully during multiple reported aptamer selection 
experiments, and therefore may be incorporated more easily into kinase deoxyribozyme selection 
experiments.  
4.2.3 DNA-Catalyzed Phosphorylation of Untethered Peptides 
In separate efforts, Chih-Chi Chu evaluated the use of hexahistidine (His6) tags on 
peptide substrates to recruit deoxyribozymes for peptide modification.33 A similar recruiting 
strategy has been used for DNA-templated protein modification.34 This general strategy used a 
DNA anchor oligonucleotide with a 3′-tris(NTA) moiety (NTA = nitrilotriacetic acid). The NTA 
moiety binds to divalent metal ions and interacts with the His6 tag on the peptide substrate. The 
DNA anchor base-pairs to the binding arm of the deoxyribozyme. Therefore, the deoxyribozyme 
is recruited to the peptide substrate in solution and catalyzes the modification of the peptide. This 
recruiting strategy improved the kobs and Km of the nucleopeptide-forming 8XJ105 
deoxyribozyme that was identified from selection experiments in which untethered peptide 
substrates were used.  
The His6 recruiting strategy was then evaluated with tyrosine kinase deoxyribozymes that 
were previously unable to phosphorylate untethered peptide substrates (Figure 4.20).33 The 
6CF134 tyrosine kinase deoxyribozyme phosphorylates a peptide substrate only when the 
peptide is covalently tethered to a DNA anchor oligonucleotide (Chapter 2).5 6CF134 
successfully phosphorylated a His6-tagged peptide substrate when the 3′-tris(NTA) 
oligonucleotide and 100 µM Cu2+ was present, as determined by matrix-assisted laser desorption 
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ionization (MALDI) mass spectrometry. This is the first example of DNA-catalyzed 
phosphorylation of a non-covalently tethered peptide substrate. The interaction between the His6 
tag and the tris(NTA) was sufficient to replace the previously used covalent tether and enabled 
6CF134-catalyzed phosphorylation of an untethered peptide substrate. 
 
Figure 4.20. Evaluation of the 6CF134 tyrosine kinase deoxyribozyme with recruiting of His6-
tagged peptide substrate. (A) Original arrangement of the 6CF134 deoxyribozyme with a 
disulfide-tethered peptide substrate required for 6CF134-catalyzed phosphorylation. The PAGE 
image shows the phosphorylation of the DNA-anchored peptide substrate with ~50% 
phosphorylation yield; t = 30 s, 30 min, 2 h, 5 h, and 16 h. YOH = substrate; YP = product. 
Incubation conditions were 70 mM HEPES, pH 7.5, 0.5 mM ZnCl2, 20 mM MnCl2, 40 mM 
MgCl2, and 150 mM NaCl at room temperature. (B) Recruiting of a His6-tagged peptide 
substrate by an NTA-modified DNA anchor oligonucleotide resulted in 88% phosphorylation 
yield by 6CF134 as determined by MALDI mass spectrometry. Peptide phosphorylation was 
only observed when the DNA anchor was 3′-tris(NTA) modified. The peptide substrate was 
H6SAGERASAEDMARAAYAA. Incubation conditions were 70 mM HEPES, pH 7.5, 2 mM 
ZnCl2, 20 mM MnCl2, 40 mM MgCl2, 150 mM NaCl, and 100 µM Cu(NO3)2 at room 
temperature for 20 h. Figure reprinted with permission from Ref. 33. 
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4.3 Summary and Future Directions 
DNA enzymes that catalyze the modification untethered peptide and protein substrates 
are desired. The development of a method to reliably identify deoxyribozymes with untethered 
peptide and protein reactivity is valuable in the pursuit of catalysts to enable studies of biological 
protein modifications. The use of DNA-anchored HEG-tethered peptide substrates during in vitro 
selection has not reliably led to the identification of deoxyribozymes with untethered peptide 
reactivity. This includes all current tyrosine kinase deoxyribozymes, which require DNA-
anchored HEG-tethered peptide substrates. The identification of kinase deoxyribozymes requires 
that the phosphopeptide product is connected to the DNA sequence that catalyzed its 
phosphorylation. Therefore, a tethered peptide substrate is required during in vitro selection.  
The original hypothesis was that a sufficiently long tether between the peptide and DNA 
anchor would mimic an untethered peptide substrate. Unfortunately, selection experiments to 
identify capture deoxyribozymes or tyrosine kinase deoxyribozymes using HEG6 or HEG10-
tethered peptide substrates were unsuccessful. The 8XJ105 nucleopeptide-forming 
deoxyribozyme with untethered peptide reactivity was evaluated with tethered peptide substrates, 
and the results suggest that the longer tethers do not mimic an untethered peptide substrate. 
Therefore, the longer tethers were not inert as expected and prevented DNA enzymes from 
binding or reacting with the peptide substrate. The combined results of many unsuccessful 
selection experiments and the inability of 8XJ105 and 15MZ36 to catalyze the nucleopeptide 
formation of HEG6 and HEG10-tethered peptide substrates suggest that the hypothesis that long 
tethers are similar to the absence of a tether was incorrect. Thus, HEG6 and HEG10-tethered 
peptide substrates will no longer be used during in vitro selection experiments. 
The identification of deoxyribozymes and aptamers with modified nucleotides has 
expanded the catalytic scope of deoxyribozymes and the binding affinities of aptamers. The 
incorporation of hydrophobic modifications into deoxyribozymes may increase the binding 
affinity between the peptide substrate and the DNA enzyme, thus leading to untethered peptide 
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reactivity. The modified TrpdUTP was successfully synthesized and incorporated into a DNA 
pool. Unexpected challenges in PCR amplification of active DNA sequences during in vitro 
selection experiments were encountered and attributed to the TrpdU modification. Decrease in the 
percentage of TrpdU residues in the initially random region of the pool enabled selection 
experiments. The data shows that the use of TrpdU resulted in the identification of tight-binding 
aptamers for all proteins evaluated, whereas the use of BndU lead to tight-binding aptamers for 
only 60% of proteins evaluated. Despite these results, the majority of SOMAmers were 
identified using BndU for an unknown reason. Future efforts to identify deoxyribozymes with 
modified nucleotides will try the hydrophobic benzyl modification. The magnitude of the 
binding interaction required between the deoxyribozyme and its peptide substrate to enable 
untethered peptide reactivity is not known, and BndU may be sufficient to enable untethered 
peptide reactivity. The BndUTP can be synthesized similarly to the TrpdUTP by replacing 
tryptamine with benzylamine. 
The aptamers with hydrophobic modifications bind tightly to their protein substrates. 
Therefore, the in vitro selection strategy may want to avoid a bead-based immunoprecipitation 
method in which tight-binding aptamers for the resin or immobilized proteins may prevent the 
successful enrichment of catalytic DNA sequences. The previously used, PAGE-based 8VP1 
capture method was not amenable to the longer peptide substrates. A new PAGE-based capture 
method using Phos-tag acrylamide is promising to enable a sufficient PAGE separation of active 
DNA sequences connected to their phosphotyrosine-containing peptide products from the 
inactive DNA sequences.35-39 The Phos-tag PAGE capture method should prevent the enrichment 
of DNA aptamers for the proteins or resin used in the immunoprecipitation capture method and 
still allow for the use of long peptide substrates. 
DNA enzymes containing modified nucleotides with protein-like functional groups have 
expanded the scope of DNA-catalyzed reactions to include amide bond cleavage.15 The active 
sites of known protein kinases contain aspartate and lysine residues.40 Therefore, incorporation 
of amino or carboxyl modifications into kinase deoxyribozymes may be beneficial for catalysis 
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and provide improved rate, yield, or substrate binding (either peptide or NTP substrate). Ongoing 
selection experiments VJ1-VN1, initiated by Stephanie Konecki and continued by Tiyaporn 
Tangpradabkul, are seeking tyrosine kinase deoxyribozymes with AmdU or COOHdU modifications 
in the initially random region. The DNA-anchored HEG-tethered peptide substrate is 
CMTGYVAT, and the phosphoryl donor is either pppRNA or 100 µM ATP. Selection 
experiments use the 8VP1 capture deoxyribozyme method.  
While the DNA-catalyzed phosphorylation of untethered peptide substrates and a reliable 
method to identify these deoxyribozymes are still desired, the ability to recruit peptide substrates 
to the DNA enzyme does enable phosphorylation of peptide substrates. The interaction between 
a His6 tag and a tris(NTA)-oligonucleotide is sufficient to replace the previously used covalent 
tether and enables 6CF134-catalyzed phosphorylation of an untethered peptide substrate.  
4.4 Materials and Methods 
4.4.1 Substrate Preparation Procedures 
Oligonucleotides, peptides, and DNA-anchored peptide conjugates were prepared as 
described in Chapter 2. 
4.4.2 In Vitro Selection Procedures 
Procedures for ligation, selection, 8VP1 PAGE-based capture, and PCR were performed 
as described in Chapter 2. Phosphotyrosine antibody bead-based capture and preclear was 
performed as described in Chapter 3. Any changes to incorporate modified nucleotides are 
described below. 
Primer extension to generate modified pools for round 1. To generate the initial 15% Trp-
modified pools by primer extension, a reverse-complement of the pool containing 15% A was 
synthesized and ligated to a 3′-tail to enable separation from the product after primer extension. 
A 25 µL sample containing 250 pmol of reverse-complement template, 300 pmol of forward 
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primer, 7.5 nmol each of dATP, dGTP, dCTP, and TrpdUTP, 2.5 µL of 10× KOD XL polymerase 
buffer (1.2 M Tris-HCl, pH 8.0, 60 mM (NH4)2SO4, 100 mM KCl, 1% Triton X-100, 0.01% 
BSA), and 2 µL of KOD XL polymerase. To generate the initial pool, 8 × 25 µL reactions were 
performed. Primer extension was performed in a PCR thermocycler according to the following 
program: 94 °C for 2 min, 47 °C for 2 min, 72 °C for 1 h. The 8 × 25 µL samples were 
combined, precipitated with ethanol, and separated by 8% PAGE. 
Primer extension to generate modified pools for subsequent rounds. A 25 µL sample 
containing the reverse-complement single strand, 50 pmol of forward primer, 7.5 nmol each of 
dATP, dGTP, dCTP, and TrpdUTP, 20 µCi of α-32P-dCTP (800 Ci/mmol), 2.5 µL of 10× KOD 
XL polymerase buffer (1.2 M Tris-HCl, pH 8.0, 60 mM (NH4)2SO4, 100 mM KCl, 1% Triton X-
100, 0.01% BSA), and 0.5 µL of KOD XL polymerase. Primer extension was performed in a 
PCR thermocycler according to the following program: 94 °C for 2 min, 47 °C for 2 min, 72 °C 
for 1 h. The sample was separated by 8% PAGE, providing the modified DNA pool for the next 
selection round. 
Procedure for ligation of modified pools in round 1. A 30 µL sample containing ~200 
pmol of modified DNA pool, 250 pmol of DNA splint, and 300 pmol of 5′-phosphorylated 
DNA-anchored peptide substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this solution were added 4 
µL of 10× T4 DNA ligase buffer (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) and 1 
µL of 5 U/µL T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 14 h and 
separated by 8% PAGE. 
Procedure for PCR of modified pools. In each selection round, two PCR reactions were 
performed, a 10-cycle PCR followed by a 30-cycle PCR. First, a 100 µL sample was prepared 
containing the capture product, 50 pmol of forward primer, 200 pmol of reverse primer, 20 nmol 
of each dNTP, and 10 µL of 10× KOD XL polymerase buffer (1.2 M Tris-HCl, pH 8.0, 60 mM 
(NH4)2SO4, 100 mM KCl, 1% Triton X-100, 0.01% BSA), and 1 µL KOD XL polymerase. This 
sample was primer-extended and then cycled 10 times according to the following PCR program: 
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94 °C for 2 min, 47 °C for 2 min, 72 °C for 30 min; then 94 °C for 2 min, 10× (94 °C for 1 min, 
47 °C for 1 min, 72 °C for 1 min), 72 °C for 5 min. KOD XL polymerase was removed by 
phenol/chloroform extraction. Second, a 50 µL sample was prepared containing 1 µL of the 100 
µL 10-cycle PCR product, 25 pmol of forward primer, 100 pmol of reverse primer, 10 nmol of 
each dNTP, 5 µCi of α-32P-dCTP (800 Ci/mmol), 5 µL of 10× Taq polymerase buffer, and Taq 
polymerase. This sample was cycled 30 times according to the following PCR program: 94 °C 
for 2 min, 30× (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Samples were 
separated by 8% PAGE, and the reverse-complement single strand was separated for the 
subsequent primer extension. 
4.4.3 Synthesis of TrpdUTP 
Reagents were commercial grade and used without purification. Thin-layer 
chromatography (TLC) was performed on silica gel plates pre-coated with fluorescent indicator, 
with visualization by UV light (254 nm). Flash column chromatography was performed with 
silica gel (230-400 mesh). NMR spectra were recorded on a Varian Unity instrument. Mass 
spectrometry data were obtained at the UIUC School of Chemical Sciences Mass Spectrometry 
Laboratory using a Waters Quattro II instrument (LR-ESI).  
Synthesis of TrpdU. The TrpdU was synthesized from (E)-5-(2-carbomethoxyvinyl)-2′-
deoxyuridine N-hydroxysuccinimide ester (Berry & Associates, cat. no. PY7190). The 2′-
deoxyuridine (118 mg, 0.30 mmol) was dissolved in 2 mL of dimethylformamide (DMF). To this 
solution was added tryptamine (48 mg, 0.30 mmol) and N,N-diisopropylethylamine (105 µL, 
0.60 mmol), and the solution was stirred overnight at room temperature. The solution was dried 
on a rotary evaporator and the oily residue was purified by silica gel column chromatography, 
eluting with 10% CH3OH in CH2Cl2 to yield the desired product as a colorless oil (39 mg, 30%). 
TLC: Rf = 0.55 [10% CH3OH in CH2Cl2]. 
ESI-MS: m/z calculated for C22H24N4O6 [M–H]– 439.2; found 439.1. 
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Synthesis of TrpdU 5′-triphosphate (TrpdUTP). The triphosphorylation procedure was 
modified from the procedure reported by Huang and co-workers.41 2-Chloro-1,3,2-
benzodioxaphosphorin-4-one (TCI, cat. no. C1210) was portioned into a dried vial in a glove 
box. TrpdU and tributylammonium pyrophosphate (Sigma, cat. no. P83533) were dried under 
vacuum. Tributylamine was dried over 4 Å molecular sieves. Tributylamine (0.35 mL, 1.47 
mmol) was added to a solution of tributylammonium pyrophosphate (99 mg, 0.18 mmol) 
dissolved in 1 mL of anhydrous DMF under argon. This solution was added into a stirred 
solution of 2-chloro-1,3,2-benxodioaphosphorin-4-one (26 mg, 0.13 mmol) in 0.55 mL of 
anhydrous DMF under argon. The resulting solution was stirred at room temperature for 1 h and 
then was added dropwise over 5 min to a solution of TrpdU (38 mg, 0.09 mmol) in 1 mL of 
anhydrous DMF under argon, cooled in an ice-salt bath at 0 to –10 °C. The solution was stirred 
for 5 h and raised to room temperature and incubated for 30 min. A solution of 0.02 M iodine in 
THF/pyridine/water (Glen Research, 8 mL) was added until a permanent brown color was 
maintained. The brown solution was stirred at room temperature for 30 min. Two sample 
volumes of water were added. The two-layer mixture was stirred vigorously at room temperature 
for 1.5 h, followed by addition of 0.1 volumes of 3 M NaCl and 3 volumes of ethanol. The 
thoroughly mixed sample was precipitated at –80 °C overnight and centrifuged for 1 h at 
10,000 × g and 4 °C. The precipitated sample was dried, dissolved in water, and purified by 
HPLC [Shimadzu Prominence instrument; Phenomenex Gemini-NX C18 column, 5 µm, 10 × 250 
mm; linear gradient of 0.5% solvent A (20 mM triethylammonium acetate in 50% 
acetonitrile/50% water, pH 7.0) and 99.5% solvent B (20 mM triethylammonium acetate in 
water, pH 7.0) at 0 min to 25% solvent A and 75% solvent B at 45 min with a flow rate of 3.5 
mL/min]. The TrpdUTP was purified as its triethylammonium salt [41 mg, 20% from (E)-5-(2-
carbomethoxyvinyl)-2′-deoxyuridine N-hydroxysuccinimide ester]. 
ESI-MS: m/z calculated for C22H23N4O15P3 [M–H]– 679.1; found 679.2. 
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4.4.4 Procedures for Expression of KOD Polymerase 
Construction of the KOD and KOD exo– plasmids. The introns from the full-length KOD 
polymerase gene (GenBank D29671.2) were removed, and the gene was codon-optimized for 
expression in E. coli using the Integrated DNA Technologies (IDT) Codon Optimization Tool. 
Table 4.1. Oligonucleotide sequences of the KOD polymerase gBlocks and related primers. 
oligonucleotide purpose oligonucleotide sequence 
forward primer GTCCACATATGATTTTAGACACCG 
reverse primer TGTCAGGATCCTCGAGTG 
forward mutagenic primer AGAAAGATCCAGACGTCCTGATTACCTATGATGGCGACAACTTTGATTTTGCGTACCTG 
reverse mutagenic primer CAGGTACGCAAAATCAAAGTTGTCGCCATCATAGGTAATCAGGACGTCTGGATCTTTCT 
sequencing primer 1 GCGCACGCGTGATTACAT 
sequencing primer 2 TGGCTCCCAACAAGCCAG 
sequencing primer 3 TCAATGCGAAACTCCCAG 
gBlock1a 
GTCCACATATGATTTTAGACACCGACTATATCACGGAAGATGGCAAGCCAGTGATCCGTATCTTCAAAAAGGAGAATGGCGAGTTCAAAATCGAGTA
TGACCGTACGTTTGAACCGTACTTTTACGCTCTGCTGAAAGATGACTCCGCCATCGAGGAGGTAAAGAAGATCACCGCGGAACGGCATGGCACGGTG
GTTACGGTTAAACGCGTGGAAAAGGTTCAAAAGAAATTCCTGGGCCGCCCGGTAGAAGTCTGGAAACTTTATTTCACCCACCCTCAGGACGTGCCGG
CGATCCGGGACAAGATTCGCGAACATCCCGCTGTAATTGACATCTATGAATATGATATCCCCTTCGCGAAACGTTATCTGATCGATAAAGGTTTAGT
CCCCATGGAGGGCGATGAGGAACTCAAAATGCTGGCGTTCGACATTGAGACCTTATATCATGAAGGCGAGGAATTTGCCGAAGGTCCGATTTTAATG
ATTAGTTACGCGGATGAAGAAGGCGCACGCGTGATTACATGGAAGAACGTTGACTTGCCTTATGTGGACGTTGTGTCCACAGAGCGCGAAATGATTA
AACGTTTCCTTCGTGTGGTGAAGGAGAAAGATCCAGACGTCCTGATTACCTATAATGGCGACAACTTTGATTTTGCGTACCTGAAAAAACGTTGCGA
GAAACTGGGAATCAATTTTGCGCTGGGTCGCGACGGTTCTGAGCCAAAAATTCAGCGTATGGGAGATCGCTTCGCCGTTGAAGTTAAAGGCCGTATT
CATTTCGATCTGTATCCAGTCATCCGGCGCACTATCAACCTTCCGACTTATACTCTTGAAGCCGTATATGAAGCTGTGTTTGGACAGCCTAAAGAAA
AAGTGTATGCGGAAGAAATTACTACCGCTTGGGAAACAGGCGAGAACTTAGAACGCGTGGCGCGTTATAGCATGGAAGATGCAAAAGTTACCTATGA
ATTAGGTAAAGAGTTTTTGCCTATGGAAGCACAGCTGTCGCGTCTGATCGGGCAGAGTCTTTGGGATGTGAGCCGTAGCTCAACAGGCAACCTGGTG
GAATGGTTCCTGCTCCGTAAAGCTTATGAACGCAACGAGCTGGCTCCCAACAAGCCAGATGAAAAAGAACTGGCGCGGCGCCGCCAGTCGTATGAAG
GGGGTTACGTAAAAGAGCCGGAACGCGGTCTGTG 
gBlock2b 
TTACGTAAAAGAGCCGGAACGCGGTCTGTGGGAGAACATCGTCTATTTGGACTTTCGTAGCCTGTATCCTTCTATCATTATTACTCACAACGTCAGC
CCTGACACGCTGAATCGCGAAGGGTGCAAGGAGTACGACGTTGCGCCGCAAGTCGGGCACCGCTTTTGTAAAGATTTCCCGGGATTTATTCCATCTC
TGCTGGGCGATCTGTTGGAAGAACGTCAAAAGATTAAGAAAAAAATGAAAGCAACCATTGATCCGATCGAACGTAAGCTCCTGGACTATCGCCAGCG
CGCAATCAAAATCCTGGCAAACTCGTATTACGGGTATTACGGCTACGCGCGTGCCCGTTGGTATTGCAAGGAGTGTGCCGAGTCCGTAACCGCATGG
GGCCGCGAATATATTACTATGACCATTAAAGAGATTGAAGAGAAGTATGGTTTCAAGGTCATCTACTCGGATACAGATGGGTTCTTTGCCACTATCC
CTGGCGCGGACGCGGAGACTGTGAAGAAAAAGGCAATGGAGTTTTTAAAATACATCAATGCGAAACTCCCAGGTGCACTGGAACTGGAATATGAAGG
GTTTTATAAACGCGGCTTTTTCGTGACGAAAAAGAAGTATGCGGTAATCGATGAAGAGGGGAAGATTACTACCCGCGGCCTGGAAATCGTTCGGCGT
GATTGGTCGGAAATTGCAAAAGAAACTCAAGCGCGTGTGCTGGAAGCCCTCCTGAAGGACGGGGACGTGGAGAAAGCAGTCCGCATCGTTAAGGAGG
TGACAGAGAAATTGTCGAAGTACGAGGTGCCGCCTGAAAAGCTGGTAATTCATGAACAGATCACGCGCGATCTGAAGGATTACAAAGCGACCGGACC
GCACGTGGCGGTGGCAAAACGGTTGGCCGCGCGTGGTGTTAAAATCCGTCCGGGGACCGTGATCTCCTATATCGTCCTGAAAGGAAGTGGCCGGATT
GGCGATCGGGCTATTCCGTTTGACGAATTCGACCCGACCAAACATAAATATGATGCAGAATACTATATCGAAAATCAGGTTCTGCCGGCGGTAGAAC
GCATTTTGCGGGCTTTTGGCTATCGCAAAGAAGATCTGCGCTATCAGAAGACGCGTCAGGTGGGTCTGAGCGCGTGGCTGAAGCCGAAAGGCACCTA
AAAAAGCGATAGATATCACTCGAGGATCCTGACA 
  
aThe 8 underlined bp at the 5′-end are removed upon cleavage by NdeI, and the red nucleotides are the NdeI recognition site. The 
bold nucleotides represent the codon for N210 and the mutagenic primers change the first A to G. The 30 underlined bp at the 3′-
end base-pair with the 5′-end of gBlock 2. 
bThe 30 underlined bp at the 5′-end base-pair with the 3′-end of gBlock 1. The underlined bp at the 3′-end are removed upon 
cleavage by Bam HI, and the red nucleotides are the BamHI recognition site. The bold nucleotides are the stop codon. 
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PCR amplification of the full-length KOD and KOD exo– polymerase genes. A 50 µL 
sample was prepared containing 10 ng of each gBlock gene fragment, 25 pmol of each primer, 
10 nmol of each dNTP, 5 µL of 10× Pfu polymerase buffer (200 mM Tris-HCl, pH 8.8, 100 mM 
KCl, 100 mM (NH4)2SO4, 20 mM MgSO4, 1% Triton X-100), and 0.5 uL of Pfu polymerase. 
This sample was cycled 30 times according to the following PCR program: 94 °C for 2 min, 30× 
(94 °C for 30 s, 47 °C for 30 s, 72 °C for 5 min), 72 °C for 5 min. The sample were purified on 
1% agarose gel. Site-directed mutagenesis to generate the KOD exo– gene was performed using 
mutagenic primers and 10 ng of the full-length KOD polymerase gene. PCR was performed as 
above with each of the mutagenic primers, and the full-length KOD exo– gene was prepared by 
PCR and purified on a 1% agarose gel. 
Restriction digestion of the KOD genes and vector. Each of the full-length KOD 
polymerase genes and the pET-16b vector containing the Pfu gene were digested with BamHI 
and NdeI. A 30 µL sample was prepared containing 500 ng of vector or 300 ng of the KOD gene 
and 3 µL of 10× NEB buffer 3 (500 mM Tris-HCl, pH 7.9, 1 M NaCl, 100 mM MgCl2, 10 mM 
DTT), 100 µg/mL BSA, 1 µL of 20,000 U/mL of BamHI (New England Biolabs), and 1 µL of 
20,000 U/mL of NdeI (New England Biolabs). Samples were incubated at 37 °C for 14 h. The 
digested vector was dephosphorylate by adding 4 µL of 10× calf intestine alkaline phosphatase 
(CIAP) buffer (500 mM Tris-HCl, pH 8.5, 1 mM EDTA) and 1 µL of 20 U/µL CIAP 
(Fermentas) to the digested product for a final volume of 40 µL. The samples were incubated at 
37 °C for 2 h. The digested, dephosphorylated vector and digested genes were purified on a 1% 
agarose gel. 
Ligation and transformation of the KOD and KOD exo– polymerase plasmids. A 20 µL 
sample containing 50 ng of digested and dephosphorylated pET-16b vector, 100 ng of digested 
gene, 2 µL of 10× T4 DNA ligase buffer (400 mM Tris-HCl, pH 7.8, 100 mM MgCl2, 100 mM 
DTT, 5 mM ATP), and 1 µL of 1 U/µL of T4 DNA Ligase (Fermentas) was incubated at 16 °C 
for 16 h. To 50 µL of DH5α E. coli cells was added 4 µL of the ligation product, and the sample 
was incubated on ice for 30 min. The sample was heat-shocked at 42 °C for 45 s, followed by 
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incubation on ice for 2 min. To the sample was added 250 µL of room-temperature SOC 
medium. The sample was shaken at 220 rpm and 37 °C for 1 h, and plated on LB containing 100 
µg/mL ampicillin and incubated at 37 °C for 16 h. Individual colonies were used to inoculate 3 
mL of LB containing 100 µg/mL ampicillin, and the culture was shaken at 37 °C for 16 h. 
Plasmids were isolated by miniprep and sequenced. 
Expression and purification of KOD and KOD exo– polymerase. To 50 µL of BL21 
(DE3) pLysS E. coli was added 1 µL of a 1:100 dilution of the miniprep purified plasmid. The 
sample was mixed gently and incubated on ice for 30 min. The cells were heat-shocked at 42 °C 
for 1 min, followed by incubation on ice for 2 min. To the sample was added 500 µL of room-
temperature SOC medium. The sample was shaken at 220 rpm and 37 °C for 1 h, and then plated 
on LB plates containing 100 µg/mL ampicillin and incubated at 37 °C for 16 h. Individual 
colonies were used to inoculate 9 mL starter cultures of LB with 100 µg/mL ampicillin and 34 
µg/mL chloramphenicol. Cultures were grown by shaking at 220 rpm and 37 °C for 16 h. The 
starter culture with the highest OD600 was used to inoculate the induction culture. To 750 mL of 
LB containing 100 µg/mL ampicillin and 34 µg/mL chloramphenicol, 7.5 mL of starter culture 
was added. The culture was grown by shaking at 220 rpm at 37 °C until OD600 = 0.3. The culture 
was induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 
0.5 mM and was shaken at 220 rpm at 37 °C for an additional 4 h. The cells were pelleted by 
centrifugation at 9,000 ×g and 4 °C for 10 min. 
The cell pellet was resuspended in 22 mL of Buffer A (50 mM Tris-HCl, pH 7.9, 50 mM 
glucose, 1 mM EDTA, 5 mg/mL lysozyme) and incubated at room temperature for 30 min. The 
sample was sonicated for 90 s at 35% amplitude with 4 s pulse-on and 9.9 s pulse-off. To the cell 
lysate, 22 mL of Buffer B (10 mM Tris-HCl, pH 7.9, 50 mM KCl, 1 mM EDTA, 0.5% Tween-
20, 0.5% Nonidet P40) was added, and the sample was stirred at 75 °C for 30 min. Cell debris 
was removed by centrifugation at 12,000 ×g and 4 °C for 20 min. An equal volume of 50% 
glycerol storage buffer (50 mM Tris-HCl, pH 8.0, 0.1 mM EDTA, 1 mM DTT, 0.1% Tween-20, 
0.1 % Nonidet P40) was added slowly. Next, an equal volume of 75% glycerol storage buffer 
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was added slowly, resulting in a final solution of 50% glycerol. The polymerase was stored at –
20 °C. PCR. The 10× KOD XL polymerase buffer contains 1.2 M Tris-HCl, pH 8.0, 60 mM 
(NH4)2SO4, 100 mM KCl, 1% Triton X-100, and 0.01% BSA. 
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Chapter 5: Identification of Serine Kinase Deoxyribozymes† 
5.1 Introduction 
Serine and threonine phosphorylation is an abundant regulatory post-translational 
modification in biology. The hydroxyl group of the amino acid side chain attacks the γ-phosphate 
of a phosphoryl donor, resulting in transfer of a phosphoryl group. The aromatic hydroxyl group 
of tyrosine is more nucleophilic than the aliphatic hydroxyl group of serine or threonine side 
chains, making phosphorylation of serine and threonine side chains more challenging. However, 
the ability to site-specifically phosphorylate serine or threonine residues within peptide and 
protein substrates will enable the study of phosphoserine modifications of biological relevance. 
5.1.1 Serine-Modifying Deoxyribozymes 
While many peptide-modifying deoxyribozymes have focused on tyrosine because it is a 
good nucleophile, efforts have expanded to include DNA-catalyzed serine modification. The first 
DNA-catalyzed serine modification was nucleopeptide formation.1 The serine-containing 
                                                            
† University of Illinois graduate student Amit Sachdeva performed kinase deoxyribozyme 
selection experiments using γ-thiophosphoryl donors for the phosphorylation of 2′-hydroxyl of 
RNA and the 3′-hydroxyl of DNA.12  
University of Illinois undergraduate student Alison J. Camden identified and characterized 
kinase deoxyribozymes that catalyze phosphorylation of the 3′-hydroxyl of DNA.13  
University of Illinois undergraduate student Nickolaus C. Lammer performed selection 
experiments for serine kinase deoxyribozymes using complex peptide sequences and investigated 
the results. 
University of Illinois undergraduate student Stephanie N. Konecki performed the initial 
selections for serine kinase deoxyribozymes using ATP as the phosphoryl donor. S. Konecki also 
began selections for serine kinase deoxyribozymes using modified nucleotides within the 
initially random region. 
University of Illinois undergraduate student Tiyaporn Tangpradabkul performed selections for 
serine kinase deoxyribozymes using modified nucleotides within the initially random region. 
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tripeptide was incorporated between two DNA binding arms, which base-paired to the 
deoxyribozyme in a highly organized three-helix-junction configuration. Deoxyribozymes were 
identified to catalyze the reaction of the hydroxyl of the serine side chain with the α-phosphate 
of a 5′-triphosphorylated RNA oligonucleotide (pppRNA), resulting in nucleopeptide formation. 
Two of the deoxyribozymes identified, SerB1 and SerB2, have 85% yield in 20 h. Both 
deoxyribozymes also catalyzes the modification of tyrosine with yields of 10% and 65% for 
SerB1 and SerB2, respectively.  
Subsequent efforts for DNA-catalyzed nucleopeptide formation of serine residues used a 
DNA-anchored tethered peptide substrate with an open architecture in place of the three-helix-
junction architecture.2 Selection experiments were performed with a tethered aliphatic hydroxyl 
group, and when activity was observed during the selection the substrate was changed to a 
tethered CSA tripeptide substrate. The 15MZ36 deoxyribozyme identified from this selection 
experiment catalyzed nucleopeptide formation of a C3-tethered CSA substrate with 60% yield. 
However, only 5% activity was observed with a HEG-tethered CSA substrate, and no activity 
was observed with a free CSA peptide. 15MZ36 also has 80%, 80%, and 50% yield with C3-
tethered, HEG-tethered, and untethered CYA peptide substrates, respectively. Therefore, 
15MZ36 favors tyrosine-containing peptide substrates. 
5.1.2 Nucleic Acid-Catalyzed Phosphorylation 
Artificial ribozymes have been identified to catalyze self-phosphorylation at their 5′-
terminus or at an internal 2′-hydroxyl group.3-7 These catalysts used ATPγS as the phosphoryl 
donor. Separate efforts identified DNA enzymes to catalyze self-phosphorylation at their 5′-
terminus as well.8-11 In the Silverman Lab, early efforts by Amit Sachdeva to identify kinase 
deoxyribozymes using γ-thiophosphoryl donors resulted in activity for selection experiments 
seeking phosphorylation of 2′-hydroxyl of RNA and the 3′-hydroxyl of DNA.12 Additional 
efforts by Alison Camden identified a deoxyribozyme for phosphorylation of the 3′-hydroxyl of 
DNA.13 Oligonucleotide phosphorylation is distinct from peptide phosphorylation. The 2′-
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hydroxyl of RNA, the 3′-hydroxyl of DNA, and the hydroxyl of threonine are secondary 
aliphatic hydroxyl groups. The 5′-hydroxyl of DNA and the hydroxyl group of serine are primary 
hydroxyl group. The ability of DNA to catalyze the phosphorylation of RNA and DNA suggests 
that serine and threonine phosphorylation may also be possible.  
All of the previously identified tyrosine kinase deoxyribozymes were identified from in 
vitro selection experiments using tyrosine-containing peptide substrates (Chapter 2, 3).14-16 When 
each of these deoxyribozymes were evaluated with analogous serine-containing peptide 
substrates, no phosphorylation activity was observed. Therefore, all of these deoxyribozymes are 
specifically tyrosine kinase deoxyribozymes. All five of the deoxyribozymes identified from the 
selection experiments using the CADPYDQS peptide substrates were peptide sequence-specific, 
and all of the deoxyribozymes phosphorylated the tyrosine residue despite the presence of a 
serine residue within the same peptide substrate (Chapter 3).16 Therefore, separate selection 
experiments with serine-containing peptides may enable the identification of serine kinase 
deoxyribozymes. 
5.2 Results and Discussion 
5.2.1 Capture of Phosphoserine-Containing Peptides 
Similarly to selection for tyrosine kinase deoxyribozymes, in vitro selection for serine 
kinase deoxyribozymes also requires a method to separate the catalytically active DNA 
sequences from the inactive DNA sequences. The nucleopeptide-forming deoxyribozyme 8VP1 
was identified from selection experiments performed with a HEG-tethered phosphotyrosine-
containing peptide substrate.17 The 8VP1 capture deoxyribozyme has been used successfully in 
selection experiments to identify tyrosine kinase deoxyribozymes (Chapter 2).14 Upon 
evaluation, 8VP1 was shown to also catalyze reaction of tethered phosphoserine-containing 
peptide substrates. The tether dependence of the 8VP1-catalyzed phosphoserine reactivity was 
evaluated (Figure 5.1). 8VP1-catalyzed capture of the CAASPAA peptide substrate connected to 
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a DNA anchor via a C3, HEG, HEG3, or HEG6 tether was 29%, 40%, 41%, and 24%, 
respectively. No activity was observed with the CAASAA peptide substrate. Therefore, the 
8VP1 capture method could also be applied to selection experiments for the identification of 
serine kinase deoxyribozymes.  
 
Figure 5.1. DNA-catalyzed covalent modification of phosphoserine substrates. (A) The 8VP1 
deoxyribozyme catalyzes attachment of a 5′-triphosphorylated RNA oligonucleotide to the 
phosphorylated amino acid residue within a DNA-anchored hexapeptide substrate. The tethers 
between the DNA anchor and the CAASPAA peptide substrate are shown. The plot shows 8VP1-
catalyzed capture yields of phosphoserine-containing peptide substrates connected via various 
tether lengths. No activity was observed with serine-containing peptide substrates. Incubation 
conditions were 50 mM HEPES, pH 7.5, 20 mM MnCl2, and 150 mM NaCl at 37 °C for 16 h.  
5.2.2 Identification of Serine Kinase Deoxyribozymes 
In vitro selection experiments AC1-AD1, BC1-BD1, and ED1 were performed to identify 
deoxyribozymes to catalyze serine phosphorylation. The peptide substrate was HEG-tethered 
CAASAA, and Mn2+ and Mg2+ were used as divalent metal ion cofactors during the selection 
step. No activity was observed in any of these selection experiments, and they were discontinued 
after 12 rounds. However, similar selection experiments to identify tyrosine kinase 
deoxyribozymes using Zn2+, Mn2+, and Mg2+ during the selection step were successful (Chapter 
2, 3).14-16 The tyrosine kinase deoxyribozymes required Zn2+ for catalysis. Based on these results, 
149 
all three divalent metal ions were used in new selection experiments to identify serine kinase 
deoxyribozymes (Figure 5.2). In addition, the tether connecting the DNA anchor to the peptide 
substrate was decreased in length to a C3 tether and a 5′-triphosphorylated RNA oligonucleotide 
(pppRNA) was used as the phosphoryl donor. Three selection experiments were performed using 
N30, N40, and N50 random region lengths. 
 
Figure 5.2. Design for the HV1-HX1 in vitro selections to identify serine kinase 
deoxyribozymes. In all selections, the peptide substrate CAASAA was connected to a DNA 
anchor via a disulfide bond and a C3 tether, and the phosphoryl donor was pppRNA. The HV1, 
HW1, and HX1 selections had N30, N40, and N50 initially random regions, respectively. The 
selection step was performed in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM 
MgCl2, and 150 mM NaCl at 37 °C for 14 h.  
Each of these three selection experiments led to activity (Figure 5.3). Selection pressure 
for the ability to phosphorylate a more loosely HEG-tethered peptide substrate was applied after 
activity was observed. Selection pressure began at rounds 8, 7, and 10 for HV1, HW1, and HX1, 
respectively. After 7 rounds with the selection pressure, activity did not increase for either the 
HV1 or HX1 selection experiments. Therefore, the HV1 and HX1 selections using the short C3 
tether were cloned from rounds 7 and 10, respectively. Upon imposition of selection pressure, an 
increase in activity was observed in the HW1 selection. Therefore, the HW1 selection was 
cloned at round 6 from the selection using the short C3 tether and round 11 from the selection 
pressure using the longer HEG tether.  
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Figure 5.3. Progression of the in vitro selection experiments for serine kinase deoxyribozymes. 
In each round, “control” refers to the yield for the 8VP1-catalyzed capture reaction using a 
CAASPAA substrate, and the 8VP1-catalyzed capture reaction for the indicated selection 
experiment is shown. Arrows mark the cloned rounds. The HV1, HW1, and HX1 selections have 
N30, N40, and N50 random regions, respectively. The HV1, HW1, and HX1 selections have C3-
tethered peptide substrates, and the HV1b, HW1b, and HX1b selections have HEG-tethered 
peptide substrates.  
Four, two, and two sequences were identified for each of HV1 (N30), HW1 (N40), and 
HX1 (N50), respectively (Fig 5.4). All of the deoxyribozymes were assayed for serine 
phosphorylation activity in trans (without the substrate ligated to the pool). The seven 
deoxyribozymes identified from selection with the C3-tethered peptide substrate all show robust 
phosphorylation yields ranging from 47 to 81% in 16 h (Fig 5.5A). None of these 
deoxyribozymes catalyze the phosphorylation of HEG-tethered CAASAA, and thus require the 
short C3 tether. The 11HW104 deoxyribozyme identified from selection pressure with a longer 
HEG-tethered CAASAA peptide substrate has modest phosphorylation yields of 15% and 9% 
with the C3 and HEG-tethered peptide substrate, respectively (Fig 5.5B). None of the 
151 
deoxyribozymes catalyze phosphorylation of a C3-tethered CAAYAA substrate. Therefore, they 
are all specifically serine kinase deoxyribozymes.  
 
Figure 5.4. Sequences of the initially random region of the serine kinase deoxyribozymes. Only 
the initially random region is shown. Next to the sequence length on the right, in parentheses, is 
the number of times each sequence was found. 
 
Figure 5.5. Activity of the serine kinase deoxyribozymes. All assays were performed in trans. 
Incubation conditions were 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM 
MgCl2, and 150 mM NaCl at 37 °C. SOH = substrate; SP = product. (A) Deoxyribozymes 
identified from selection with the C3-tethered CAASAA peptide substrate. The PAGE image 
shows representative time points (t = 30 s, 2 h, 16 h) for seven of the deoxyribozymes assayed 
with the C3-tethered peptide substrate. (B) The 11HW104 deoxyribozyme identified from 
selection with the HEG-tethered CAASAA peptide substrate. The PAGE image shows 
representative time points (t = 30 s, 2 h, 16 h) for 11HW104 with both the C3 and HEG-tethered 
peptide substrate.  
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The identification of these serine kinase deoxyribozymes establishes that DNA can 
catalyze the phosphorylation of serine. However, limitations remain in the utility of these 
deoxyribozymes. Improvements necessary include the ability to phosphorylate more loosely 
tethered and untethered peptide substrates, to use ATP as the phosphoryl donor, and to 
phosphorylate serine residues in a sequence-selective manner. 
Subsequently, the KW1-KZ1 selection experiments were performed using a HEG or 
HEG6-tethered CAASAA peptide substrate and pppRNA as the phosphoryl donor (Figure 5.6A). 
Surprisingly, none of these efforts were successful, despite the previous success of HEG-tethered 
tyrosine-containing peptide substrates. Separately, LF1-LJ1 selection experiments were 
performed by Stephanie Konecki with tethered CAASAA peptide substrates and 100 µM ATP as 
the phosphoryl donor (Figure 5.6B). Previous efforts with DNA-catalyzed tyrosine 
phosphorylation were successful using GTP or ATP as the phosphoryl donor (Chapter 2),14,15 
suggesting that ATP could also be used in serine phosphorylation. However, no activity was 
observed for selection experiments with 100 µM ATP using N30, N40, or N50 initially random 
region lengths with C3-tethered CAASAA or N40 with HEG-tethered CAASAA, and they were 
discontinued after 14 rounds.  
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Figure 5.6. Design for the KW1-KZ1 and LF1-LJ1 in vitro selection experiments to identify 
serine kinase deoxyribozymes. In all selections, the peptide substrate CAASAA was connected 
to a DNA anchor via a disulfide bond and tether. Selection conditions were 70 mM HEPES, pH 
7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C for 14 h. (A) The 
KW1-KZ1 selection experiments. The phosphoryl donor was pppRNA. The KW1-KY1 
selections used a HEG tether, and the KZ1 selection used a HEG6 tether. The KW1 selection was 
a reselection of 11HW104 from a partially randomized pool. The KX1 and KZ1 selection had an 
N40 initially random region, and the KY1 selection had an N50 initially random region. (B) The 
LF1-LJ1 selection experiments. The phosphoryl donor was 100 µM ATP. The LF1-LH1 
selections used a C3-tethered peptide substrate, and the LJ1 selections used a HEG-tethered 
peptide substrate. The length of the initially random region is indicated.  
5.2.3 Use of Complex Serine-Containing Peptide Sequences 
Tyrosine’s aromatic hydroxyl group is more nucleophilic than serine’s aliphatic hydroxyl 
group, and the tyrosine side chain is larger than serine’s. Increasing the ability of the DNA 
catalysts to interact with the serine-containing peptide substrate may enable reactivity of more 
loosely tethered peptide substrates. To increase the ability of the DNA catalyst to interact with 
the serine-containing peptide substrate, peptides with non-alanine residues flanking the serine 
residue were used during in vitro selection experiments.  
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Separate selection experiments were performed by Nickolaus Lammer with three peptide 
substrates: CAASFA, CQKESTLH, and CNRTSLPW (Figure 5.7). The CAASFA peptide 
substrate was designed to contain serine and a single phenyl side chain via the phenylalanine 
residue. This aromatic group is most similar to a tyrosine residue, and DNA-catalyzed 
phosphorylation of peptide substrates containing a single tyrosine residue flanked by alanine 
residues is successful. The two other complex peptide sequences are derived from the amino acid 
sequence flanking the naturally phosphorylated serine residues. The CQKESTLH peptide 
corresponds to residues 62-68 of ubiquitin.18-20 The CNRTSLPW peptide corresponds to residues 
215-221 of casein kinase 1α (CK1α).21 The N-terminal cysteine residue is incorporated to enable 
conjugation of each peptide substrate to the DNA-anchor. 
 
Figure 5.7. Design for the TC1-TL1 in vitro selection experiments to identify serine kinase 
deoxyribozymes. In all selections, the initially random region was N40. In the TC1, TF1, and TJ1 
selections, the peptide substrate was connected to a DNA anchor via a C3 tether, and the 
phosphoryl donor was pppRNA. In the TD1, TG1, and TK1 selections, the peptide substrate was 
connected to a DNA anchor via a C3 tether, and the phosphoryl donor was 100 µM ATP. In the 
TE1, TH1, and TL1 selections, the peptide substrate was connected to a DNA anchor via a HEG 
tether, and the phosphoryl donor was pppRNA. The peptide substrates were as indicated. All 
selections were performed in 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM 
MgCl2, and 150 mM NaCl at 37 °C.  
For each peptide substrate, three selection experiments were performed. A C3-tethered 
peptide acceptor was used with either pppRNA or 100 µM ATP as the phosphoryl donor, and a 
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HEG-tethered peptide acceptor was used with a pppRNA phosphoryl donor. After 13 rounds of 
selection, activity was only observed in the TD1 selection experiment. Upon evaluation of the 
round 13 and 14 pools in trans, no phosphorylation activity was observed. Similar to previous 
kinase deoxyribozyme selections (Chapter 2, 4), the 8VP1 capture method was used, and the 
length and sequence of the capture oligonucleotide was alternated. The short capture 
oligonucleotide was a 17 nt pppRNA. The long capture oligonucleotide is a 54 nt pppRNA-DNA 
chimera made by ligating a 17 nt pppRNA oligonucleotide to a 37 nt DNA oligonucleotide using 
a DNA splint and T4 DNA ligase. Continuation of selection rounds showed that activity was 
observed only when the short capture oligonucleotide was used, suggesting that the activity was 
not due to the desired phosphorylated serine product (Figure 5.8).  
 
Figure 5.8. Results of the TD1 selection experiment. (A) The diagram of the 8VP1-catalyzed 
capture reaction shows the difference between the short and long capture oligonucleotide in 
alternating selection rounds. The long capture oligonucleotide was a RNA-DNA hybrid and has a 
different sequence than the short capture oligonucleotide. (B) The PAGE image shows the in cis 
capture reaction for rounds 13 and 14 using both the short and long capture oligonucleotide, and 
the diagram shows the capture yields of the selection rounds with the capture oligonucleotide 
indicated. No activity is observed when the long capture oligonucleotide was used.  
156 
Further evaluation showed that the pppRNA capture oligonucleotide was attached to the 
DNA pool and not the DNA-anchored peptide substrate. However, only the short capture 
oligonucleotide reacted with the pool, which is consistent with the in cis selection results. Both 
the short and long capture oligonucleotides share the same four nucleotides at the 5′-end 
(pppGGAA...), which may explain the tolerance of the long capture oligonucleotide despite the 
lack of observable yield. When the 5′-hydroxymethyl group of the DNA pool was replaced with 
only a methyl group, the pool was still modified. The location of the modification within the pool 
was not investigated further. The product resulting from attachment of the capture 
oligonucleotide to the DNA pool caused a PAGE shift in the same region as the desired capture 
product, and these DNA sequences were enriched. An alternate capture method for in vitro 
selection of serine kinase deoxyribozymes is needed to avoid this issue. 
5.3 Summary and Future Directions 
Serine phosphorylation is a common biological post-translational modification of 
proteins. Based on success with DNA-catalyzed tyrosine phosphorylation, deoxyribozymes that 
catalyze serine phosphorylation were sought. Previous DNA-catalyzed serine modification 
suggested that DNA-catalyzed serine phosphorylation was possible. The previously identified 
tyrosine kinase deoxyribozymes were identified from selection experiments using tyrosine-
containing peptide substrates and are all specifically tyrosine kinase deoxyribozymes without 
serine reactivity. Therefore, selection experiments for serine kinase deoxyribozymes were 
performed with serine-containing peptide substrates. Similarly to the tyrosine kinase 
deoxyribozyme selection experiments, the 8VP1 capture deoxyribozyme was used in serine 
kinase selection experiments to isolate the active DNA sequences. 
Serine kinase deoxyribozymes were identified to phosphorylate C3-tethered CAASAA 
from these selection efforts. All of the DNA enzymes are specific for serine and do not catalyze 
tyrosine phosphorylation. This specificity is unlike the previously identified nucleopeptide-
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forming deoxyribozymes that catalyze the modification of serine but also tyrosine. However, of 
the current serine kinase deoxyribozymes, only one can catalyze the phosphorylation of HEG-
tethered peptide substrates. These results establish that DNA can catalyze serine 
phosphorylation, but some limitations remain. Selection experiments with HEG-tethered serine-
containing peptide substrates or ATP as the phosphoryl donor were unsuccessful, and the use of 
small-molecule NTP phosphoryl donors remains a goal of future efforts. The characteristics of 
the serine kinase deoxyribozymes are similar to those of nucleopeptide-forming deoxyribozymes 
with serine substrates.2 Robust activity is observed with C3-tethered peptides, but little activity is 
observed with more loosely HEG-tethered substrates. 
The use of more complex serine-containing peptide sequences was thought to enable 
more interactions between the peptide substrate and the deoxyribozyme. These interactions may 
enable phosphorylation of peptides connected via longer HEG tethers or untethered peptide 
substrates and may enable peptide-sequence selectivity. Unexpectedly, these experiments led to 
DNA-catalyzed reaction of the capture oligonucleotide with the DNA pool instead of 
phosphorylation of the peptide substrate. To prevent this undesired reaction from dominating the 
pool during selection experiments, a new capture method is needed. The phosphotyrosine 
immunoprecipitation capture method works well for tyrosine kinase deoxyribozyme selections, 
and a parallel method for phosphoserine could be developed. However, there are only a few 
commercially available phosphoserine antibodies, and they are cost-prohibitive for use during in 
vitro selection experiments. Therefore, a Phos-tag PAGE selection method may be useful for 
these efforts.22-25 Phos-tag will bind to the phosphoserine products connected to the active DNA 
sequences and cause these DNA sequences to migrate slower on a PAGE gel, therefore 
separating the active sequences from the inactive ones. Preliminary tests indicate that this 
method may provide a large enough PAGE shift for use during in vitro selection experiments. 
Currently, efforts are underway to synthesize Phos-tag acrylamide.26 
The use of modified nucleotides has been successful at enabling catalysis of reactions 
previously unable to be catalyzed by deoxyribozymes with only natural nucleotides.27 While 
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serine phosphorylation can be catalyzed by natural DNA, incorporation of modified nucleotides 
may enable catalysis to have more desired features such as increased rate and yield, reactivity 
with untethered peptides, and peptide-sequence specificity. The mechanism of known protein 
kinases involves interactions between lysine, aspartate, glutamate, and asparagine residues with 
the phosphoryl donor and serine hydroxyl substrate.28 Therefore, nucleotides with amino 
modifications (AmdU, mimicking lysine) or carboxyl modifications (COOHdU, mimicking 
aspartate and glutamate) were incorporated into the initially random region of the DNA catalysts.  
The VP1-VS1 selection experiments were initiated by Stephanie Konecki and continued 
by Tiyaporn Tangpradabkul. The four selection experiments were performed with the 
CQKESTLH peptide substrate. The longer HEG tether was used with pppRNA as the phosphoryl 
donor. Separately, the short C3 tether was used with 100 µM ATP as the phosphoryl donor. For 
each, either AmdU or COOHdU was incorporated. These efforts are ongoing. 
5.4 Materials and Methods 
5.4.1 Substrate Preparation Procedures 
Oligonucleotides, peptides, and DNA-anchored peptide conjugates were prepared as 
described in Chapter 2.  
Table 5.1: Oligonucleotide sequences of the pools, substrates, and primers used in the selection 
experiments. 
oligonucleotide purpose oligonucleotide sequence 
  
HV1 selection with N30 random region 
DNA-C3-CAASAA substrate GGACTACCTTTATGCGTAT-C3-CAASAA 
pppRNA phosphoryl donor pppGGAAGGAGGCUUUCGGG 
forward primer for selection CGAACGAAAGCCTCCTTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAACGAAAGCCTCCTTC-N30-ATACGCATAAAGGTAGAGCTGATCCTGATGG 
splint for ligation step during selection ATACGCATAAAGGTAGTCCTCCATCAGGATCAGCTCTACCTTTATGCGTAT 
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Table 5.1 (cont.) 
oligonucleotide purpose oligonucleotide sequence 
  
HW1 selection with N40 random region 
DNA-C3-CAASAA substrate GGAATATCTCGTTTCTTAT-C3-CAASAA 
pppRNA phosphoryl donor pppGGAAUUCAGUCUUAAGG 
forward primer for selection CGAATTAAGACTGAATTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
partially randomized pool for selection CGAATTAAGACTGAATTC-N40-ATAAGAAACGAGATATAGCTGATCCTGATGG 
splint for ligation step during selection ATAAGAAACGAGATATTCCTCCATCAGGATCAGCTATATCTCGTTTCTTAT 
  
HX1 selection with N50 random region  
DNA-C3-CAASAA substrate GGAATGGCTTGATTGGTAT-C3-CAASAA 
pppRNA phosphoryl donor pppGGAAUAUUUACUCAAGG 
forward primer for selection CGAATTGAGTAAATATTC 
reverse primer for selection (AAC)4-HEG-CCATCAGGATCAGCT 
reverse primer for cloning TAATTAATTAATTACCCATCAGGATCAGCT 
random pool for selection CGAATTGAGTAAATATTC-N50-ATACCAATCAAGCCATAGCTGATCCTGATGG 
splint for ligation step during selection ATACCAATCAAGCCATTCCTCCATCAGGATCAGCTATGGCTTGATTGGTAT 
  
5.4.2 In Vitro Selection Procedures  
Procedures for ligation, selection, 8VP1 capture, and PCR) were performed as described 
in Chapter 2.  
5.4.3 Cloning and Screening 
Procedures for cloning and screening were performed as described in Chapter 2. 
5.4.4 Deoxyribozyme Activity Assay Procedure 
The DNA-anchored hexapeptide substrate was 5′-32P-radiolabeled using γ-32P-ATP and 
T4 polynucleotide kinase (Fermentas), using 10× buffer that lacks DTT (500 mM Tris, pH 7.6, 
100 mM MgCl2, and 1 mM spermidine). A 10 µL sample containing 0.25 pmol of 5′-32P-
radiolabeled DNA-anchored peptide substrate, 10 pmol of deoxyribozyme, and 20 pmol of 
pppRNA phosphoryl donor was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The DNA-catalyzed 
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phosphorylation reaction was initiated by bringing the sample to 20 µL total volume containing 
70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl (or 
other ion concentrations as appropriate). The Mn2+ was added from a 10× stock solution 
containing 200 mM MnCl2. The Zn2+ was added from a 10× stock solution containing 5 mM 
ZnCl2, 10 mM HNO3, and 100 mM HEPES at pH 7.5; this stock solution was freshly prepared 
from a 200× stock of 100 mM ZnCl2 in 200 mM HNO3. The metal ion stocks were added last to 
the final sample, which was divided into 2-µL aliquots that were all incubated at 37 °C. At 
appropriate time points, 2 µL aliquots were quenched with 5 µL stop solution (80% formamide, 
1× TBE [89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3], 50 mM EDTA, 0.025% 
bromophenol blue, 0.025% xylene cyanol). Samples were separated by 20% PAGE and 
quantified with a PhosphorImager. Values of kobs were obtained by fitting the yield versus time 
data directly to first-order kinetics; i.e., yield Y = Ymax•(1 – e–kt), where k = kobs and Ymax is the 
final yield. Errors in kobs values were calculated as the standard deviation from the indicated 
number of independent determinations. 
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